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SUMMARY 
A critical step in the biopharmaceutical industry is the capacity to properly 
manufacture biological products in animal cell cultures. The ability to exploit 
the full potential of the underlying “cellular factories” is essential to reduce 
manufacturing costs and improve yield and product quality, thus freeing up 
resources to pursue other added value activities, such as clinical 
development and pharmacovigilance of new products. Bioprocess 
optimization efforts have mostly relied on empirical experience and rational, 
hypothesis-driven studies, rather than by fully leveraging the knowledge of 
how complex cells behave in culture. Despite the vast amount of 
information available on different cellular features, specific productivity 
improvements have been essentially incremental. The relatively recent 
developments in Systems Biology and computational methodologies 
present a paradigm-shifting opportunity to develop biotechnology 
processes with high efficiencies in a consistent, systematic way. 
The present thesis focuses on optimizing baculovirus vectors (BV) 
production in Sf9 insect cell cultures, where a significant bioprocess 
challenge is the tendency for specific product yields to decrease when cell 
cultures are infected at later stages of growth, the so-called cell density 
effect. Given the complexity of the biological system under study, there is a 
need to address this issue from a fundamental, integrated perspective.  
In chapter I, the basic bioprocess parameters affecting BV production are 
assessed in serum-free medium, analyzing how productivity is affected by 
varying cell concentrations and infection conditions. The results confirm a 
cell density effect, which can be partly overcome by replacement of the 
medium upon infection. However, metabolic substrate limitations were not 
observed, suggesting a more complex phenomenon. To explore this 
further, a stoichiometric model of the central energetic metabolism of Sf9 
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cells is developed in Chapter II to investigate physiological adaptations 
incurred along culture growth and as a response to infection. It is shown 
that cells undergo a progressive inhibition of their central metabolism when 
grown to high cell densities, and that an up-regulation of their central 
energy metabolism occurs at low cell concentrations after infection (CCI); 
nevertheless, this up-regulation fails to occur or is inhibited at high CCI 
when compared to uninfected cultures. To test the hypothesis that the 
energetic status of the cells is a key determinant of system productivity, we 
screened the effect of culture supplementation with a variety of nutrients 
and energetic intermediates of their central metabolism (Chapter III). Since 
productivity is independent of the availability of nutrients in the medium, it 
was not significantly improved upon addition of amino acids, lipids or 
complex nutrient mixtures; on the other hand, specific BV yields could be 
increased up to 7 fold after supplementation of pyruvate and 
α-ketoglutarate at the time of infection. These results represent a rational 
and cost-efficient strategy for high cell density production of recombinant 
BVs, confirming that more complex mechanisms underlie the cell density 
effect. 
Though based on a rational study, this early work does not represent a 
systematic means to optimize bioprocesses since our model could not 
explicitly account for product formation, being based instead on empirical 
inspection. In Chapter IV, we attempt to demonstrate how a more global 
quantitative understanding of cell function can be translated into predictable 
bioprocess benefits. For this, a hybrid framework combining the same 
stoichiometric model with a statistical sub-model able to bridge the 
estimated metabolic fluxes with measured productivities is developed. 
Based on the data accumulated in the previous chapters, the importance of 
the same determinant pathways for viral replication is highlighted by using 
an unbiased subset of preliminary experiments, while the productivity of 
independent cultures was predicted within experimental error. 
Finally, chapter V describes the first proteomic survey of the Sf9 cell line, 
an attempt to explore the application of omic technologies as 
high-throughput, hypotheses generating tools in this system. In order to 
circumvent the lack of a complete genome sequence and annotation, a 
database was constructed with available sequences of related species, 
followed by a homology-based computational search. A thorough statistical 
analysis of biological replicates allowed us to confidently discriminate 
differentially expressed proteins due to culture growth and BV infection. Our 
findings suggest a possible mechanism for the cell density effect that is 
related with the differential accumulation of BV-encoded proteins detected 
during the initial stages of infection, which is influenced by the cell 
physiological state. While the results presented here have revealed deeper 
insight into the basis of this phenomenon, it is likely that a complete 
understanding can only come from an integrated view of the complex cell, a 
fundamental scientific goal that has yet to be accomplished.  
In conclusion, a case-study is presented of how existing bioprocesses can 
be greatly improved with Systems Biology approaches that decode 
biological complexity beyond traditional R&D efforts. It is expected that 
Systems Biotechnology will follow the fields of biomedicine and drug 
discovery into this paradigm shift. 
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SUMÁRIO 
Um dos passos críticos na indústria biofarmaceutica é a capacidade de 
manufactura de produtos biológicos em culturas de células animais. A 
possibilidade de explorar completamente o potencial destas “fábricas 
celulares” é essencial para reduzir custos de produção, melhorar o 
rendimento e a qualidade do produto, desta forma libertando recursos para 
outras actividades de valor acrescentado, como o desenvolvivmento clínico 
e a fármaco-vigilância de novos produtos. A optimização de bioprocessos 
tem assentado principalmente em conhecimento empírico e estudos 
racionais dirigidos por hipóteses, mas pouco alavancado numa 
compreensão da complexidade celular e do seu comportamento em 
cultura. Apesar da vasta informação gerada a diferentes níveis celulares, a 
melhoria no rendimento de produtos biológicos tem sido apenas 
incremental. Neste sentido, os desenvolvimentos recentes em Biologia de 
Sistemas e métodos computacionais constituem uma oportunidade para 
mudar o paradigma actual e desenvolver processos biotecnológicos 
altamente eficientes de uma forma consistente e sistemática. 
A presente tese foca-se na optimização da produção de vectores de 
baculovirus (BVs) em células de insecto (Sf9), em que um importante 
desafio a nível de bioprocesso é a tendência para o rendimento específico 
diminuir substancialmente quando a infecção é efectuada a alta densidade 
celular, o chamado efeito da densidade celular. Tendo em conta a 
complexidade do sistema biológico em estudo, existe uma necessidade de 
abordar esta questão através de uma perspectiva fundamental e integrada. 
No Capítulo I, os parâmetros de bioprocesso básicos que afectam a 
produção de BVs, tais como concentração celular e condições de infecção, 
são analisados em meio sem soro. Os resulados confirmam um efeito 
negativo da densidade celular na produtividade, o qual foi possivel 
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minimizar recorrendo a uma troca de meio de cultura no momento da 
infecção. No entanto, não se verificaram quaisquer limitações de nutrientes 
no meio antes da troca, o que sugere tratar-se de um fenómeno de maior 
complexidade. Por conseguinte, desenvolveu-se no Capítulo II um modelo 
do metabolismo energético central das células Sf9 para investigar as 
adaptações fisiológicas que ocorrem ao longo do crescimento celular e em 
resposta à infecção. É mostrado que as células sofrem uma inibição 
progressiva do seu metabolismo central quando cultivadas até elevadas 
concentrações, e, quando infectadas a baixa concentração, o metabolismo 
energético é estimulado. Em contrapartida, esta estimulação não acontece 
após infecção a elevadas densidades celulares, ocorrendo mesmo uma 
inibição quando comparado com células não infectadas. Para testar a 
hipótese de que o estado energético é um determinante chave da 
produtividade neste sistema biológico, efectuou-se um rastreamento de 
diferentes suplementos nutricionais e intermediários do metabolismo 
energético central (Capítulo III). Uma vez que a produtividade é 
independente do nível nutricional disponível no meio de cultura, não foi 
possével ser significativamente melhorada pela adição de aminoácidos, 
lípidos ou uma mistura complexa de nutrientes. Pelo contrário, o 
rendimento específico de BVs aumentou até 7 vezes depois da 
suplementação de piruvato e α-cetoglutarato juntamente com a infecção. 
Estes resultados representam uma estratégia racional e eficiente para 
produção de BVs recombinantes a alta densidade celular, confirmando que 
mecanismos mais complexos estão na base do efeito da densidade 
celular. 
Apesar de baseado num estudo racional, o trabalho até aqui efectuado não 
representa uma forma sistemática de optimizar bioprocessos porque o 
modelo desenvolvido não considera explicitamente a formação de produto, 
sendo por isso essencialmente empírico. No Capítulo IV, propomo-nos 
demonstrar como um conhecimento quantitativo global do funcionamento 
celular pode ser traduzido, de forma preditiva, em benefícios para o 
bioprocesso. Para isto, estabeleceu-se uma metodologia matemática 
híbrida que assenta no mesmo modelo estequiométrico aqui proposto e 
combina uma componente estatística visando estabelecer a “ponte” entre 
fluxos metabólicos estimados e produtividades medidas. Baseado nos 
dados previamente obtidos, foi possível determinar a importância das 
mesmas vias metabólicas para a replicação viral usando apenas um sub-
grupo imparcial de experiências preliminares, enquanto a produtividade de 
culturas independentes foi prevista dentro do error experimental. 
Finalmente, o Capítulo V descreve o primeiro estudo proteómico em larga 
escala de células Sf9, numa tentativa de explorar a aplicação de novas 
tecnologias “ómicas”  como ferramentas geradoras de hipóteses. De forma 
a obviar a inexistência da sequência genómica completa para este 
organismo, foi construída uma base de dados com sequências disponíveis 
de espécies de insectos relacionadas, as quais foram usadas para 
pesquisa computacional baseada em homologia. A análise estatística de 
replicados biológicos permitiu distinguir várias proteínas diferencialmente 
expressas em resposta ao crescimento em cultura e à infecção por 
baculovirus. Os resultados obtidos sugerem um mecanismo para o efeito 
da densidade celular relacionado com a acumulação diferencial de 
proteínas codificadas pelo próprio baculovirus durante a fase inicial após 
infecção, a qual é influenciada pelo estado fisiológico da célula. Apesar 
destes resultados revelarem um importante contributo para o 
aprofundamento deste fenómeno, é provável que a sua completa 
resolução dependa de um conhecimento integrado da complexidade 
celular, um objectivo científico fundamental ainda por alcançar. 
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Em conclusão, nesta tese é apresentado um caso de estudo em que se 
demonstra como um bioprocesso típico pode ser melhorado e 
compreendido aplicando uma abordagem de Biologia de Sistemas que 
foca a complexidade biológica para além da tradicional I&D.  Espera-se 
que a disciplica emergente de Biotecnologia de Sistemas siga o caminho 
das áreas de Biomedicina e da descoberta de novos medicamentos no 
sentido desta mudança de paradigma. 
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1. ANIMAL CELL TECHNOLOGY IN THE BIOPHARMACEUTICAL 
MARKET 
Animal cell culture is currently the prime technology for the production of 
complex biopharmaceuticals such as therapeutic proteins, vaccines and 
gene delivery vectors. Its key advantage over competitor microbial cell 
factories lies in the ability to correctly process recombinant products, 
including structural and chemical alterations at the protein level, essential 
for therapeutic efficacy. The increased interest in complex 
biopharmaceuticals that have to be produced in animal cells derives mainly 
from 1) the need to address unmet medical needs and 2) diversification of 
the Big Pharma business model to participate in a high margin, rapidly 
growing market. Cultured cell lines derived from animal organisms are well 
positioned in this biotechnology revolution, a market globally valued at $US 
99 billion in 2009 (Walsh, 2010). 
A central concern in biopharmaceutical R&D is the capacity to properly 
manufacture complex biologicals in animal cell cultures, i. e., the ability to 
deliver enough product quantity at the right quality per unit volume of cell 
culture (Butler, 2005). In particular, if the productivity of a given biological 
can be improved, then resources can be used to pursue other activities 
such as development of new biological entities and clinical testing. 
However, the lengthy and expensive regulatory path for approval of a new 
market candidate significantly constrains the timeline and spending for 
process development.  In addition, once manufacturing approval has been 
granted, changing the process may require new clinical trials to assure 
product safety. As a result, this often leads to production processes being 
run far below their maximum performance potential (Sommerfeld and 
Strube, 2005). Obviously, the need to have platforms for fast and efficient 
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development of production processes is a critical need for the 
biopharmaceutical industry. 
The ability to tap the full potential of the underlying biological system would 
be even more relevant if recombinant products were a commodity-like 
business. In fact, for many of the initially marketed biologics, patent 
expirations are glooming the landscape for several companies, with an 
estimated $US 33.2 billion worth of biopharmaceuticals loosing patent 
protection by 2016 (Walsh, 2010). This is backed up by a continuous 
pipeline of innovative and potentially lucrative new products, either 
internally or externally developed, but concurrently opens the way for a 
large biosimilars market. In this business, the operational strategy must 
necessarily be different than the previous one, justifying a bigger emphasis 
on achieving productivity levels able to substantially reduce the cost per 
dose of the final copycat products (Hoe et al., 2011). 
 
2. IMPROVING CELL CULTURE PERFORMANCE: FROM CLASSICAL 
TO RATIONAL APPROACHES  
For recombinant monoclonal antibodies, volumetric yields above 5g/L are 
achievable today (Birch and Racher, 2006). Compared with a typical 
process in the mid 80’s, with an average yield around 50mg/L, this 
represents at least a 100 fold increase (Wurm, 2004). Certainly, this 
accomplishment has alleviated capacity pressures and increased 
cost-efficiency of today’s manufacturing processes. However, as pointed 
out before, the corresponding increment in per cell productivity accounted 
for less than half the overall volumetric increase, the majority of which 
resulting from a massive improvement in the accumulated viable cell 
number. In fact, specific productivities in 2004 were of the same magnitude 
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as during the early 90’ for a mAb-producing myeloma cell line (Wurm, 
2004). It seems therefore clear that the classical methods used to obtain 
high-producing cell clones have not changed materially in the past 
decades. These include gene selection and amplification techniques, while 
improvements in transfection, molecular biology of expression systems and 
clone screening have led primarily to an increased proportion of stable, 
high producer clones generated in much shorter time periods, rather than 
step improvements in per cell protein yields (O’Callaghan and James, 
2008). 
In order to improve cell culture performance, a great amount of effort has 
been given to the design of media formulations able to support high cell 
densities and, to a lesser extent, improved cell specific productivities. 
Media optimization is usually performed on an individual basis for each cell 
line; often, more than one formulation is used at different phases of the 
manufacturing process, typically including medium designed for growth and 
for production. Such knowledge has accumulated over many years of 
experience and empirical trial-and-error, culminating with the breakthrough 
of complete removal of undefined medium components (such as serum and 
hydrolisates) in several processes. The current state of the art, however, is 
simply a more elaborate form of trial-and-error, design of experiments 
(DoE), whereas the long development times required for this step remain a 
bottleneck.  
A general approach to directly increase specific productivity is to alter the 
growth phenotype of the cell line, namely by impairing proliferation after 
reaching a desired cell density in order to shift resources to productivity. 
Several methods of manipulation have been used for this purpose, 
including reduced temperature (Yoon et al., 2004), hyper-osmolarity 
(Ozturk and Palsson, 1991), the addition of cell cycle inhibitors (Carvalhal 
7 
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et al., 2003) or proliferation inhibitors (Balcarcel and Stephanopoulos, 
2001). However, strategies to halt or reduce proliferation, though leading to 
increased productivities on a per cell basis, result in less impressive 
volumetric titers owing to limited cell growth. Other straightforward 
strategies to directly increase specific productivity at the expense of growth 
include the supplementation of dimethyl sulfoxide (Rodriguez et al., 2005), 
thought to assist protein folding and processing in the cell, or sodium 
butyrate (Jiang and Sharfstein, 2008), a histone deacetylase inhibitor. Apart 
from culture manipulation, cell engineering has been used to either prolong 
the lifespan of cultured animal cells by preventing apoptosis or, as in the 
previous examples, genetically halting growth (reviewed in Gòdia and 
Cairó, 2002). While successful results have been achieved for specific cell 
lines, there is still a difficulty in predicting the effects of a given engineering 
strategy (Mastrangelo et al., 2000); in one example, the outcome of 
manipulating single genes to induce growth arrest was the induction of 
apoptosis (Mazur et al., 1998). This is explained by limited knowledge of 
these complex pathways and the varying genetic backgrounds of individual 
cell lines. 
A substantial body of work on the rational improvement of cell culture 
performance demonstrates the potential of Metabolic Engineering. These 
efforts have relied mainly on assessing and optimizing central metabolism 
to reduce overflow by-product secretion (lactate and ammonia) through 
either bioprocess (Cruz et al., 2000; Lee et al., 2003a) or cell (Chen et al., 
2001; Irani et al., 1999) engineering approaches. Again, the major outcome 
has been an increased overall production associated with the generation of 
more productive biomass and prolonged viability rather than increasing 
specific productivity itself.  Concurrent with the engineering of central 
metabolism, some rational studies have been directed towards the 
engineering of protein secretory pathways (Dinnis and James, 2005).  
8 
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In summary, most of what has been done comes from empirical experience 
and hypothesis-driven studies rather than by knowing how the complex cell 
functions in culture (O’Callaghan and James, 2008). Despite the long 
accumulated knowledge on specific cellular aspects, significant productivity 
improvements have come mainly as result of increased cell growth and 
viability. There is still great pressure to reduce manufacturing costs by 
increasing specific product yields through effective redesign of producer 
cells. In particular, this could lead to the establishment of high producer 
“mother” cell lines that would then be transfected with the desired 
recombinant gene. Owing to outstanding technological advances, the 
molecular traits associated with high producer cells are coming to light. In 
what follows, a brief overview of the application of the “omics” in 
biotechnology is given.   
 
3. THE CURRENT STATUS OF SYSTEMS BIOLOGY IN ANIMAL CELL 
CULTURE 
Systems biology is the endeavor to organize in a comprehensive and 
actionable manner the data generated through high-throughput omic 
technologies covering the entire cellular landscape. Precursor disciplines 
debated with questions that are now globally addressed by the systems 
biologist: what are the functions of the genes sequenced in the Human 
Genome project? – Functional Genomics; what enzyme(s) should be 
manipulated to increase the production of a particular compound? – 
Metabolic Engineering. When applied to animal cell culture, only timid 
advances have been reported so far, significantly lagging the development 
already witnessed for industrial microorganisms (Lee et al., 2005; Otero 
and Nielsen, 2010; Stephanopoulos et al., 2004). This is mostly because of 
the unavailability of databases for biotechnologically relevant animal cell 
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lines, namely the lack of complete genome sequences and annotations, 
whereas accumulated knowledge on pathway and enzymatic activities is 
also scarcer (for instance, see: BRENDA – The Comprehensive Enzyme 
Information System, www.brenda-enzymes.org). 
The most widely used omic technology in animal cell culture has been 
transcriptomics, the quantitative analysis of gene expression at the mRNA 
level (Jaluria et al., 2008). Interestingly, applications reported to date have 
focused on investigating the global effects of many of the traditional tools 
used to improve cell culture performance described above, including 
butyrate treatment (Gatti et al., 2007), hypothermic cultivation (Baik et al., 
2006), osmotic shock (Shen and Sharfstein, 2006), metabolic shift (Korke 
et al., 2004), amongst others. A striking example of the lag in systems 
biotechnology development of animal cells is that transcriptomic surveys of 
the unsequenced CHO cell line have been based on a constructed library 
of expressed sequence tags (ESTs), or alternatively performed against the 
mouse genome sequence (Griffin et al., 2007), the pitfalls of which are 
illustrated in Gatti et al. (2007).  
The prevalence of transcriptomics in cell culture studies can be attributed to 
the convenience of exploiting the microarray technology, which enables 
covering the entire genome in a single experiment. However, such surveys 
only give information at a basal regulatory level within the complex cell.  
Molecular signatures can be explored at other levels of information that are 
more close to its phenotypic portrait, namely expressed proteins 
(proteomics) and metabolites (metabolomics). In particular, proteomic 
studies can give qualitative and quantitative information on the effector 
molecules that govern cellular processes, including gene expression, 
metabolic reactions and cell regulation. Though somewhat limited to date, 
examples exist of the application of proteomics to evaluate the effects of 
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animal cell culture manipulations (Baik et al., 2006; Lee et al., 2003b; van 
Dick et al., 2003) and metabolic shift (Seow et al., 2001). One particularly 
interesting work explores how parental B cells develop into 
antibody-secreting plasma cells, therefore gaining insights into what makes 
a hyper-producer cell line (van Anken et al., 2003). These studies, 
however, are far from being “omic”, given the considerable lower coverage 
of the classical 2D-gel electrophoresis technology when compared with 
transcriptomic microarrays. More recently, breakthrough technological 
advances have been accomplished that put proteomics side-by-side with 
transcriptomics in giving a closer to genome-wide quantitative coverage of 
the cell (Ong and Mann, 2005). Unfortunately, these gel-free approaches 
have had virtually no application in animal cell biotechnology, with only one 
exception known from the literature (Seth et al., 2007a). 
The main result from these omic studies is the high-throughput generation 
of hypotheses on how to manipulate cells to achieve a better production 
phenotype. Amongst others, genes/proteins involved in protein folding and 
secretion, cytoskeletal reorganization, growth control, energy metabolism 
and redox balance are consensually found (Seth et al., 2007b). The key 
question is how to exploit the data to design more productive cells and 
processes. Given the observed complexity, a dilemma exists over finding, if 
they exist, a few master regulators that could elicit system-wide responses 
or, alternatively, engage in the manipulation of complete pathways or 
networks. For instance, the existence of a reduced number of master 
regulators seems congruent with the concept of “metabolite hub” 
connecting different modules in metabolic networks (Guimerà and Amaral, 
2005) and the existence of “global metabolite reporters” crosstalking to 
regulatory processes in the cell (Grüning et al., 2010). However, the 
complexity of phenotypes arising from the integration of multiple molecular 
layers of information makes the identification of such central molecules 
11 
Introduction 
extremely difficult. Thus, the integration of cellular data in a mathematical 
formalism can provide superior systems insights with consistent benefits for 
biotechnology. 
 
4. INTEGRATION OF CELLULAR INFORMATION IN PREDICTIVE 
MODELS 
Beyond the state-of-the-art of Systems Biotechnology, systems biologists 
today ponder how to: 1) measure the complete molecular state of the cell 
(molecular concentrations), 2) measure physical interactions between cell 
components (molecular networks), 3) model concentrations and 
interactions, and 4) integrate different layers of information (Ideker and 
Lauffenburger, 2003; Sauer et al., 2007). The major goal is to be able to 
predict how the complex cell responds to environmental or genetic 
perturbations, going an enormous step forward from the empirical 
hypotheses-driven approaches currently prevailing in bioprocess 
optimization.  
Metabolic models play an important role in our understanding of biological 
systems as they are more closely connected with cell behavior. For 
instance, the growth and productive phenotypes are a direct output of 
metabolic flows within the cell. However, protocols for metabolome 
assessment and enzyme characterization have substantially lower 
throughput than other “omic” technologies. This is in part due to the wide 
range of concentrations and chemical properties of metabolites, while 
enzyme assays are inherently metabolite specific. For this reason, most 
metabolic models are based on steady-state assumptions, such as in 
classical metabolic flux analysis (MFA). Here, intracellular fluxes are 
calculated by closing intracellular metabolite balances and measuring a 
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number of extracellular consumption/production rates (Stephanopoulos et 
al., 1998). To increase flux resolution, 13C labeling experiments have been 
conducted (Sauer, 2006), and optimization algorithms were developed to 
identify larger scale metabolic models (Kauffman et al., 2003).  
The past decade has witnessed an exponential growth in metabolic 
reconstructions in microorganism, accompanying the surge in genome 
sequences available (Oberhardt et al., 2009). The practical effects of this 
investment are materialized in the innumerous applications of such models 
for in silico metabolic redesign of microbial strains (Blazeck and Alper, 
2010; Boghigian et al., 2010). As expected, examples for animal cells are 
much scarcer, including the large-scale reconstruction of hybridoma cells 
(Sheikh et al., 2005) and human (Duarte et al., 2007) metabolic networks. 
In addition, several smaller scale models were also developed for animal 
cell lines under bioprocess-relevant conditions (see Quek et al., 2010 for a 
review); however, these have been mostly restricted to the evaluation of 
optimal conditions for cell growth and metabolic efficiency rather than 
leading to pronounced improvements in per cell productivity. Indeed, the 
complexity associated with the engineering of complex, multi-genic 
phenotypes, such as improving the yields of recombinant proteins, is much 
larger than for microorganims producing small molecules. Clearly, currently 
available metabolic models, either small-scale or genome-scale, do not 
embrace all layers of information that confer the cell phenotype, in 
particular detailed biosynthesis mechanisms. Nevertheless, metabolic 
networks provide convenient scaffolds to integrate different types of cellular 
data and mathematical formalisms. Efforts in this direction have included 
constraining metabolic fluxes with gene expression (transcription, 
translation) and regulation at multiple levels (Covert et al., 2008; Lee et al., 
2008). 
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5. THE BACULOVIRUS-INSECT CELL SYSTEM 
Insect cell lines, in particularly those derived from lepidopteran species, 
constitute an attractive alternative to mammalian cells for recombinant 
protein expression. This status is given by their susceptibility to baculovirus 
infection, a diverse family of arthropod pathogens containing large DNA 
genomes reaching up to 180 kbp (Okano et al., 2006). As happens with 
other viruses, not all genes are essential for viral propagation in cell culture; 
this has led to the technological achievement of the baculovirus expression 
vector system (BEVS) in the 1980’s (Smith et al., 1983). The BEVS 
technology is commonly based on the replacement of the gene coding for a 
protein named polyhedrin by the gene coding for the desired recombinant 
protein (O’Reilly et al., 1994). In nature, polyhedrin makes up a protective 
matrix in which newly formed virions are stacked just prior to release from 
the infected insect, conveying resistance to harsh environmental conditions. 
Given its importance in assuring the horizontal transmission of 
baculoviruses, the genetic promoter of the polyhedrin gene is very strong, 
leading to substantial accumulation of the expressed proteins, which can be 
as high as 25-50 % of the total cellular protein (Ramachandran et al., 
2001). Even though average volumetric productivities attained by animal 
cell cultures are far lower than those reported for microbial cultures, protein 
yields using the BEVS can be 20-250 times higher than those reported for 
some mammalian cell cultures, often reaching titers above 500 mg of 
protein per liter (Palomares et al., 2006). 
The best characterized baculovirus is the Autographa californica multiple 
nuclear polyhedrosis virus (AcMNPV), which has been primarily used in 
biotechnology to direct gene expression in cells derived from the 
Spodoptera frugiperda (fall armyworm) species. The first cell line to be 
widely used was the Sf21 clone (Vaughn et al. 1977), originated from S. 
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frugiperda ovaries. Sf9, a clonal isolate of Sf21, has progressively replaced 
its parent in the research and industrial fields owing to its improved growth 
and production characteristics. Several other cell lines exist that are derived 
from the lepidopteran Trichoplusia ni, namely Tn5 and its clonal isolate 
High-Five, commercially available from Invitrogen. The later is known to 
permit higher specific recombinant protein production than Sf9 cells, 
probably due to their larger cell size. However, this is largely compensated 
by the higher cell densities achieved by Sf9 cells (Aucoin et al., 2010), 
which can be easily grown to around 10×106 cells/mL in shake flasks using 
serum-free medium.  
One of the most distinctive aspects of physiology of insect cell lines relates 
to their particular central metabolism: in mammalian cells, accumulation of 
lactate and ammonia are the main causes for poor culture performance, 
which has been tackled by fed-batch, medium design or cell engineering 
strategies; on the contrary, insect cells do not significantly accumulate 
lactate or ammonia, which has been attributed to a more active tricarboxylic 
acids (TCA) cycle in culture (Neermann and Wagner, 1996), while the 
primary overflow metabolite, alanine, is not known to cause growth 
inhibition. From a product quality viewpoint, insect cell lines provide an 
animal eukaryotic environment for protein processing, including folding, 
modification, trafficking and secretion of polypeptides. However, the 
complexity of such processing mechanisms is not at the same level as in 
mammalian cells. In terms of glycosylation, insect cells are naturally 
defective in galactosyltransferases and sialyltransferases, both enzymes 
being involved in the complex N-glycosylation pathway of higher 
eukaryotes (Kost et al., 2005). Nevertheless, the humanization of 
glycosylation pathways in insect cells has already been dealt with (Hollister 
et al., 2002), and a commercially modified Sf9 cell line is available (Mimic 
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Sf9, Invitrogen), opening the way for the production of therapeutic 
glycoproteins. 
Due to the attributes described above, a wide repertoire of recombinant 
products has been expressed in insect cells using the BEVS (Summers, 
2006). Besides the expression of proteins for academic research, quite a 
few therapeutic proteins have also been produced (reviewed in Palomares 
and Ramirez, 1998). In addition, the large genomic capacity and versatility 
of the BEVS has allowed the production of multi-subunit complexes such as 
Virus-Like Particles (VLPs) for vaccination (Maranga et al., 2002; Noad and 
Roy, 2003) and viral gene therapy vectors (Urabe et al., 2002). Currently, 
two biopharmaceuticals produced with this system are in the market: a 
human papiloma virus vaccine produced in High-Five cells (Cervarix, 
GlaxoSmithKline) and a seasonal influenza vaccine produced in Sf9 cells 
(FluBlok, Protein Sciences Corp.). More recently, an increasing number of 
investigators have tackled the use of the baculovirus vector (BV) itself for 
gene therapy applications (Airenne et al., 2009; Hu, 2006; Vicente et al., 
2009).The manufacturing of modified BVs able to direct gene expression in 
mammalian cells represents a safer alternative over classical mammalian 
viruses. Apart from bioprocess issues, the validation of this approach still 
requires generating knowledge on the mechanisms governing tissue 
targeting, gene delivery, and host immunological responses to the 
engineered BVs.   
 
6. STANDING BIOPROCESS CHALLENGES IN THE BACULOVIRUS-
INSECT CELL SYSTEM 
Although insect cell lines and the BEVS constitute a promising eukaryotic 
environment for recombinant protein production, significant bioprocess 
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challenges remain to be addressed. An inherent bottleneck of this 
technology is that it is a lytic system. Protein production takes place within 
a limited time-span during which the cell is already deteriorating from viral 
infection. Therefore, to increase process productivity, it is desirable to infect 
an insect cell culture at later stages of growth, when higher cell densities 
can lead to higher accumulation of product. However, early on investigators 
have come to the conclusion that recombinant protein yields decrease in 
batch cultures infected at later stages of growth (Caron et al., 1990; 
Reuveny et al., 1993), a bottleneck common to different biological systems 
and especially relevant in animal cell bioprocesses (Ferreira et al., 2005; 
Henry et al., 2005).  
Despite multiple speculations regarding the reasons behind this so-called 
“cell density effect” (nutrient limitation, exhaustion of precursors, 
accumulation of toxic compounds, cell-to-cell contact inhibition, 
autocrine/paracrine secreted factors), the fundamental mechanisms remain 
elusive (Doverskog et al., 1997; Taticek and Shuler, 1997). A number of 
strategies have been attempted to overcome this phenomenon, ranging 
from improving medium composition, total or partial replenishing of medium 
at infection, nutrient supplementation schemes, fed-batch processes and 
perfusion cultures (Ikonomou et al., 2003). However, these have only led to 
modest and/or cost inefficient improvements. Although the literature related 
to the production of BV vectors is much scarcer, early works demonstrated 
similar effects of cell density on the yields of wild type viruses in a 
Trichoplusia ni cell line (Stockdale and Gardiner, 1977; Wood et al., 1982). 
Accordingly, Klöppinger et al. (1990) found that the production of AcMNPV 
using a S. frugiperda cell line was inhibited at a cell density of 1.5×106 
cells/mL.  
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Another significant factor influencing productivity is the multiplicity of 
infection (MOI), i.e., the number of infectious particles (IP) per cell added to 
a culture. More specifically, the interplay between MOI and the cell 
concentration at infection (CCI) is of utmost importance for the design of 
efficient infection strategies and to better understand the baculovirus-insect 
cell system. Reports addressing this issue agree that, in batch cultures, 
recombinant protein titers are relatively insensitive to MOI when the cells 
are infected during the early exponential phase, whereas from middle to 
late exponential phase a positive correlation exists between the two so that 
productivity can be maintained up to a certain cell density (Licari and 
Bailey, 1992; Power et al., 1994). Information on how the MOI and CCI 
interplay affect BV yields has not been systematically studied. 
 
7. THESIS SCOPE AND OVERVIEW 
The central objective of the present thesis was to develop novel cell culture 
strategies to overcome or mitigate the cell density effect in the 
baculovirus-insect cell system. This overall goal can be broken down into 
two parts. The first is to understand the mechanisms underlying the cell 
density effect at the physiological level. The second is to design and 
validate strategies to overcome it in real culture conditions. Our focus was 
on the production of BV vectors for gene therapy purposes, for which 
knowledge is most scarce. Given the complexity of the biological system 
under study, the approach followed in this work stems from previous work 
performed on protein production by first evaluating the basic process 
parameters affecting BV production, and then progressively evolving 
through rational and systems biology approaches. A brief description of the 
thesis chapters and the main conclusions resulting thereof follows. 
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In chapter I, the basic bioprocess parameters affecting BV production were 
assessed. Sf9 cells were cultured and infected in serum-free medium, and 
the patterns of production were analyzed under varying CCI and MOI 
conditions. The results confirm a cell density effect on production, with a 
high MOI “delaying” the drop in productivity to higher cell densities. Medium 
replacement was also tested as this is a classical strategy previously 
attempted to improve protein expression in animal cells, leading to higher 
BV titers and specific yields at high CCI. Substrate limitations were not 
observed in infected cultures, even without medium renewal, thus an 
alternative cause for the cell density effect has to be identified. 
In chapter II, a stoichiometric model of the central metabolism of Sf9 cells 
was developed to investigate the metabolic basis for this phenomenon. The 
main pathways of carbon and nitrogen flow were included, as well as 
cellular growth and energetics. MFA revealed that Sf9 cells undergo a 
progressive inhibition of central metabolism when grown to high cell 
densities, mainly associated with a down-regulation of the TCA cycle and 
glycolysis. The combined output of these alterations was a progressive 
depression of the energetic state with increasing cell densities, as 
measured by the steady-state production of adenosine triphosphate (ATP) 
molecules. Following BV infection and cell growth arrest, central energy 
metabolism was significantly up-regulated at low CCI, but this failed to 
occur or was even inhibited at high CCI. The results obtained in this 
chapter led to the hypothesis that the cellular energetic state was a key 
determinant of system productivity, as it correlated well with the decrease in 
BV production at high CCI. 
In chapter III, this hypothesis was evaluated by the application of metabolic 
engineering techniques. The main challenges were i) how to specifically 
manipulate the energetic state of the cells and ii) how can this be made 
feasible in real bioprocess conditions. To avoid the high costs and 
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development times associated with classical cell genetic engineering 
approaches, we opted to supplement the culture medium with TCA 
intermediaries not usually used as carbon sources, such as pyruvate or 
α-ketoglutarate.  Consumption of these energetic metabolites at the time of 
infection resulted in up to 7 fold higher specific BV yields at high CCI when 
compared to un-supplemented cultures. This consequently pushed 
volumetric titers to levels higher than those obtained for low cell density 
infections. Furthermore, the quantitative analysis of intracellular fluxes 
confirmed a direct stimulation of carbon flow through the TCA cycle and 
increased ATP generation. These results represent a rational and 
cost-efficient strategy for high cell density production of recombinant BVs. 
Importantly, supplementation of amino acids, lipids or complex nutrient 
mixtures did not significantly improve production, confirming that nutrient 
exhaustion is not the primary cause of the cell density effect.  
Chapter IV represents a leap from the rational bioprocess studies 
undertaken in the previous chapters to an approach more closely 
connected to the current Systems Biology trends. Here, it is attempted to 
demonstrate how a global quantitative understanding of cell function can 
lead to predictable bioprocess benefits. As mentioned before, a standing 
bottleneck is that current stoichiometric models, such as the one developed 
in Chapter II, cannot explicitly consider the synthesis pathways of 
recombinant proteins or viruses. Hence, the metabolic engineering 
approach performed in Chapter III was driven by a rational hypothesis but 
was not a result of model prediction. Given our still rudimentary knowledge 
of the mechanistic link between complex product biosynthesis and central 
metabolism, a hybrid framework was developed combining classical MFA 
with projection to latent structures (PLS) to bridge estimated metabolic 
fluxes with measured productivities. The main result from this study was the 
quantitative prediction of the effect of the metabolic manipulations applied 
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in Chapter III for the optimization of BV production, namely the 
supplementation of energy-generating metabolites. Also, the developed 
framework should be directly applicable to other production systems for the 
design of customized optimization strategies. 
Finally, in chapter V, we attempt to explore the application of the omics as 
high-throughput hypotheses generation tools in the baculovirus-insect cell 
system, namely quantitative mass spectrometry (MS)-based proteomics. 
This task was complicated by the absence of genomic information on Sf9 
cells, certainly one of the main limitations to Systems Biotechnology in 
general. Nevertheless, this requirement was partially overcome by 
cross-referencing the mass spectra obtained to a database constructed 
with available annotations from S. frugiperda and related insect species. 
This homology-based methodology gave the framework for extracting 
large-scale information from limited resources. To analyse the quantitative 
proteomic response to baculovirus infection and culture growth, stable 
isotope labeling with amino acids in cell culture (SILAC) was performed. A 
thorough statistical analysis of biological replicates allowed to confidently 
discriminate differentially expressed proteins due to each effect, including 
several proteins related to energy metabolism, endoplasmic reticulum 
stress and oxidative stress, which can be effective targets for the design of 
improved bioprocesses. In particular, the viral protein LEF3 was highlighted 
as a key determinant of a productive infection cycle and potentially related 
with decreased viral replication at high cell density culture. This finding 
suggests that the differential accumulation of other BV-encoded proteins 
early in infection could also play a role in determining the level of viral DNA 
replication and recombinant protein expression. Most probably, this is 
influenced by the cell physiological state at the time of infection, in 
particular the energetic state, therefore constituting a possible physiological 
mechanism for the cell density effect.  
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Overall, the present thesis substantially advances our understanding of the 
baculovirus-Sf9 cell system from the current state of the art, constituting a 
reference case-study of the application of system biology approaches to a 
biotechnologically relevant bioprocess. Some of the highlights of the work 
include i) the first comprehensive metabolic characterization of infected Sf9 
cells and ii) the first quantitative large-scale proteomic survey of this cell 
line. The material result was an up to 7 fold increase of specific BV yields 
under unfavorable high cell density conditions. The knowledge generated in 
the overall work has also implications for recombinant protein expression 
as well as virological research of the baculovirus-insect cell molecular 
interaction. Future work should be directed towards deciphering the 
molecular interplay underlying the cell density effect; given its complexity, 
this will be greatly facilitated when genomic information of the Sf9 cell line 
is available.  
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1. SUMMARY 
One significant concern when using insect cells and baculovirus expression 
vectors for the production of recombinant proteins is the drop in production 
observed when infecting cultures at high cell densities. This chapter revisits 
this so-called “cell density effect” in the scope of baculovirus production for 
gene therapy purposes. Sf9 cells were cultured in serum-free medium, and 
the patterns of production of a recombinant baculovirus were analyzed for 
different infection strategies. The results show viral titers and yields 
decrease when infections are performed at increasing cell concentrations, 
demonstrating a cell density effect comparable to that affecting protein 
expression. By infecting with a high multiplicity of infection, it is possible to 
“delay” the drop in baculovirus production to higher cell densities. Further, 
medium replacement at the time of infection considerably improves 
baculovirus production; volumetric titers as high as 2.6×1010 infectious 
particles/mL were obtained in cultures infected at 3.5×106 cells/mL, while 
viral amplification was roughly 19 times higher than the highest value 
obtained without medium exchange. 
 
2. INTRODUCTION 
While the first gene therapy-based product has yet to be approved for 
commercialization, research efforts have been directed towards delivery 
technologies representing a safer alternative over classical mammalian 
viruses. During the past decade, the suitability of baculovirus vectors (BVs) 
to direct gene expression in mammalian cells has been explored (Kost and 
Condreay, 2002). The validation of this approach still lacks sufficient 
knowledge on the mechanisms governing tissue targeting, gene delivery, 
and host immunological responses. Importantly, in order to facilitate the use 
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of BVs for gene therapy, the development of efficient production processes 
to amplify the engineered vectors is needed.  
In terms of process productivity, it would be desirable to infect a highly 
productive insect cell culture at later stages of growth, but higher cell 
densities often lead to lower specific product yields. Most of the studies 
reported on bioprocesses using the BV/insect cell system are focused on 
the production of recombinant proteins rather than the vector itself 
(Ikonomou et al., 2003). The present work focuses on assessing the 
interplay between cell concentration at infection (CCI) and multiplicity of 
infection (MOI) on the production of recombinant BVs assuming a 
comparative perspective with knowledge related with protein production. 
The questions addressed in this work are: Is there a cell density effect on 
the production of BVs by infection of Sf9 cells in serum free medium? If so, 
is this effect dependent on the MOI used? Finally, can this effect be 
repressed by restoring initial medium conditions at the time of infection? 
For this purpose, several indicators of system productivity were evaluated 
in infection experiments where different CCIs at both low and high MOIs 
were tested. Then, the combinations of CCIs and MOIs that yielded better 
production results were subject to medium replacement at the time of 
infection. 
 
3. MATERIALS AND METHODS 
3.1. Cell line, culture medium and maintenance 
The host insect cell line Sf9, ECACC 89070101, originally isolated from the 
pupal ovaries of Spodoptera frugiperda, was provided by Dr. Otto W. 
Merten (Genethon, France). Cultivation was performed in 500 mL 
Erlenmeyer flasks (Corning, USA) with 50 mL working volume after thawing 
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cells from an initial passage number of 17. SF900II serum-free medium 
(Gibco, Invitrogen, USA), specifically designed for Sf9 cells, was used 
throughout this work. Cells for maintenance were re-inoculated every 3 
days at a cell density of 4-5×105 cells/mL, and kept in a humidified 
incubator operated at 27oC and 90 rpm. Cellular concentration was 
determined by cell count in a Fuchs-Rosenthal chamber and the viability 
assessed by the Trypan Blue exclusion method. To assess cellular lysis, 
the activity of lactate dehydrogenase (LDH; EC 1.1.1.27) released to the 
medium was measured by following the rate of pyruvate reduction to 
lactate. This reaction is coupled with the oxidation of NADH to NAD+, which 
can be measured spectrophotometrically at 340 nm (Racher et al., 1990). 
 
3.2. Virus and viral stock 
The recombinant baculovirus Ac-hisgfp, provenient from the parental 
Autographa californica nuclear polyhedrosis virus, was provided by Dr. 
Monique M. van Oers (Laboratory of Virology, Wageningen University, The 
Netherlands), containing a gfp gene under the control of the polyhedrin 
promoter. Recombinant BVs were amplified by infecting Sf9 cells at 1×106 
cells/mL with a MOI of 0.1 infectious particles (IP)/cell, in a 250 mL spinner 
flask (Wheaton, USA), and culture bulk was harvested after 5 days 
incubation at 27oC and 150 rpm. After harvesting, cells were seeded by 
centrifuging at 1700×g for 10 minutes, and the supernatant was stored at 
4ºC and protected from light for several months. 
 
3.3. Experimental cultures and sampling 
After several passages to ensure consistent high viabilities above 95%, Sf9 
cells were infected with recombinant BVs for evaluation of virus production 
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and culture behavior. Experimental cultures were at a passage number not 
higher than 31. Cultures were performed in 125 mL spinner flasks 
(Wheaton, USA) at 27oC, with caps partially open and with an agitation of 
150 rpm. A total of six independent experiments were performed varying 
the CCI (1×106 cells/mL (CCI 1), 2×106 cells/mL (CCI 2) and 3-4×106 
cells/mL (CCI 3), corresponding to 24h, 48h and 72h of culture, 
respectively) for two different MOIs (0.6 IP/cell – low MOI, and 30 IP/cell – 
high MOI). Three additional infections with a high MOI of 6 IP/cell were 
carried with medium exchange at the time of infection, and the same set of 
CCIs was used. In these cultures, cells were centrifuged and re-suspended 
to the desired concentration in 10 mL of spent medium. Thereafter, 
recombinant BVs were inoculated, the volume was completed to 50 mL 
with fresh medium, and the cultures were maintained under continuous 
stirring to promote virus adsorption during 1 hour. Finally, the volume was 
completed to 125 mL with fresh medium. Every 24 h, culture samples were 
taken and centrifuged at 1700×g at room temperature for 10 minutes in 
order to separate cells from supernatant. Aliquots of the supernatant were 
then maintained at 4oC for virus titration and at - 20oC to measure glucose, 
lactate, ammonia and concentrations of free amino acids. 
 
3.4. Analytical methods 
Glucose and lactate concentrations were determined with automated 
enzymatic assays (YSI 7100 Multiparameter Bioanalytical System; Dayton, 
Ohio, USA). Ammonia was quantified enzymatically using a UV assay (No 
1112732035; Boehringer Manheim, R-Biopharm AG, Darmstadt, Germany). 
Amino acids were quantified by high performance liquid chromatography 
(HPLC) analysis using a reverse phase 3.9×150 mm column (AccQ.Tag, 
Waters, USA). A pre-column derivatization technique was used based on 
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the Waters AccQ.Tag Amino Acid Analysis method. Briefly, both primary 
and secondary amino acid derivatives were produced by mixing with 
6-aminoquinolyl N-hydroxysuccinimidyl-carbamate, allowing their 
separation and quantification by fluorescence detection at 395 nm. Prior to 
derivatization, sample proteins were precipitated by adding an equal 
volume of acetonitrile and discarded by centrifugation at 12400×g for 15 
min, at room temperature. An internal standard (α-aminobutyric acid) was 
added to ensure consistent measurements between runs. Mobile phases 
were prepared following the manufacturer’s instructions, filtered and 
degassed before usage. 
 
3.5. Virus titration 
Virus titers were determined by an end-point dilution assay. In this method, 
96-well plates containing 100 µL of cellular suspension at a density of 
0.5×106 cells/mL were incubated for 1 hour at 27 oC. Dilutions of the virus 
samples were performed serially in SF900II medium, from 1:104 to 1:1011, 
and 100 µL were used to infect Sf9 cells monolayers after medium 
aspiration from the plate wells. Ten replicates for each dilution were 
performed in the same plate, and two independent plates were infected for 
each viral sample. A dilution of 1:102 was used as positive control. SF900II 
medium was used as negative control. Plates were screened after seven 
days for GFP signal under an inverted fluorescence microscope, using an 
excitation wavelength range between 450 and 490 nm. The 50% 
tissue-culture infectious dose (TCID50), i. e. the dilution which is sufficient to 
infect half of the cells, was calculated using equations described elsewhere 
(King and Possee, 1992). This value was then converted to plaque-forming 
units (or number of IPs) by the relationship: PFU = 0.69 x TCID50 (King and 
Possee, 1992). 
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3.6. Estimation of specific metabolic rates and production 
indicators 
Specific consumption and production rates of important molecules of cell 
metabolism such as glucose, lactate, glutamine, serine and alanine, were 
estimated by dividing the slopes of concentration profiles by the average of 
cell density along defined time intervals (48-144 h, 72-168 h and 96-192 h). 
For the infection experiments, the average of cell density was calculated for 
the entire post-infection time, since linear concentration profiles after 
infection were observed for these compounds. The specific yield values 
presented were estimated by dividing the maximum titer (IP/mL) by the CCI 
used in each infection experiment. The amplification factor was calculated 
as the ratio between maximum titer and the inoculated value of IP/mL at the 
time of infection. TOH corresponds to the culture time when the maximum 
titer was obtained. 
 
4. RESULTS 
The effect of cell density on the production of recombinant BVs was 
assessed by infecting Sf9 cultures at CCIs of 1, 2 and 3-4×106 cells/mL, 
both at a MOI of 0.6 and 30 IP/mL, in SF900II serum-free medium. The 
production indicators calculated for each condition tested were the 
maximum titer, specific yield, amplification factor and TOH. Additionally, 
specific metabolic rates of glucose, lactate, glutamine, serine and alanine 
were assayed, and the metabolic profiles of glucose and lactate were 
analyzed. Three additional experiments were carried out by exchanging the 
medium at the time of infection with a high MOI. 
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4.1. Infections at low MOI 
When Sf9 cells were infected with a recombinant BV (Ac-hisgfp) at a low 
MOI, a marked decrease in the growth rates upon infection was obtained, 
followed by a drop in viable cell density (Figure 1.1A). Cellular lysis was 
also monitored throughout culture time, with an increase in extracellular 
LDH activity consistent with loss in viability (data not shown). Figure 1.2 
shows typical profiles of glucose and lactate in uninfected and infected Sf9 
cultures. It is clear from the lower slopes in the glucose concentration 
profiles when compared to the uninfected culture that glucose uptake was 
down-regutated after infection (Figure 1.2A). Lactate accumulated in the 
uninfected culture up to approximately 12 mM (Figure 1.2B), with a mean 
specific production rate of 10.57±0.75 nmol/106 cells/h, its concentration 
decreasing then at the end of the culture. In the infected cultures, lactate 
accumulation only occurred at CCI 3, with a specific production rate of 
9.59±0.57 nmol/106 cells/h. In contrast, ammonia did not accumulate 
significantly in the medium at any stage of cultivation in all experiments 
performed, remaining approximately constant in the range of 4 to 6 mM 
(Figure 1.3). 
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Figure 1.1. Uninfected (NIC) and infected Sf9 cultures growth in serum-free 
medium. Infections with a recombinant BV (Ac-hisgfp) were carried either with a 
low MOI (A) and a high MOI (B), for different CCIs, without medium exchange. 
37 
Chapter I 
0
2
4
6
8
10
12
14
0 50 100 150 200
NIC
CCI1
CCI2
CCI3
0
10
20
30
40
50
60
70
0 50 100 150 200
NIC
CCI1
CCI2
CCI3
0
10
20
30
40
50
60
70
0 50 100 150 200
NIC
CCI1
CCI2
CCI3
A
B
C
Low MOI High MOI
G
lu
co
se
 (m
M
)
Time (h)
G
lu
co
se
 (m
M
)
Time (h)
La
ct
at
e 
(m
M
)
Time (h)
0
2
4
6
8
10
12
14
0 50 100 150 200
NIC
CCI1
CCI2
CCI3
D
La
ct
at
e 
(m
M
)
Time (h)
Figure 1.2. Metabolic profiles of glucose (A and C) and lactate (B and D) for 
uninfected and infected Sf9 cultures with a low and a high MOI, without medium 
exchange. Arrows indicate the time of infection for the three CCIs tested. 
Figures 1.4 and 1.5 show the specific glucose and amino acid uptake rates 
for uninfected and infected cultures without medium exchange. It can be 
seen that the consumption of these nutrients clearly decreased after viral 
infection at low MOI. Interestingly, glucose uptake decreased both during 
the later stage of growth and after infection at a high CCI. The same pattern 
was observed for the consumption rates of serine and, more prominently, in 
the case of glutamine. The rates of alanine production are also 
represented. This was the only amino acid accumulating in the culture 
medium. None of the amino acids analyzed was depleted in the infected 
cultures, although serine was totally consumed at 170-190 h (data not 
shown), while cells had already stopped growing. 
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Figure 1.3. Concentration profiles of ammonia in the culture medium during growth 
and after infection with recombinant Ac-hisgfp. Infections were carried out either 
with a low or high MOI, both for three different CCIs, without medium exchange. 
NIC refers to uninfected cultures. 
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Figure 1.4. Specific consumption rates of glucose and selected amino acids 
calculated for uninfected Sf9 cultures. The values presented for alanine represent 
rates of accumulation in the culture medium. r1, r2 and r3 refer to the rates 
calculated for the following time spans: 48-144 h, 72-168 h and 96-192 h, 
respectively. The error bars presented correspond to the linear regression error of 
the corresponding slopes. The errors involved in the measurements of the primary 
variables were 5% (Glc) and 10% (Ser, Gln, Ala and cell concentration). Glc – 
glucose; Ser – serine; Gln – glutamine; Ala – alanine. 
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Figure 1.5. Specific consumption rates of glucose and selected amino acids 
calculated for infected Sf9 cultures at two MOIs and different CCIs, without medium 
exchange. The values presented for alanine represent rates of accumulation in the 
culture medium. 
Regarding recombinant BV production, it can be seen in Table 1.1 that all 
the production indicators declined by one order of magnitude when cells 
were infected at progressively higher CCIs. The titer decreased from 0.18 
to 0.007×109 IP/mL and the specific yield decreased from 172 to 2 IP/cell. 
Moreover, the amplification factor dropped from 287 to 3, and the TOH was 
120 h for all CCIs tested. 
 
4.2. Infections at high MOI 
For the infections performed at high MOI, it is clear from the growth curves 
(Figure 1.1B) that cell growth was strongly inhibited after virus infection, 
independently of the CCI. Glucose profiles were qualitatively similar to 
those of the low MOI infections (Figure 1.2C), although evidencing a further 
down-regulation of glucose uptake which is probably associated with the 
synchronous infection of the cells. As in the case of the low MOI infections, 
lactate accumulated only at CCI 3 (Figure 1.2D) with a specific production 
rate of 5.90±0.28 nmol/106 cells/h. The ammonia concentration remained in 
the same interval of 4 to 6 mM (Figure 1.3). After calculating the specific 
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consumption fluxes of glucose (Figure 1.5), it was possible to confirm that 
these were lower than the uninfected culture and lower than the low MOI 
infections for CCIs 2 and 3. A decreasing trend of glucose consumption 
fluxes with increasing CCI was evident in these experiments. The uptake 
rates of serine and glutamine were lower than the uninfected and low MOI 
infected cultures for all CCIs. None of the amino acids analyzed was 
exhausted as for the previous infections. 
The results of virus production at high MOI were quite contrasting with what 
was observed for infections at low MOI (Table 1.1). The titer increased with 
CCI from 0.55×109 IP/mL to 9×109 IP/mL, while the maximum specific yield 
was obtained at CCI 2, corresponding to a value of 2475 IP/cell. In the 
same way, the amplification factor for this set of infections was higher for 
CCI 2 (83), but lower than the highest amplification factor obtained at low 
MOI (287 for CCI 1).  
 
4.3. Infections at high MOI with medium exchange  
In order to discriminate the influence of medium condition on the cell 
density effect, experiments with medium exchange at the time of infection 
were performed using a high MOI. As explained in the Materials and 
Methods section, cells were centrifuged and re-suspended in fresh medium 
to the three CCIs tested. The main observations related to the metabolic 
activity of Sf9 cells after infection are depicted in Figure 1.6. Glucose 
uptake rate was lower in these experiments when compared to what was 
observed for uninfected and the other infected cultures (Figure 1.6). 
Besides, the characteristic decrease of glucose and amino acids 
consumption with increasing CCI appears to be reversed. 
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Table 1.1. Summary of Ac-hisgfp baculovirus production indicators for different cell 
concentrations at infection (CCIs) and multiplicities of infection (MOIs). 
Low MOI 
 Titera Specific Yieldb Amplificationc TOHd 
CCI 1 0.18 172 287 120 
CCI 2 0.07 36 61 120 
CCI 3 0.007 2 3 120 
High MOI 
 Titera Specific Yieldb Amplificationc TOHd 
CCI 1 0.55 486 17 120 
CCI 2 5.6 2475 83 120 
CCI 3 9 2060 69 96 
aInfectious particles per mL (109 IP/mL); bInfectious particles per cell (IP/cell); 
cRatio between volumetric productivity and number of viruses per mL at the time of 
infection (Volumetric productivity/(CCI×MOI)); dTime of harvest (hours). 
Higher amounts of recombinant BV were obtained for this set of infections 
(Table 1.2). It can be seen that all the production parameters increased 
with CCI. At CCI 3, a specific yield of 9306 IP/cell was obtained, 
corresponding approximately to a 3 fold increase with respect to the higher 
value obtained for high MOI without medium exchange (2475 IP/cell, CCI 
2). Additionally, the highest amplification factor was roughly 19 times higher 
than that obtained without medium exchange at CCI 2. In terms of 
bioprocess time, a significant decrease in TOH was observed in relation to 
the previous infections. 
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Figure 1.6. Specific consumption rates of glucose and selected amino acids 
calculated for Sf9 cultures infected at high MOI and different CCIs, with medium 
exchange at the time of infection. The values presented for alanine represent rates 
of accumulation in the culture medium. 
 
5. DISCUSSION 
The inhibition of cell division observed after virus inoculation demonstrates 
that viral entry into the cells has a profound impact on their physiology and 
metabolic state (Figure 1.1). This drop, which has been reported before in 
other works (Elias et al., 2000), was more pronounced for the infections at 
high MOI and reflects the synchronous infection of the cells.  
Several authors have shown that lactate does not accumulate to high levels 
in Sf9 cultures. Therefore, the significant build up of lactate in the 
uninfected cultures during later stages of growth (Figure 1.2B and D), with 
viable cell densities above 5×106 cells/mL, suggests a possible limitation in 
oxygen availability in spinner flasks (Rhiel and Murhammer, 1995). On the 
other hand, the final drop at the end of cultivation time indicates an uptake 
of lactate as a result of the lower glucose concentrations (Mendonça et al., 
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1999). During the infection experiments, lactate accumulation was reduced, 
probably due to the lower consumption of glucose. Final levels around 4-5 
mM were obtained in the infections at CCI 3. The low levels of ammonia 
production along all uninfected and infected cultures (Figure 1.3) have 
already been described to be related with its detoxification through the 
production of alanine, which is normally released by Sf9 cells (Drews et al., 
2000). Besides, the concentration values measured were between 4 to 6 
mM, being lower than the 20 mM previously reported to be inhibitory for Sf9 
cells (Öhman et al., 1996). 
 
Table 1.2. Summary of Ac-hisgfp baculovirus production indicators for different cell 
concentrations at infection (CCIs) and a high multiplicity of infection (MOI) with 
medium exchange. 
 Titera Specific Yieldb Amplificationc TOHd 
CCI 1 0.3 177 30 96 
CCI 2 13 5652 942 72 
CCI 3 26 9306 1550 72 
a109 IP/mL; bIP/cell; cVolumetric productivity/(CCI×MOI)); dHours. 
Comparing the metabolic rates presented in Figures 1.4 and 1.5, it can be 
seen that glucose uptake is lower after viral infection, hence directly 
correlating with its utilization for cell growth. An interesting observation was 
that this rate also decreased at later stages of growth in the uninfected 
cultures, and after infection at high CCI. Oxygen limitation could in principle 
play a role, as indicated by the accumulation of lactate both at later stages 
of growth and after high cell density infection. However, experiments in fully 
controlled bioreactors have shown a similar uptake pattern for glucose, 
despite negligible production of lactate (data not shown), thus suggesting 
that the effects assessed were not primarily determined by oxygen 
limitation.  
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Besides glucose, glutamine and serine were consistently consumed during 
all experiments. This was expected since glutamine has been 
demonstrated to be the major nitrogen source for Sf9 cells biosynthetic 
metabolism, being also used as a carbon and energy source (Drews et al., 
2000), while serine can be directly incorporated in the central metabolism 
by conversion to pyruvate. Overall, lower specific consumption rates, as 
described for glucose, can be observed for these two amino acids after 
infection, especially at high MOI when infections tend to be synchronous. 
The decrease in serine consumption rates at higher CCI is less evident 
when compared with those of glucose and glutamine uptake rates; 
however, one should take into consideration the proportionality between 
rate values and associated errors that, even with low deviations, may blur 
the interpretation of the results.  
The only amino acid to build up in the culture medium was alanine, which 
has been described as the major metabolic by-product in Sf9 cells (Drews 
et al., 2000). It can be estimated from the specific fluxes presented in 
Figures 1.4 and 1.5 that the amount of glucose diverted to alanine 
production ranged from 8 to 23% in uninfected cultures, and from 12 to 
30% in infected cultures without medium exchange, considering glucose as 
the sole pyruvate source for alanine synthesis. Although concentrations up 
to 100 mM have not been shown to impact productivity (Bédard et al., 
1993; Öhman et al., 1995), the channeling of glucose to by-product 
formation implies a decrease in the efficiency of its oxidation for energy 
production and biosynthesis. Nevertheless, these results indicate an 
efficiency of carbon utilization in Sf9 cells that is significantly higher than in 
cultured mammalian cell lines (Doverskog et al., 1997). 
The metabolism of Sf9 cells after exchanging the medium at infection with a 
high MOI yielded relevant results (Figure 1.6). The lower consumption rates 
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of glucose in comparison to the values of uninfected and the other infected 
cultures (Figures 1.4 and 1.5) show a marked shift in cell physiology. The 
literature is scarce in information regarding the metabolic behavior of cells 
after medium restoration at infection. We suggest that exposing the cells to 
fresh medium induces an adaptation process somewhat resembling the lag 
phase present after inoculating a new culture. In Sf9 cells, this is 
characterized by extremely low consumption rates of glucose (see Figure 
1.1). Thereafter, viral infection takes over preventing biomass formation 
and increased substrate consumption.  Besides, the characteristic 
decrease of the consumption rates at high CCI is not as evident for glucose 
in this set of experiments, and even appearing to be reversed in the case of 
glutamine. This is probably related with the requirements for higher BV 
productivities seen at higher CCI. 
Considering the production of BVs in the infections performed at low MOI, it 
is possible to see that Sf9 cells grown in serum-free medium exhibit the 
same behavior previously described for the production of recombinant 
proteins, clearly demonstrating a cell density effect in the system (Table 
1.1). When infections were carried out at high MOI, higher productivities 
were obtained in cultures infected at higher CCI. Studies that have 
adressed the combined effects of CCI and MOI on recombinant protein 
titers demonstrate that for each CCI there is an optimum MOI for maximum 
protein production (Licari and Bailey, 1992; Power et al., 1994). More 
specifically, Power et al. (1994) showed that for a high MOI, the protein titer 
increases exponentially in proportion to the concentration of infected cells 
until a certain point beyond which production starts to decrease. In their 
particular case, this occured for a cell density of 2.4×106 cells/mL. Herein, 
the titers obtained increased until CCI 3 (9×109 IP/mL), although the 
highest value is in the same order of magnitude than that obtained at CCI 2 
(5.6×109 IP/mL).  
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The cell density effect in high MOI infections can be more markedly 
observed when considering specific yields, where the highest value was 
obtained at CCI 2 (2475 IP/cell), decreasing thereafter at CCI 3 (2060 
IP/cell). In this work, the values presented are based on the initial infection 
cell density (Wang et al., 1993). We also estimated specific yields by two 
other methods: 1) dividing by the highest cell density obtained after 
infection and 2) considering the average number of cells from infection until 
the maximum titer was obtained. Overall, the values show the same pattern 
along the CCI range for both MOIs.  
There is a scarcity of data in the literature regarding the factors that affect 
BV vectors production by insect cells. One of the few studies that has 
addressed this issue also shows the same pattern of decreased 
productivity with increasing CCIs along a wide range of cell densities at 
infection, obtaining a maximum specific yield of 657 plaque forming units 
(pfu)/cell for a cell concentration of 4.5×106 cells/mL (Radford et al., 1997). 
In our work, the maximum specific yield for high MOI infections (Table 1.1) 
was obtained at 2×106 cells/mL, corresponding to a value of 2475 IP/cell 
which is approximately 4 times higher than the 657 pfu/cell reported 
previously. Differences can be attributed to the different MOIs, recombinant 
viruses and culture systems used in each case: Radford’s BV had been 
constructed for the expression of secreted β-galactosidase and infections 
were performed at a MOI between 1 and 2 IP/cell in biorreactors, where cell 
densities over 20×106 cells/mL were reached without infection. 
The viral amplification factor was higher for CCI 2, decreasing then at CCI 
3; the fact that this higher value of 83 was still lower than the highest 
amplification factor obtained at low MOI (287 for CCI 1) suggests that, in 
terms of bioprocess performance, working at low CCI and low MOI is the 
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best option for virus propagation if no improvements in the culture 
conditions are attempted. 
After exchanging the medium at the time of infection, the cell density effect 
was completely overcome for the range of CCIs tested, since all the 
production indicators were maximized at CCI 3, with maximum titer and 
specific yield of 2.6×1010 IP/mL and 9306 IP/cell, respectively (Table 1.2). 
Furthermore, a marked decrease in the culture time for the titers to reach 
maximum values (TOH = 72h) was observed, which contributes to the 
efficiency of the bioprocess. According to the literature, the replenishment 
of fresh medium along with the inoculation of viruses has proved to be an 
efficient way of restoring the yields of different proteins in high-density Sf9 
cultures (Caron et al., 1990; Lindsay and Betenbaugh, 1992; Tom et al., 
1995). From a metabolic perspective, this increase in protein yield after 
medium replacement has been related with nutrient depletion rather than 
the accumulation of inhibitory by-products (Bédard et al., 1994; Weiss et 
al., 1992). This is consistent with the fact that the common by-products 
excreted by mammalian cell lines, ammonia and lactate, do not accumulate 
to toxic levels in Sf9 cells (Drews et al., 1995). Also, the addition of complex 
nutrient mixtures such as different kinds of serum substitutes and 
hydrolysates were reported to be beneficial to increase protein production 
(Ikonomou et al., 2003). However, these studies generally lacked a detailed 
description of cellular metabolism, failing to identify the specific 
components responsible for improved productivities. Exceptionally, Radford 
et al. (1997)  have reported a complete depletion of cystine in infected 
cultures above 5×106 cells/mL, which was correlated with the decrease in 
recombinant protein production. In our study, we could not observe a 
depletion of any of the carbon sources and amino acids analyzed during 
infection, including cysteine. In fact, the depletion of serine in uninfcted 
cultures only occurred after cells had stoped growing. This fact might 
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indicate that the depletion of other components of the medium (eventually 
vitamins or trace elements) are limiting BV production.  
Alternative hypothesis have been pointed as possible explanations for 
limited productivities in older culures without medium exchange. Some 
authors have shown previously the linking between oxygen uptake rate, 
infection and protein production in the BV-insect cell expression system 
(Lecina et al., 2006; Palomares et al., 2004), while others even stated that 
control of oxygen supply after infection is critical and determined that in 
order to obtain good productivities, oxygen concentration should be kept 
above 20% (Taticek and Shuler, 1997). As mentioned, it is not conclusive 
that this is the determinant factor given the metabolic depression also 
observed in oxygen-controlled bioreactors along culture growth (data not 
shown). Most of the reports that have systematically addressed the cell 
density effect in insect cells performed infections in shake or spinner flasks, 
after growing cells to the desired cell densities in bioreactor at different 
oxygen concentrations (Caron et al., 1990; Radford et al., 1997; Reuveny 
et al., 1993); therefore, oxygen was not limiting at the time of infection. 
From another perspective, the constitutive secretion of regulatory factors 
down-regulating metabolic activity could limit productivities at high cell 
densities (Doverskog et al., 1997), as an intrinsinc mechanism for cell 
density control. This hypothesis is consistent with our data, including the 
positive effect of ressuspending the cells in fresh medium prior infection. 
In conclusion, data presented in this work provide a systematic analysis of 
how culture and infection parameters affect BV production. The main 
bottleneck appears to be the decreased productivities observed at high cell 
density culture, paralleling abundant information reported on recombinant 
protein production with the BEVS technology. One of the main strategies to 
overcome the cell density effect is the re-suspension of cells in fresh 
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medium prior to infection. However, total medium replacement, though 
feasible for small scale cultures, is not suitable for higher production scales, 
increasing the cost of the bioprocess due to the need for separation 
devices and extra medium costs. On the other hand, the simple addition of 
complex nutrient mixtures hinders the identification of the individual 
components that may be limiting production, besides involving higher 
operation costs and inducing variability in process performance. 
Considering this, we believe that future improvement of the insect 
cell-baculovirus system is highly dependent on a detailed characterization 
of insect cells metabolism along culture time and after infection. The 
growing application of recombinant BVs for gene therapy represents an 
opportunity to deepen the knowledge around this system. 
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1. SUMMARY 
In this chapter, a model for the central metabolism of serum-free 
suspension cultures of Sf9 cells is proposed and used to investigate the 
metabolic basis for the so-called cell density effect. The main metabolic 
pathways (glycolysis, pentose-phosphate pathway, tricarboxylic acids 
cycle, glutaminolysis and amino acids metabolism), cellular growth and 
energetics were considered. The analysis of the stoichiometric model 
allowed further understanding of the interplay of the consumption of carbon 
and nitrogen sources in insect cells. Moreover, metabolic flux analysis 
revealed that Sf9 cells undergo a progressive inhibition of central 
metabolism when grown to high cell densities, for which the lower 
incorporation of amino acids carbon backbones into the tricarboxylic acids 
cycle (mainly glutamine) and the down-regulation of glycolysis are partially 
responsible. Following infection by baculovirus and cellular division arrest, 
central energy metabolism depended on the infection strategy chosen (cell 
concentration at the moment of infection and multiplicity of infection), an 
inhibition being observed at high cell densities. Interestingly, the energetic 
status of the cells correlated with the decrease in production of baculovirus 
vectors, meaning that there is room for process optimization through the 
application of metabolic engineering techniques.  
 
2. INTRODUCTION 
Metabolic Flux Analysis (MFA) is a well established technique for the 
assessment of metabolic adaptations undergone by any type of cell in 
culture (Stephanopoulos et al., 1998). Since the early 90’s, metabolic 
models have been developed for the study of cellular physiology and for the 
optimization of bioproduction systems in many organisms. Because of their 
higher simplicity and the wealth of data existing on the metabolism and 
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physiology of yeast and bacteria, most of the initial applications of MFA 
were developed for microorganisms. However, the increasing interest 
gained by animal cell-based bioprocesses for high added value products 
has encouraged the application of these techniques to the more complex 
eukaryotic cells. Improvement of cell metabolism would yield increased 
growth, viability, productivity, substrate spectrum, energy yield and/or 
bioprocess robustness, thus reducing process costs. 
Although some authors have highlighted the need for an in depth analysis 
of the main metabolic constraints limiting productivity in the 
baculovirus-insect cells system, to date very few works have dealt with this 
issue (Bhatia et al., 1997; Ferrance et al., 1993; Ikonomou et al., 2003). In 
particular, a fundamental understanding of the well documented loss in 
specific productivity when insect cells are infected at high densities would 
be valuable to design optimized bioprocesses (Bhatia et al., 1997; 
Ikonomou et al., 2003; Palomares et al., 2006; Taticek and Shuler, 1997). 
As current practice, infection is normally performed at a low cell 
concentration at infection (CCI) to obtain higher protein yields (Maranga et 
al., 2003). Moreover, depending on the infection strategy, cell culture 
system and medium used, a wide range of cell concentrations have been 
considered to be either low or high densities (for example, compare 
Chapter I with Radford et al., 1997). 
Reports on the metabolism and physiology of insect cells, and on 
Spodoptera frugiperda Sf9 cells in particular, are scarce. Nutrient depletion 
has been proposed as the main cause for reduced recombinant protein 
yields in cultures of intermediate cell densities rather than inhibition by 
waste products (Drews et al., 1995). In fact, unlike most mammalian cell 
lines, alanine and ammonia are not related to growth inhibition (Doverskog 
et al., 1997). Glucose is the preferred carbon source, while there are 
contradictory reports concerning the consumption of disaccharides such as 
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maltose and sucrose (Ikonomou et al., 2003; Rhiel et al., 1997; Sugiura and 
Amann, 1996). Lactate and pyruvate cannot support Sf9 cell growth, which 
led some to propose that gluconeogenesis does not operate efficiently in 
insect cells (Bhatia et a., 1997). An important difference with respect to 
mammalian cell lines is that some insect cell lines, including Sf9 cells, do 
not significantly accumulate lactate, which has been attributed to a more 
active tricarboxylic acids (TCA) cycle (Neermann and Wagner, 1996). 
Finally, regarding nitrogen metabolism, there is a preference for the uptake 
of amino acids over their synthesis (Bhatia et al., 1997; Doverskog et al., 
1997; Ferrance et al., 1993).  
Remarkably, even fewer works have dealt with the metabolism of Sf9 cells 
after baculovirus infection. There are reports on the increase in oxygen 
uptake after infection (Cruz et al., 1998; Palomares et al., 2004) and on the 
effect of supplementation of growth media with glucose and glutamine, 
yeastolate or total/partial medium exchange at infection, which may 
increase protein production (Bhatia et al., 1997; Chapter I; Ikonomou et al., 
2003; Palomares et al., 2004). Recently, RNA interference has been 
demonstrated as a useful strategy for the improvement of bioprocess 
performance using Sf9 cells (Kim et al., 2007). Nevertheless, there is still a 
lack of knowledge on the correlation of metabolic shifts occurring with 
cellular productivity. Moreover, model derived information would be crucial 
for the development of rational feeding strategies in order to increase the 
production of proteins or BVs by insect cells.  
In this work, Metabolic Flux Analysis has been applied to assess the 
metabolic shifts in Sf9 insect cells as a consequence of cell density and 
baculovirus infection. 
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3. METABOLIC NETWORK 
A metabolic model considering the central pathways of Sf9 cells was herein 
constructed. For that purpose, available information from previous models 
developed for other animal cell lines, basic biochemistry text books and 
public access databases were considered (Altamirano et al., 2006; Berg et 
al., 2002; Bonarius et al., 1996; Caspi et al., 2008; Henry et al., 2005; 
Nadeau et al., 2000; Wahl et al., 2008). Moreover, specific information 
available for Sf9 cells metabolism was also included (Doverskog et al., 
2000b; Doverskog et al., 1997; Drews et al., 2000; Drews et al., 1995; 
Ferrance et al., 1993; Ikonomou et al., 2003; Öhman et al., 1995). The 
model considers the main reactions of central metabolism of cultured 
animal cells, namely glycolysis, pentose-phosphate pathway (PPP), 
anaerobic fermentation, TCA cycle, respiratory pathways, amino acids 
metabolism (including glutaminolysis) and biomass formation. The 
complete set of reactions, along with an index of metabolite/cell component 
abbreviations, is provided in Appendix 1; Figure 2.1 shows a simplified 
scheme of the metabolic network. The energy dependence of membrane 
transport was also taken into account (Doverskog et al., 1998; Wahl et al., 
2008). The 26 transmembrane transport systems considered are also listed 
in Appendix 1. 
 
3.1. Glycolysis and pentose-phosphate pathway 
Carbohydrates are assumed to be the main carbon source of Sf9 cells. 
Consumption of three carbohydrates was considered (glucose, maltose and 
sucrose), in accordance with previous reports (Ikonomou et al., 2003). 
Carbohydrates are taken up by facilitated transport and metabolized 
through glycolysis (Bhatia et al., 1997). The pentose-phosphate pathway 
serves as a source of building blocks for nucleic acids and reducing power 
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for biosynthetic purposes. In our model, the PPP diverges from glycolysis to 
yield R5P and NADPH, and it does not reconnect back to glycolysis, being 
directly determined by the demand of R5P for nucleic acids biosynthesis. 
This is a reasonable simplification since it is not possible to distinguish 
between parallel pathways using solely metabolite balances. Nevertheless, 
the underestimation of the PPP flux due to a higher demand of NADPH 
than that of R5P would amount to only 27%, based on the stoichiometry of 
the biomass synthesis reactions. The gluconeogenesis pathway was not 
included since it is not active in insect cells (Bhatia et a., 1997; Ferrance et 
al., 1993). 
LA
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Figure 2.1. Main metabolic pathways considered in the central metabolism of Sf9 
cells. See the text for details and Appendix 1 for the complete list of reactions and 
abbreviations index. 
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3.2. TCA cycle and malate-pyruvate shunt 
The TCA cycle has been reported to be fully functional in cultured Sf9 cells, 
in contrast to what has been observed in cultured mammalian cell lines 
(Neermann and Wagner, 1996) and also in some other insect cell lines 
(Bhatia et a., 1997). For simplicity, reactions linking the TCA cycle with 
biosynthetic pathways were lumped into the malate-pyruvate shunt (malic 
enzyme, ME). 
 
3.3. Pyruvate and α-ketoglutarate metabolic nodes 
The role of pyruvate and α-ketoglutarate nodes is key in redirecting 
intracellular metabolic fluxes. Pyruvate participates in various reactions as 
an intermediary in the metabolism of a few amino acids, recipient of the 
ammonia group for detoxification, as an electron sink in fermentative 
pathways and, specially, as the link between glycolysis and the TCA cycle. 
Pyruvate formed by glycolysis can either be used as metabolic fuel in the 
TCA cycle to obtain reducing power or to be used for the formation of 
alanine or lactate by means of alanine aminotransferase (AlaAT) or lactate 
dehydrogenase (LDH) activities, respectively (Figure 2.1). On the other 
hand, α-ketoglutarate has a pivotal role connecting the metabolism of 
amino acids with the TCA cycle, also being connected with the pyruvate 
pool through AlaAT (Figure 2.1). 
 
3.4. Amino acids transport 
The requirements of amino acids by Sf9 cells have been reported to be 
higher than those strictly necessary for the synthesis of cellular proteins. 
Amino acids such as glutamine, glutamate, aspartate, serine, arginine and 
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methionine are used for energy production (Drews et al., 1995; Ferrance et 
al., 1993). The uptake of amino acids from the growth medium is 
energy-dependent, while outflow can be assumed to occur by diffusion 
(Caspi et al., 2008; Doverskog et al., 1997; Wahl et al., 2008). For our 
modelling purposes, amino acids outflow was relevant only in the case of 
alanine, which is the only amino acid with a net positive production rate.  
Importantly, the thermodynamics of amino acids transport is highly 
dependent on their chemical nature (Wahl et al., 2008). Negatively charged 
glutamate and aspartate use the System X-AG Transporters, consuming 1 
molecule of ATP for each molecule transported, in order to overcome 
electrochemical gradients. Neutral amino acids are transported through two 
main systems: short chained neutral amino acids (methionine, threonine, 
serine, proline, glycine, asparagine and alanine) are taken up by System A 
Transporters, while large hydrophobic amino acids (tryptophan, 
phenylanine, valine, leucine, isoleucine, glutamine, histidine and tyrosine) 
use System L Transporters. These two systems consume 0.33 molecules 
of ATP per molecule taken inside the cell. Positively charged amino acids 
can be transported through various mechanisms, but System y+L 
Transporters are assumed in this work for the transport of lysine and 
arginine. This system also consumes 0.33 ATP molecules per transported 
amino acid. Cysteine uptake occurs through the XC- Transporter, an antiport 
system that exchanges glutamate for cysteine and is driven by the 
concentration gradients of these amino acids (Doverskog et al., 1998). 
The regulation of amino acids uptake by cell cycle and growth arrest has 
been already demonstrated. In fact, System A Transporters are closely 
related to the position in the cell cycle and in mammalian cells they are 
regulated by growth factors (such as insulin), also causing, indirectly, the 
cessation of System L Transporters (Doverskog et al., 1997). 
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3.5. Nitrogen metabolism and ammonia detoxification 
Amino acids can face various metabolic fates, either being used for protein 
production or degraded to be used as carbon and nitrogen sources. In a 
rich medium such as SF900II, biosynthesis of amino acids can be 
neglected. The reactions for amino acids degradation were taken from the 
literature (Berg et al., 2002; Caspi et al., 2008; Voet and Voet, 1995). For 
simplicity, non-ramified reactions in these pathways were lumped into 
simpler reactions, as indicated in Appendix 1. 
Some peculiarities of the nitrogen metabolism of insect cells have already 
been reported. A NADH-dependent glutamate synthase (GOGAT) activity 
has been detected in cell free extracts of Sf9 cells and other Lepidopteran 
species (Doverskog et al., 2000b). This activity catalyzes the reductive 
transfer of the amido group of glutamine to α-ketoglutarate, forming 
glutamate and by-passing the production of ammonia. Moreover, in 
glutamine-free medium, ammonium ions can be incorporated into amino 
acids such as alanine and glutamine (Drews et al., 2000). In fact, 
NADH-dependent glutamate dehydrogenase (GDH) and glutaminase 
activities were also detected using 1H,15N-NMR-based methods, although 
activities were about 55% and 11% of that of GOGAT, respectively 
(Doverskog et al., 2000b). Additionally, the fact that these activities are 
dependent on NADH and not on NADPH further supports a catabolic rather 
than anabolic role. 
Cultured Sf9 cells do not accumulate ammonia in the presence of excess of 
glucose and glutamine, alanine being the main by-product (Drews et al., 
2000). Pyruvate functions as a recipient of the ammonia group from 
glutamate in a reaction catalyzed by the alanine aminotransferase (AlaAT) 
activity. This activity allows coupling the entrance of glutamate (formed 
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from other amino acids) to the TCA cycle as α-ketoglutarate without the 
concomitant production of free ammonia. 
 
3.6. Energy production 
Reduced cofactors generated by the central metabolism (NADH and 
FADH2) are oxidized in the mitochondrial electron transport chain with 
oxygen as a final acceptor. A transhydrogenase reaction was included to 
account for the interconversion of NADH and NADPH. The balance of ATP 
was not closed, since not all the phenomena leading to energy 
consumption (cellular maintenance, futile cycles) can be incorporated. A 
unidirectional flux was set to represent the expense of ATP molecules 
associated with other metabolic events, including waste through futile 
cycles. 
 
3.7. Cellular growth 
In order to account for cellular growth, Sf9 cells biomass was considered to 
be formed mostly of proteins, lipids and nucleic acids. The cellular dry 
weight of Sf9 cells and macromolecular composition was estimated from 
previously published data for insect cells (Ferrance et al., 1993); these 
were similar to data published for other cell lines (Gambhir et al., 2003; 
Nadeau et al., 2000; Xie and Wang, 1994; Zupke and Stephanopoulos, 
1995). 
To account for protein synthesis, the amino acids composition was taken 
from the literature (Ferrance et al. 1993; Xie and Wang 1994). 
Consumption of ATP for protein synthesis was also considered. 
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The total lipidic bulk of Sf9 cells was assumed to be composed of oleic 
acid, which accounts for almost half of the total fatty acids, being the most 
prevalent component of the most abundant phospholipids in this cell line 
(Marheineke et al., 1998). A lumped equation for oleic acid synthesis from 
acetyl-CoA was derived, calculating the extra ATP necessary for the 
transport of acetyl-CoA from the mitochondria to the cytosol as citrate (1 
ATP per acetyl-CoA molecule) and for the transfer of reducing equivalents 
from mitochondria to the cytosol (Berg et al., 2002). 
The GC content of lepidopteran DNA is about 35-40% (The international 
Lepidopteran Genome Project). The lumped equation for DNA synthesis 
was determined considering a G/C content of 40%. The size of the haploid 
genome of S. frugiperda is 8·108 bp; from this data, 1.4% of the cellular 
weight is computed to correspond to DNA. However, polyploidy and 
chromosome instability have previously been reported for this insect cell 
line (Jarman-Smith et al., 2002), and the value of 4.8% previously 
determined experimentally by Ferrance et al. (1993) was considered to 
obtain the biomass production equation shown in Appendix 1.  
 
3.8. Mitochondrial compartmentalization 
Mitochondrial compartmentalization is not explicitly considered in the model 
since mitochondrial shuttle mechanisms have not been characterized in 
insect cell lines. Moreover, mitochondrial and cytosolic pools of redox 
nucleotides can be considered to be in equilibrium since lactate production 
is much lower than in mammalian cells. However, the energetic 
requirements for certain mitochondrial transmembrane transport 
phenomena were taken into account, as already underlined in the case of 
the lumped equation for the synthesis of lipids. 
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4. MATERIALS AND METHODS 
Detailed materials and methods on cell maintenance, baculovirus 
amplification and titration, experimental cultures and infections, glucose, 
lactate, ammonia and amino acids analyses can be found in Chapter I. In 
addition to these metabolites, the concentrations of maltose and sucrose 
were measured in the culture medium. These were enzymatically 
hydrolyzed using α-glucosidase and baker’s yeast invertase from 
Sigma-Aldrich (St. Louis, MO, USA), respectively. Glucose resulting from 
these reactions was measured using the YSI 7100 system as before.  
 
4.1. Metabolic Flux Analysis 
A system of mathematical equations was formulated on the basis of 
material balances for the metabolic network, according to general MFA 
theory (Stephanopoulos et al., 1998): 
Av(t)r(t) =   ,       (Eq. 1) 
where r(t) is the vector for the accumulation rates of each compound 
considered in the network, A is the stoichiometric matrix of the metabolic 
network and v(t) is the vector of the fluxes through the various biochemical 
reactions listed in Appendix 1.  
The pseudo-steady-state hypothesis for intracellular metabolites, 
considering their accumulation inside the cells as negligible, is generally 
accepted as reasonable (Altamirano et al., 2006; Nadeau et al., 2000). In a 
typical biochemical network, the number of reaction rates is higher than the 
number of metabolites, resulting in an underdetermined system with a 
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variable number of degrees of freedom (meaning that not all the rates can 
be uniquely computed). In order to solve the system of equations, some 
fluxes have to be experimentally determined. The most common case is to 
determine transmembrane rates of metabolites consumed and/or secreted 
by the cells. Together with the irreversibility of some reactions, these are 
the modelling constraints that cannot be violated when solving metabolic 
network. 
In the model hereby considered, the total number of reactions was 73, with 
52 internal (balanced) intracellular metabolites/cell components. The 
balances of urea, mevalonate and ADP could not be closed, as these 
metabolites intervene in reactions not considered in the network. As stated 
above, an unidirectional flux was used to represent the expense of ATP 
molecules associated with cellular maintenance and waste through futile 
cycles.  The rank of the resulting stoichiometric matrix was 49, meaning 
that there are 3 (52 less 49) conservation relations (corresponding to the 
balances of redox cofactors: NAD+/NADH, NADP+/NADPH and 
FAD/FADH2). The resulting number of degrees of freedom of the system is 
thus 24 (73 reactions less 49 independent balances).  From the profiles of 
extracellular concentrations, 24 metabolite consumption/production rates 
were experimentally determined. Additionally, the specific growth rate was 
measured, and some intracellular reaction rates (namely the intracellular 
hydrolysis of maltose and sucrose and the synthesis of lactate from 
pyruvate), were set equal to the respective extracellular measured fluxes. 
In total, 28 known rates were considered. 
The vector of fluxes in Eq. (1) was then partitioned into known flux and 
unknown flux vectors, vb and vn, respectively. Similarly, the stoichiometric 
matrix A was partitioned into Ab and An. Eq. (1) was rewritten as: 
nnbb vAvAAv0 +==   .            (Eq. 2) 
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The analysis of the matrices showed that the system is determined 
(meaning that it is possible to uniquely compute all rates of vn) and also 
redundant, according to the classification proposed by Klamt et al. (2002). 
The redundant system at hand was solved by the weighted least squares 
method using the Penrose pseudo-inverse matrix. The balanceable rates, 
which arise from system redundancy, were used to calculate the 
consistency index, h, according to Wang and Stephanopoulos (1983). 
Comparison of h with the χ2-test function was done in order to evaluate the 
consistency of the experimental values along with the assumed 
biochemistry and the pseudo-steady-state assumption within the error 
dictated by measurement uncertainties. From our analysis, errors for 
disaccharides and amino acid uptake rates stood below 12%, while for 
glucose consumption was below 6%. All the calculations were performed 
using the CellNetAnalyzer software (Klamt et al., 2007). In addition, 
material balances were performed to confirm that all key components of the 
system were covered and, on average, fit within 100% ± 15% for all phases 
(100% ± 10% for more than half of the phases analyzed). This shows that 
the experimental data are consistent with the assumed biochemistry and 
the pseudo-steady state assumption, and that there were no systematic or 
gross measurement errors. 
 
5. RESULTS 
5.1. Effect of cell density on the central metabolism of Sf9 insect 
cells 
In order to determine the effect that the different phases of cellular growth 
have on the energetic metabolism of S. frugiperda, Sf9 cells were cultured 
in SF900II serum free medium as explained in Chapter I. For the analysis 
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of metabolic adaptations undergone, seven phases were defined by 
considering the growth and metabolic profiles (see Figure 1.1 in Chapter I). 
The pseudo-steady state hypothesis for intracellular metabolites was 
assumed to be valid within each phase, and consumption and production 
rates (extracellular fluxes) were determined from bulk concentrations of 
carbon sources, amino acids and the main by-products (alanine, lactate 
and ammonia). Main extracellular fluxes of sugars, amino acids and 
by-products are shown in Table 2.1, expressed in nmol/106 cells/h. 
Preliminary analysis showed that the application of MFA to the lag and cell 
death phases did not yield any interpretable result, since the consistency 
index condition (h < χ2) was not fulfilled, probably due to the high 
experimental error associated to the determination of low 
consumption/production rates and/or to the liberation of intracellular 
compounds to the growth medium as a consequence of cell lysis, 
respectively. Consequently, only five phases were ultimately considered: 
initial, medium and late exponential growth (cell densities: 1-2×106 
cells/mL, 24-48 h; 2-3.5×106 cells/mL, 48-72 h; 3.5-8×106 cells/mL, 72-96 h, 
respectively), and early and late stationary phases (8-9×106 cells/mL, 
96-120 and 120-168 h, respectively). 
As previously described, growth of Sf9 cells was linked to sugar 
consumption. Three carbon sources are used by Sf9 cells for growth in 
SF900II medium. The major carbon source is glucose (which is present at 
high concentration, around 55 mM), while consumption of alternative sugar 
sources (maltose and sucrose, present at lower concentrations) was 
detected, although at much lower rates than glucose (Table 2.1). Lactate 
production was only detected when high cell densities were attained, while 
ammonia levels remained in the range of 4-6 mM throughout the culture, 
with little or no accumulation. As already described, alanine was the most 
important by-product (Bédard et al., 1993; Kamen et al., 1991), its 
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production spanning the whole culture. Sf9 cells consumed the amino acids 
present in the growth medium, especially asparagine, arginine, aspartate, 
glutamine and glutamate, which are known to be processed through the 
TCA cycle for energy generation and biosynthesis, and are also those 
existing at the higher concentrations (around 10 mM). Serine was the only 
amino acid to be totally consumed at 170-190 h (as pointed out in Chapter 
I), while cells had stopped growing by that time and the specific growth rate 
significantly decreased much before (Table 2.1). At end of the culture, the 
rest of the amino acids and sugar sources were still available in the growth 
medium.  
The extracellular rates determined were used to estimate intracellular 
metabolic fluxes using the model described. The main intracellular fluxes 
for uninfected Sf9 cells are shown in Figure 2.2. 
Glycolysis and pentose-phosphate pathway. The three sugars taken up 
(glucose, maltose and sucrose) were mainly channelled to pyruvate 
through the glycolytic pathway (Figure 2.2A). Fluxes of 
glucose-6-phosphate through the pentose-phosphate pathway (PPP) were 
directly proportional to cellular growth rate, reaching a maximum during the 
early exponential growth phase (2.5-3.5 nmol/106cells/h). This flux was 
positive along all the phases considered and evolved from 3.3% of the flux 
through the glycolytic pathway during the early exponential growth phase to 
0.6% at the stationary phase, thus representing a lower proportion of 
glucose consumed than the 10-14% previously reported for animal cells 
(Benslimane et al., 2005; Neermann and Wagner, 1996). 
 
 
 
71 
Chapter II 
Table 2.1. Specific consumption/production rates of the main metabolites of Sf9 
cells during culture growth. Cultures were performed as described in Chapter I. 
Five phases (I-V) are considered (initial, medium and late exponential phases and 
early and late stationary phases).  Rates are expressed as nmol/106cells/h.  
Extracellular fluxes for uninfected Sf9 cells 
Phase I II III IV V 
Time span (h) 24-48 48-72 72-96 96-120 120-168 
Cell density 
(cells/mL) 1.4×10
6 2.7×106 4.7×106 6.6×106 7.7×106 
Glc -82.74 -82.13 -51.11 -43.51 -45.23 
Lac 9.43 3.36 17.05 7.62 12.44 
Sucr -1.54 -7.01 -4.12 -2.91 -0.46 
Malt -13.61 -5.47 -8.24 -2.99 -3.07 
Amm -2.84 -2.92 0.41 1.79 1.52 
Asp -14.25 -8.10 -3.97 -2.81 -2.81 
Glu -19.64 -14.86 -4.25 -7.16 -4.48 
Ser -5.32 -9.42 -4.33 -3.60 -3.32 
Asn -7.80 -4.02 -2.36 -1.43 -0.93 
Gly -6.81 -4.12 -1.24 -0.55 -0.39 
Gln -33.11 -34.06 -13.21 -7.28 -5.70 
Thr -5.10 -4.74 -1.61 -1.18 -0.93 
Ala 13.54 14.78 23.12 15.74 9.42 
Pro -14.40 -5.22 -0.69 -0.71 -0.57 
Tyr -5.32 -4.12 -0.32 -0.64 -0.44 
Val -7.44 -8.98 -1.46 -0.80 -0.97 
Met -9.22 -6.90 -0.43 -0.47 -0.67 
Ile -7.09 -8.32 -0.94 -0.88 -0.61 
Leu -4.68 -6.72 -2.45 -1.44 -1.06 
Phe -7.66 -8.87 -2.06 -0.77 -0.50 
His -5.74 -2.45 -0.86 -0.68 -0.23 
Arg -10.99 -8.76 -1.89 -2.64 -1.65 
Lys -10.78 -7.70 -1.82 -0.67 -0.35 
Growth rate  
(/h) 0.029 0.025 0.022 0.011 0.004 
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I                   II                 III                 IV                V
 
Figure 2.2. Main metabolic fluxes for uninfected Sf9 cells. (A) Glycolysis and 
related fluxes; (B) TCA cycle and malate-pyruvate shunt, (C) nitrogen metabolism 
fluxes and (D) macromolecules synthesis. Error bars correspond to standard 
deviations computed with the CellNetAnalyzer software. Deg. stands for 
degradation. 
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TCA cycle. The TCA cycle was fully active in Sf9 cells (Figure 2.2B), the 
ratio between the fluxes of citrate synthase (first step of the TCA cycle) and 
glycolysis ranging from 0.76 to 0.86, meaning that carbon oxidation was 
high during all phases of culture considered, even increasing at the 
stationary phase paring a lower use of acetyl-CoA for the synthesis of lipids 
under non-growing conditions (Figure 2.2B). The parallel decreasing trend 
observed in the fluxes of glycolysis and the TCA cycle along culture time 
did not correlate with the exhaustion of any medium component. The fluxes 
through the TCA cycle at the early and late stationary phases were around 
50% of those of exponentially growing cells, revealing a high activity of 
maintenance metabolism and high energy needs (Figure 2.2B). Moreover, 
the high metabolic activity of TCA cycle was also due to amino acids 
consumption, since a high incorporation of carbon backbones was 
assessed at the α-ketoglutarate node (Figures 2.2B and 2.3C). This was 
especially relevant during the initial growth phases, when the highest amino 
acid consumption rates were observed and most of the amino acids were 
transformed into glutamate to enter the TCA cycle as α-ketoglutarate (Table 
2.1).  
Malate-pyruvate shunt. To allow for the complete oxidation of the carbon 
backbones of amino acids in the TCA cycle or diversion to biosynthesis, the 
functioning of the malate-pyruvate shunt is compulsory (lumped as the ME 
flux). The oxidation of amino acid carbon backbones further led to 
increased production of reduced equivalents (FADH2 and NADH). An 
important metabolic switch was observed at cell densities of around 3×106 
cell/mL, with a drastic reduction in the uptake of amino acids and in their 
incorporation into the TCA cycle; this led to a subsequent decrease in the 
flux of ME (Figures 2.2B and 2.2C). At the higher cell density phases, the 
decrease in these fluxes was much steeper than that of the TCA cycle, as a 
consequence of this cyle being fuelled mostly by glucose. 
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Nitrogen metabolism. Continued alanine production constrained ammonia 
cell excretion. All other amino acids were consumed although at very 
different rates (Table 2.1). The highest uptake rates were observed for both 
glutamine and glutamate during all the experimentation time, although their 
assimilation was highly reduced at cell densities above 3×106 cells/mL. 
Glutamine consumption was preferential, since glutamate uptake only 
increased once glutamine levels in the bulk media decreased. The most 
relevant amino acid fluxes are shown in Figure 2.2C. As shown, the 
glutamate synthase (GOGAT) pathway was more active during the initial 
phases of growth. A similar trend was observed for aspartate 
aminotransferase and glutamate dehydrogenase pathways, both of which 
were active in the synthesis of α-ketoglutarate from glutamate. 
Interestingly, metabolic flux analysis revealed net fluxes for the synthesis of 
serine from pyruvate during the initial phases of growth. This active 
pathway supports the idea that alanine aminotransferase is not the only 
pathway used for Sf9 cells for ammonia detoxification. The existence of 
various active pathways collaborating in this task are likely to provide the 
physiological robustness to ammonia described for this cell line. 
Cellular redox and energetic state. Oxidative phosphorylation allowed for 
the regeneration of the reduced cofactors produced (Figure 2.4A). The 
consumption and production of NADPH and NADH was balanced through a 
transhydrogenase reaction, although this flux revealed to be very low for all 
phases modelled (data not shown). The oxygen uptake rate (OUR) of Sf9 
cells was estimated for each phase of growth from the MFA calculations, 
reaching a maximum for exponentially growing cells (around 560 
nmol/106cells/h), these values decreasing to approximately half  (260-290 
nmol/106cells/h) during the stationary phase.  
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The net rate of energy generation was estimated from the computed fluxes 
as already described by other authors (Henry et al., 2005; Nadeau et al., 
2002; Wahl et al., 2008). It should be underlined that consumption of ATP 
for transport and protein synthesis was taken into account. The energetic 
state of the cell suffered a steep decrease at cell densities higher than 
3×106 cells/mL, coinciding with all aforementioned effects (Figure 2.5A). 
However, despite the net fall in the ATP production rate (more than 40%) at 
the stationary phase, this remained quite high, underlining the high 
necessity of ATP for cell maintenance. 
Synthesis of macromolecules. As expected, the rates of synthesis of 
biomass components (proteins, DNA, RNA and lipids) decreased with the 
specific cellular growth rate (data not shown). 
 
5.2. Effect of baculovirus infection on the central metabolism of 
Sf9 cells 
Sf9 cells were infected with a recombinant baculovirus at different times of 
culture (cell concentrations at infection, CCI, around 1, 2 and 3.5×106 
cells/mL) and at two MOIs, in order to analyze the interplay of these two 
factors on the physiology of infected cells. High MOI ensures synchronous 
infection and the arrest of cell division, thus allowing separating the effects 
of growth and infection; on the other hand, in an asynchronous infection at 
low MOI, cells keep on dividing and the interplay of both factors has to be 
considered (see Figure 1.1 in Chapter I).  
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Figure 2.3. Main metabolic fluxes of baculovirus-infected Sf9 cells at high (left) and 
low (right) MOI. Infections were performed at three different CCIs (1, 2 and 3.5×106 
cells/mL). (A) Glycolysis and related pathways, (B) TCA cycle and malate-pyruvate 
shunt, (C) nitrogen metabolism fluxes and (D) macromolecules synthesis. Error 
bars correspond to standard deviations computed with the CellNetAnalyzer 
software. Deg. stands for degradation. 
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Figure 2.4. Respiratory fluxes of Sf9 cells at (A) different phases of culture growth 
and (B) infection at high and (C) low MOI. Error bars correspond to standard 
deviations computed with the CellNetAnalyzer software. Resp. stands for 
respiration. 
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Figure 2.5. Estimation of net specific ATP production by Sf9 cells from computed 
metabolic fluxes. Net ATP production was represented by a unidirectional sink 
towards cell maintenance and futile cycles, after deducting all known expenditures 
explicit in the model. (A) Different phases of culture growth, (B) cells infected at 
different CCIs at a high and (C) at a low MOI. Error bars are standard deviations 
computed with the CellNetAnalyzer software. 
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For the determination of metabolic fluxes, a single phase post-infection was 
considered. To ensure the applicability of the steady-state hypothesis, 
experimental data were only considered such that (i) biomass levels varied 
only slightly and (ii) metabolite rates were almost linear. Data from the end 
of the experimental infections (72 hpi onwards) were not taken into account 
since metabolite profiles were then largely altered as a consequence of cell 
lysis. Additionally, the time window for baculovirus production at the MOIs 
used has been shown to be shorter.  
The correlation between the time of infection and the metabolic pattern of 
infected cells was obvious, a cell density effect being observed. In general, 
post-infection metabolic rates decreased with CCI.  
Glycolysis and pentose-phosphate pathway. The fluxes through glycolysis, 
AlaAT and LDH were in good agreement with extracellular 
consumption/production rates (Figure 2.3A and Table 2.2). Most of the 
sugars consumed were transformed into pyruvate, since the fluxes 
determined for the PP pathway were conditioned by the growth arrest after 
infection, especially in the case of high MOI. In fact, the percentage of 
glucose consumed that was metabolized through the PPP was always 
below 1%. Interestingly, the rate of glycolysis in cells infected at CCI 1 was 
higher than for uninfected cells at the same cell density (Figure 2.2A and 
2.3A). This was due to an increase in the consumption rate of 
disaccharides (maltose and sucrose), together with high consumption rates 
of glucose (Table 2.1 and 2.2). An increase in the glycolytic fluxes in the 
case of low MOI infection of around 5% was detected, which for high MOIs 
increased to 45%. For high CCIs, glucose consumption and glycolytic rates 
decreased substantially, being lower than in uninfected cells at comparable 
cell densities. This was more pronounced for high MOI infections, directly 
correlating with lower carbon utilization for cell growth. 
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Malate-pyruvate shunt. The incorporation of amino acids to the TCA cycle 
was quantitatively reduced following infection, especially at high MOI, 
correlating with reduced biosynthetic needs. Consequently, the fluxes 
through ME of Sf9 cells infected at low MOI almost doubled those of cells 
infected at high MOI (Figure 2.3B). 
TCA cycle. Similarly to what was observed for uninfected cells, a 
decreasing trend with CCI was observed for the fluxes through the TCA 
cycle at both MOIs. Interestingly, fluxes through the TCA cycle of Sf9 cells 
infected at 1·106 cells/mL were higher than those determined for uninfected 
cells at the same cell density, the differences being higher in the case of 
high MOI infection experiments (Figure 2.3B). At higher CCIs, the rates 
through the TCA cycle were sensibly lower, and closer to those observed in 
stationary phase Sf9 cells (Figure 2.3B).  
Nitrogen metabolism. As previously stated, the metabolism of amino acids 
suffered deep alterations and the effects were highly dependent on the 
strategy of infection. In general, the fluxes for amino acid metabolism 
observed for baculovirus-infected Sf9 cells were in the range observed for 
non/slow-dividing cells (Table 2.2). Alanine was produced along the whole 
time post-infection under all the infection strategies analyzed. Specific 
alanine production was higher after infection at low MOI (Table 2.2), 
confirming that amino acids consumed were not used primarily for viral 
protein synthesis. The effect on alanine production seems to be dependent 
on the cell density; indeed, for the high MOI infections, at a cell density of 
1×106 cells/mL, alanine specific production was higher for infected cells, at 
2×106 cells/mL was similar to uninfected cells, while at a CCI of 3×106 
cells/mL, alanine production after infection was lower than for uninfected 
cells.  
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Table 2.2. Specific consumption/production rates of the main metabolites of Sf9 
cells infected with Ac-hisgfp. Cells were cultured in batch and infected at low and 
high MOI, as stated in the Materials and Methods section. A single phase post 
infection was considered. Rates are expressed as nmol/106cells/h.  
Extracellular fluxes for infected Sf9 cells 
 High MOI Low MOI 
 CCI 1 CCI 2 CCI 3 CCI 1 CCI 2 CCI 3 
Glc -68.89 -37.68 -20.66 -58.10 -61.03 -37.31 
Lac -1.41 1.32 5.90 0.59 21.40 9.59 
Sucr -23.24 -7.85 -2.66 -10.02 -6.10 -4.41 
Malt -16.55 -1.96 -12.20 -14.09 -9.01 -3.50 
Amm -4.01 0.81 -1.01 -6.71 -1.46 2.26 
Asp -4.48 -4.71 -2.63 0.26 -6.31 -2.84 
Glu 0.08 0.33 -6.10 4.60 -14.31 -8.33 
Ser -0.99 -3.77 -0.82 -4.47 -4.91 -2.23 
Asn -0.33 -0.61 -1.02 2.96 -5.01 -1.22 
Gly 0.00 0.47 -0.02 0.79 -1.30 -0.43 
Gln -5.64 -3.44 -1.64 -9.21 -9.11 -5.06 
Thr -0.08 -0.38 -0.22 -0.20 -1.53 -0.61 
Ala 17.08 22.28 7.52 35.32 21.76 15.53 
Pro -0.25 0.42 0.22 -0.66 0.00 -0.25 
Tyr -0.33 -0.09 0.10 -0.39 -0.98 -0.36 
Val 0 -0.33 -0.35 0 -3.09 -0.68 
Met 0 -0.85 -0.64 0 -1.62 -0.05 
Ile -0.50 -0.14 -0.27 0 -2.18 -0.65 
Leu -0.02 -0.66 -0.22 -1.71 -2.96 -0.90 
Phe -0.41 -0.24 -0.47 0 -1.95 -0.54 
His 0 -0.04 -0.02 0 -0.55 -0.20 
Arg -0.91 -2.12 -0.35 -0.59 -2.73 -0.72 
Lys -0.06 -0.42 -0.20 0 -2.18 -0.72 
Cys -0.50 -0.57 -0.22 -1.38 -1.46 -0.20 
Growth rate 
(/h) 0.004 0.004 0.000 0.004 0.006 0.004 
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Moreover, glutamine uptake rates and intracellular related fluxes decreased 
with CCI, while the contrary effect was assessed for glutamate (Table 2.2 
and Figure 2.3C). Interestingly, flux through the GOGAT pathway followed 
a parallel trend to alanine production (Figure 2.3C), which were the most 
active pathways in nitrogen metabolism at both MOIs. Considering the rest 
of the amino acids, lower utilization rates and intracellular metabolic fluxes 
were assessed as a consequence of lower biomass synthesis after cell 
growth arrest and despite none of them being limiting in the medium 
(Figure 2.3C). All fluxes determined occurred in the direction of glutamate 
formation, while this was channelled to alanine formation by transamination 
with pyruvate (AlaAT) and α-ketoglutarate (Figure 2.1).  
Cellular redox and energetic state. As expected, the alteration of the TCA 
cycle activity was followed by a corresponding modification of mitochondrial 
respiration and ATP synthesis (Figure 2.4B,C and 2.5B,C). For low and 
high MOI infections at a CCI of 1×106 cells/mL, OUR reached 580 and 890 
nmol/106cells/h, respectively, representing an increment of 6 and 63% with 
respect to uninfected conditions. This increase is in accordance with 
previously published data for baculovirus infected insect cells (Gotoh et al., 
2004; Kamen et al., 1996; Lecina et al., 2006; Palomares et al., 2004). At 
higher CCIs, the specific OURs were lower than those determined for 
uninfected cells (around 60-80% of values obtained at equivalent cell 
densities). 
In the case of baculovirus infected insect cells, the fluxes determined 
through the transhydrogenase reaction were also very low for all conditions 
modelled, thus pointing to a balanced redox metabolism after infection 
(data not shown). 
Synthesis of macromolecules. The rates of synthesis of biomass 
components decreased 5 to 20-fold following infection as a consequence of 
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the cell division arrest. This effect was dependent on the MOI of infection 
and, therefore, more important at high MOI (data not shown). 
 
6. DISCUSSION 
Despite the wide spreading of the applications of the BEVS for the 
production of proteins, virus-like particles and viruses, the metabolic 
behaviour of Sf9 cells has not been fully characterized to date. In a first 
attempt to quantify metabolic fluxes of uninfected Sf9 cells, Ferrance et al. 
(1993) used carbon balances and a simple metabolic network. In the 
present paper, a comprehensive network describing carbon and nitrogen 
metabolism brings together, for the first time, data from published literature 
for insect cells and models previously developed for mammalian cell lines. 
To our knowledge, this is the first report on the effect of baculovirus 
infection on metabolic fluxes of Sf9 cells. The application of this 
methodology sheds light on the interplay of cell density and baculovirus 
infection on the cellular metabolic state.  
The results presented herein are in accordance with the most prevalent 
metabolic features previously stated for the Sf9 insect cell line. 
Undoubtedly, the most striking characteristic is its active TCA cycle, which 
has been considered to be responsible for the low lactate production rates. 
For mammalian cell lines, the high lactate to glucose ratio is used as an 
indication of the low efficiency of glucose oxidation, while in Sf9 cells 
70-80% of glucose is oxidized in the TCA cycle (Neerman and Wagner, 
1996). In our work, relevant lactate formation was only detected at very 
high cell densities (Table 2.1 and 2.2). Meanwhile, an important proportion 
of glucose-derived pyruvate is channelled to alanine formation through 
AlaAT activity, being the main reaction reducing the efficiency of glucose 
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utilization. Refining our estimations of metabolic efficiency provided in 
Chapter I, the metabolic model developed herein calculates that the 
proportion of pyruvate diverted for alanine and lactate production ranged 
from 6 to 18% and 0 to 11%, respectively. In addition, the ME flux was less 
active at high cell densities and after infection (Figure 2.2B and 2.3B), 
indicating that under non or slow growth conditions, anaplerotic TCA 
intermediaries are not being addressed for biosynthesis. 
Discrepancy is observed with the results shown by Benslimane et al. 
(2005), who reported a quite low experimental flux for the TCA cycle (only 
3% of metabolized glucose), despite the fact that lactate and alanine 
production could only explain around 30% of the total glucose consumed, 
the fate of the remainder not being justified. However, different growth 
media (serum supplemented IPL-41 medium vs. serum-free SF900II), 
glucose concentration (14 vs. 55 mM) and culture systems (erlenmeyer vs. 
spinner flask) were used in this work and data needs to be carefully 
compared. Moreover, Maier et al. (2008) have recently described important 
differences in flux distributions determined based on extracellular rates and 
fluxes calculated from transient 13C-labelling patterns of intracellular 
metabolites; the differences affected especially the TCA cycle and the PP 
pathway. More conclusively, Neermann and Wagner (1996) determined an 
80% of glucose entrance to the TCA in Sf21 cells cultured in serum-free 
Ex-cell-401 medium, with 35 mM glucose, which is in accordance with our 
studies.  
In contrast to what has been described for mammalian cells, the amino acid 
consumption pattern of insect cells is conditional, depending on the 
nutritional and proliferative status and cell line specific properties 
(Doverskog et al., 1997). In our experiments, no sugar limitation was 
observed throughout batch cultures of infected and uninfected cells due to 
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the high concentration of sugars in SF900II medium. Despite this fact, 
amino acid consumption was observed to be higher than the strictly 
necessary for protein synthesis, suggesting that anaplerotic fluxes were 
quantitatively important, especially at low cell densities (Tables 2.1 and 2.2, 
Figures 2.2C and 2.3C). This results in the generation of intracellular 
nitrogen in the form of glutamate and ammonia. The ammonia moiety from 
glutamate, primarily derived from glutamine through GOGAT activity but 
also from other amino acids, is transferred to pyruvate, forming alanine 
through AlaAT and resulting in a net generation of α-ketoglutarate. Alanine 
is the main carbon compound secreted by insect cells under glucose 
excess, and even consumed after glucose depletion (Bédard et al., 1993; 
Kamen et al., 1991; Öhman et al., 1995). On the other hand, our results 
indicate that the high efficiency of free ammonia recycling depends on the 
net production of serine from pyruvate, which was observed in uninfected 
fast growing cells at low densities (Figure 2.2C). Amino acids consumption 
and consequent alanine production decreased at higher cell densities 
(beyond 3-4×106 cells/mL), when glucose levels were not yet limiting. It 
should be noted that although the use of amino acids to fuel the central 
metabolism of Sf9 cells leads to a decreased efficiency of carbohydrate 
utilization for nitrogen detoxification, this is still much more efficient than 
what has been reported for mammalian cell lines (Neerman and Wagner, 
1996).  
In this work, the general down-regulation of the central metabolism of Sf9 
cells with cell density has been quantified for the first time by means of 
MFA. Namely, the fluxes through glycolysis and TCA cycle were down 
regulated with increasing cell concentrations, while ME fluxes dropped to 
half from their initial values (Figures 2.2A and 2.2B). The major impact of 
the down-regulation of the TCA cycle was the sharp decrease in the 
production of metabolic energy, in agreement with the fact that maximum 
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energy production is linked to rapid cellular growth, which, however, kept 
being produced for cell maintenance at high cell densities (Figure 2.5). The 
observed effects occurred before any major component of medium reached 
limiting concentrations, the metabolism of Sf9 cells being more active at low 
cell densities. However, minor components of the SF900II medium (namely 
those supplied by hydrolysates) were not considered for this work. In fact, 
although these components are known to have a major impact on insect 
cell growth and final infection yield (Ikonomou et al., 2003), their 
concentrations are low and can not be considered in the material balances 
of the model. It cannot thus be ruled out that the limitations assessed at 
high cell densities could be due in part to their exhaustion, since vitamins 
and oligoelements act as cofactors for key metabolic enzymes. Further 
work should be done in order to determine the role of these limitations in 
the BEVS. 
While lactate, alanine or ammonia have already been shown not to exert 
any inhibitory effect on the physiology of insect cells (Doverskog et al., 
1997; Ikonomou et al., 2003; Öhman et al., 1995), it could be hypothesized 
that this effect could be due to the accumulation of inhibitory levels of 
compounds not yet identified. The relationship of cellular growth in 
serum-free media with the production and secretion of autocrine/paracrine 
growth factors by the Sf9 cell line has already been described. The 
accumulation of a human insulin-like growth factor I (IGF-I) was described 
and correlated with the decline and cessation of growth, occurring when the 
medium was still nutritionally sufficient (Doverskog et al., 1997). Moreover, 
the same authors showed that the cysteine biosynthetic pathway was down 
regulated in cells at late exponential growth (Doverskog et al., 1998) and 
cell cycle regulation by conditioned medium components has also been 
described and related to protein productivity (Doverskog et al., 2000a). The 
results presented herein corroborate these assumptions and the discussion 
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provided in Chapter I, suggesting the existence of a regulatory mechanism 
triggered by cell density, exerting an inhibitory effect on metabolism. This 
mechanism, probably operating at the level of gene regulation and/or 
silencing, could be seen as a cell density control and protection 
mechanism, avoiding the total exhaustion of the nutrients in the growth 
medium which would lead to a steep loss of viability. Sensing mechanisms 
for cell density regulation in prokaryotes and eukaryotes alike have been 
reported before (Brazill et al., 1998; You et al., 2004). 
Results presented herein underline that alteration of cellular metabolism is 
also exerted by baculovirus infection, since the metabolic machinery of 
infected cells is fully devoted to virus replication. Early after infection, as 
BVs start controlling cellular machinery, cell cycle is arrested in the G2/M 
phase (Braunagel et al., 1998) and the expression of the host genes 
ceases (Palomares et al., 2006). Calculations allowed us to determine that 
the diversion of building blocks for the synthesis of macromolecular 
components of BVs alone does not explain the metabolic effects/limitations 
assessed; thus, equations for BV synthesis were not considered herein. 
The alteration in the metabolism of sugars, in particular the enhanced 
consumption of disaccharides (maltose and sucrose) after infection at low 
CCI (Table 2.2) led to higher glycolytic fluxes in infected cells (Figure 2.3A). 
This resulted in a higher pyruvate flux towards acetyl-CoA which, together 
with the arrest of cellular growth (and consequently the decrease in the 
synthesis of lipids) further contributed to the observed enhancement in the 
carbon flux through the TCA cycle (Figure 2.3B) and on the energetic state. 
In fact, the energetic state of infected Sf9 cells was highly dependent on the 
CCI, as shown by the net specific ATP production rate (Figure 2.5). 
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Figure 2.6. Overview of the metabolic effects of baculovirus infection on the 
metabolism of Sf9 insect cells infected at (A) CCI 1 and (B) CCI 3. The size of the 
arrows is proportional to the alteration observed on the fluxes in cells infected with 
a high MOI when compared to uninfected cells, under each condition.  
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In light of our results, the cellular energetic state seems more likely to be 
the main limitation to BV assembly and/or protein synthesis, thus 
establishing the link between metabolic state and the cell density effect 
(see Chapter I for BV production results). It has been previously described 
that intracellular ATP levels greatly increase following infection in 
High-FiveTM cells (Olejnik et al., 2004), while total cellular ATP content 
determines virus replication in Vero cell cultures (Burgener et al., 2006). In 
this work, the cellular energetic state was drastically altered following 
infection, this alteration depending on the interplay of CCI and MOI and 
reflected by the cellular OUR (Figures 2.4 and 2.5). From our calculations, 
an increase of around 60% in specific OUR of Sf9 cells infected at a high 
MOI and a CCI of 1×106 cells/mL was determined, which is in accordance 
with the literature (Gotoh et al., 2004; Kamen et al., 1991, 1996; Lecina et 
al., 2006; Palomares et al., 2004). The extent of the increase was 
dependent on the MOI used, thus further supporting the fact that it was 
related to the infection mechanism. Some authors have previously shown 
the link between OUR, infection and protein production in the BVES (Lecina 
et al., 2006; Palomares et al., 2004; Kamen et al., 1991, 1996); in order to 
obtain good productivities, other authors have stated that oxygen 
concentration should be above 20% of air saturation (Taticek and Shuler, 
1997). However, the oxygen uptake rates estimated for infections in this 
work did not suggest a limitation at high cell densities, since these were still 
lower than for uninfected cells. In addition, as pointed out in Chapter I, a 
similar metabolic pattern was also observed in Sf9 cultures performed in 
oxygen-controlled bioreactors. 
Finally, the cell density at the time of infection drastically affected the 
post-infection behaviour of the cell line. Data presented in Chapter I 
supports the occurrence of a cell density effect on the replication of BV in 
Sf9 cells. In fact, specific yields were lower at the highest cell densities 
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assayed, an effect that was especially obvious when infection was 
performed at low MOI. If productivities are analyzed in view of the 
metabolic analysis herein presented, a clear correlation between a highly 
productive metabolic state and the enhancement of oxidative 
metabolism/energetic state of the cells can be drawn. The enhancement of 
the cellular energetic state following infection assessed at CCI 1 (Figure 
2.5) is a consequence of various alterations as schematically shown in 
Figure 2.6), leading together to increased fluxes in the central carbon 
pathways and augmented ATP synthesis. This shift in metabolism failed to 
occur at CCI 3, which explains the observed effect on BV replication. 
In conclusion, the results presented hereby demonstrate the linking of cell 
density and baculovirus infection with metabolic dynamics in insect cells. 
Many authors have pointed out medium exchange at the moment of 
infection as a suitable strategy to delay the onset of the cell density effect 
(Chapter I; Ikonomou et al., 2003; Palomares et al., 2006). Nutrient 
consumption and end-product accumulation in Sf9 cultures have already 
been analyzed and amino acids levels do not seem to be limiting. 
Moreover, glutamine limitation was shown to increase the consumption of 
other amino acids, mainly aspartate, glutamate and asparagine, reflecting 
metabolic flexibility (Bhatia et al., 1997; Ferrance et al., 1993; Öhman et al., 
1995), while some authors detected consumption of central metabolism 
organic acids (α-ketoglutarate, malate,  pyruvate, citrate and succinate), 
especially at the stationary phase (Bédard et al., 1993). Therefore, the 
connection of intracellular pools of amino acids and TCA cycle 
intermediaries seems to have a central role in the metabolic dynamics of 
insect cells. Despite the potency of MFA for determining intracellular fluxes, 
it can not be ascertained whether the metabolic alterations described 
herein are due to alteration of gene expression, inefficient channelling or 
partitioning of substrates/metabolites between cytosol and mitochondria. To 
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this respect, further characterization of Sf9 metabolism and physiology is 
needed. Moreover, the development of tailored strategies for improved 
metabolic performance is a promising challenge in order to optimize insect 
cells bioprocesses.  
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1. SUMMARY 
The baculovirus-insect cells system has been recognized as a potentially 
safe and suitable technology to produce gene therapy vectors. Efficient and 
robust production processes, able to deliver higher product concentrations, 
are however still needed to cope with increased requirements for 
manufacture. The work presented in this chapter describes a combined 
experimental and modeling effort to quantify and environmentally 
manipulate the metabolism of Spodoptera frugiperda cells, targeting high 
cell density production of baculovirus vectors. Culture medium 
supplementation with energetic metabolites pyruvate or α-ketoglutarate at 
the time of infection resulted in 6-7 fold higher specific baculovirus yields at 
high cell density when compared to control cultures. This pushed 
volumetric titers to levels higher than classical low cell density infections. A 
quantitative description of intracellular pathways is provided using 
metabolic flux analysis; a direct stimulation of carbon flow through the 
tricarboxylic acids cycle was observed. Analysis of flux partitioning 
coefficients at the pyruvate and α-ketoglutarate branch-points further 
revealed a metabolic transition to a more energetically active state, which 
was confirmed by increased intracellular adenosine triphosphate generation 
rates. These results represent a cost-efficient strategy for high cell density 
production of recombinant baculovirus vectors. 
 
2. INTRODUCTION 
A bottleneck which has been recognized for several years is the loss in 
productivity after infection above 1×106cells/mL, resulting not only in poor 
specific product yields, but also considerably lower volumetric titers (Caron 
et al., 1990; Chapter I). Efforts have been directed at optimizing upstream 
99 
Chapter III 
processing of baculovirus-insect cells system so as to meet product 
demands in industrially attractive processes (Ikonomou et al., 2003). 
However, most attempts to overcome this cell density effect in insect cells 
yielded only modest improvements, often requiring cumbersome protocols 
of medium exchange, impractical for large-scale manufacture.  
An efficient strategy to optimize the output in a relevant cellular process is 
to manipulate the carbon and nitrogen pathways of host cells 
(Stephanopoulos, 1999). Given the complexity of such biological systems, 
the rapid expansion of metabolic engineering approaches to attain these 
objectives has been associated with the development of modelling tools 
aiming to simulate and analyze the outcome of such manipulations. 
Stoichiometric analysis based on metabolite balancing is an established 
framework for the quantification of intracellular fluxes and their distribution 
within a network representative of the main cellular metabolic events. In 
particular, Metabolic Flux Analysis (MFA) is an enabling tool to estimate a 
metabolic state constrained by exchange fluxes of nutrients between cells 
and the environment (Stephanopoulos et al., 1998). It has been also 
successfully exploited to identify principal nodes in the primary metabolism 
which are characterized by significant changes in flux partitioning under 
different conditions, and thus can be regarded as potential control points for 
manipulation (van Gulik et al., 2000). 
The application of MFA to BV-infected insect cells was previously carried 
out in Chapter II to address the post-infection adaptations of insect cells 
metabolism. The identification of the energetic state as a reliable sensor of 
system productivity seems conclusive from these results, making possible 
the design of rational strategies for bioprocess optimization. In the present 
work, we hold to the same hypothesis and go a step further by manipulating 
the metabolic pathways of Spodoptera frugiperda Sf9 cells through medium 
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supplementation in order to boost recombinant BV production at high cell 
density. After testing key compounds as culture supplements, the 
stimulatory effects on the host energetic metabolism are quantified, 
confirming the potential of the strategy herein presented. 
 
3. MATERIALS AND METHODS 
Cell maintenance was performed as in the previous chapters. In the 
present Chapter, a different recombinant baculovirus, Ac-vp39egfp, kindly 
provided by Dr. K. Airenne (University of Kuopio, Finland) and coding for 
the baculovirus major structural capsid protein, vp39, fused N-terminally to 
a EGFP reporter (Kukkonen et al., 2003), was used. Viral amplification and 
titration were performed as previously described (Chapter I). 
 
3.1. Effect of medium supplementation on baculovirus production 
All cultures were inoculated at a cell density of 0.5×106 cells/mL in 125 mL 
spinner flasks (Wheaton, USA), operated as previously described. 
Infections with Ac-vp39egfp were carried out at a cell density of 3-4×106 
cells/mL, using a multiplicity of infection (MOI) of 0.1 IP/mL. A series of 
exploratory experiments was carried out with supplementation at the time of 
infection. All supplements and compounds fed to the cultures were 
chemically defined (Sigma-Aldrich, USA). Stock solutions of sodium 
pyruvate (Catalogue no.: P-5280), disodium α-ketoglutarate (Catalogue no.: 
K-3752) and L-glutamine (Catalogue no.: G-8540) were prepared in PBS, 
followed by sterile-filtration (0.22 μm). Concentrations were chosen so as to 
minimize culture medium dilution upon addition of Pyr, αKG and Gln to a 
final concentration of 12 mM, or combined addition of 12 mM Pyr plus 12 
101 
Chapter III 
mM αKG. Lipids (Catalogue no.: L-0288) and amino acids (Catalogue no.: 
R-7131) mixtures were diluted 1:100 and 1:50, respectively, following 
indications of the manufacturer. A low-protein Insect Medium Supplement 
(Catalogue no.: I-7267), developed as a serum replacement for cell growth 
and containing a proprietary mixture of amino acids, lipids, vitamins, growth 
factors and trace elements, was diluted 1:10. 
In order to optimize pyruvate feeding, cultures were performed varying the 
time of supplementation (24 h before infection) and the concentration (24 
mM). Furthermore, cultures with the addition of small amounts of pyruvate 
at defined time intervals were performed in order to simulate fed-batch 
conditions: 1) starting with 2 mM at the time of infection followed by the 
addition of 1.5 and 1 mM after 14 and 10 h intervals, respectively; 2) 
applying the same supplementation schedule but starting with 13 mM Pyr. 
Samples were collected at given time points and centrifuged at 1700×g for 
10 minutes, at room temperature. Cell-free sterile supernatants were stored 
at 4oC for later virus titration, or at - 20oC to measure the concentration of 
sugars, lactate, ammonia, amino acids and organic acids. 
 
3.2. Analytical procedures  
Quantification of medium glucose, lactate, ammonia, maltose, sucrose and 
amino acids was done as described in the previous chapters. For the 
analysis of the organic acids α-ketoglutarate and pyruvate, a HPLC method 
based on ion-exclusion was developed, using a 8×300 mm sugar SH1011 
column (Shodex, USA). Operating conditions included isocratic elution 
using 5 mM sulfuric acid, with a flow rate of 1 mL/min at room temperature. 
Column regeneration prior to and after analysis was accomplished 
overnight with 25 mM sulfuric acid at 0.5 mL/min. Both compounds were 
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detected by reading absorbance at 200 nm. Standards were prepared in 
SF900II medium and, along with samples, were filtered before injection. 
 
3.3. Statistical analysis  
Hypothesis testing on the comparison between volumetric titers from 
different infection strategies was performed using single-factor analysis of 
variance (ANOVA). The least significant difference (LSD) method was 
chosen for multiple contrasts. A 95 % confidence level was considered to 
be statistically significant. 
 
3.4. Metabolic flux analysis  
The model considers the main reactions of the central metabolism of Sf9 
cells as described in Chapter II. The alterations to the previous model are 
the inclusion of uptake fluxes of pyruvate and α-ketoglutarate, which were 
not considered before since these compounds are not found in the culture 
medium. The complete list of reactions is presented in Appendix 1. 
The updated model here considered totalizes 75 reactions (instead of the 
previous 73), with 52 internal (balanced) metabolites/cell components, 
defined by a 75×52 stoichiometric matrix. The resulting number of degrees 
of freedom is now 26, as computed by the number of total reactions (75) 
minus the rank of the stoichiometric matrix (49). 27 exchange fluxes were 
experimentally determined, including the uptake/production rates of Pyr and 
αKG, as well as the formation of biomass. For the cultures where Pyr or 
αKG were not supplemented, the corresponding uptake rates were set to 0. 
As before, three intracellular reaction rates, namely the intracellular 
hydrolysis of maltose and sucrose, and the synthesis of lactate from 
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pyruvate, were set equal to the respective extracellular measured rates. 
The resultant system of equations is overdetermined, with 4 redundant 
measurements. The weighted least squares method was used to calculate 
the model solution (Stephanopoulos et al., 1998). Overall, the carbon and 
nitrogen balances closed to an average 88% and 67%, respectively, for the 
different cultures presented in this chapter. 
Balanceable rates, which arise from system redundancy, were used to 
calculate model consistency as previously described (Wang and 
Stephanopoulos, 1983). Furthermore, the propagated impact of 
experimental errors on any individual unknown reaction rate was assessed 
by analyzing how much it varies with respect to small (infinitesimal) 
changes in the measured fluxes. Sensitivity equations are based only on 
the stoichiomtry of the metabolic network and can be found in Daae and 
Ison (1999). All computational tasks were performed using the 
FluxAnalyzer software (Klamt et al., 2003). 
 
4. RESULTS 
4.1. Uptake of pyruvate and α-ketoglutarate  
The rational followed in this work arises from the possibility to enhance 
energy production through purposeful alteration of the cellular environment, 
attempting to sustain consistently high ATP generation rates even after 
infection at high cell densities. Pyruvate, a central metabolite connecting 
glycolysis with the TCA cycle, and α-ketoglutarate, a TCA cycle 
intermediate bridging this pathway with glutamine utilization and nitrogen 
metabolism, were selected to directly enhance TCA cycle fluxes and boost 
energy generation in the cell. Sf9 cells were supplemented at the time of 
infection, according to the description in Materials and Methods. To our 
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knowledge, this is the first time either Pyr or αKG are added to insect cell 
cultures, although other media formulations exist that already contain low 
amounts of these and other carboxylic acids (Bédard et al., 1993). HPLC 
results show that SF900II medium does not contain detectable amounts of 
Pyr or αKG. 
The consumption of both Pyr and αKG by Sf9 cells is demonstrated by the 
analysis of culture supernatants (Figure 3.1). It takes approximately 96 h 
and 72 h to deplete 12 mM of Pyr or αKG added at the infection point, 
respectively, specific uptake rates being comparable to those of Glc (Table 
3.1). Interestingly, rather distinct profiles were observed for both 
compounds, possibly reflecting differences in the kinetics of associated 
transport systems. In agreement, combined addition of 12 mM Pyr plus 12 
mM αKG did not affect the uptake of each compound, since similar profiles 
were obtained in relation to their individual supplementation (data not 
shown; see Table 3.1 for specific uptake rates). The specific Pyr 
consumption rate increased by over two-fold during the initial phase 
post-infection when 24 mM were added instead of 12 mM (see Table 3.1), 
indicating that, in this concentration range, Pyr transporters and 
assimilation pathways are not saturated. 
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Figure 3.1. Time profiles of pyruvate and α-ketoglutarate concentrations after 
supplementation of the culture medium at the time of infection (hpi – hours 
post-infection). Cultures were infected at a CCI of 3-4×106 cells/mL with a MOI of 
0.1 IP/cell (see Materials and Methods for details). Results were obtained using ion 
exclusion chromatography as explained in Materials and Methods. 
 
4.2. Effect of metabolic supplements on baculovirus production 
Supplementation schemes based on carboxylic acids and glutamine were 
tested in order to steer TCA cycle activity and positively impact baculovirus 
productivity. It should be highlighted that all cultures were infected and 
supplemented at high cell densities of 3-4×106 cells/mL. Therefore, in order 
to rule-out possible nutrient limitations, lipids and amino acid cocktails, as 
well as a complete Insect Medium Supplement (see Materials and Methods 
for details), were also tested in separate cultures. 
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Table 3.1. Specific consumption/production rates of the main nutrients of Sf9 cells 
metabolism, expressed as nmol/106cells/h, after infection at 3-4×106cells/mL and 
culture supplementation as described in Materials and Methods. Shown are 
average rates for the initial 48-72 h post-infection (phase I). Standard deviations 
are omitted for simplicity. 
 Control 
12mM 
Pyr 
12mM 
αKG 
12mM 
Gln 
Pyr + 
αKG 
24mM 
Pyr 
Glc -45.297 -47.938 -54.824 -40.805 -28.403 -14.861 
Lac 3.719 3.532 7.146 4.766 11.882 11.696 
Sucr 0 -6.573 0 0 -1.335 -5.562 
Malt -4.115 -6.974 0 -2.559 -5.099 -6.166 
Pyr n.a. -30.806 n.a. n.a. -44.944 -66.108 
αKG n.a. n.a. -60.501 n.a. -50.352 n.a. 
Amm 1.441 -1.946 -5.066 0.574 -5.916 -0.519 
Asp -2.811 -2.112 -11.936 -2.938 -8.991 -3.408 
Glu -4.500 0.471 0.636 -3.812 11.179 0.465 
Ser -3.788 -3.060 -4.320 -4.537 -4.823 -2.854 
Asn -0.903 -1.598 -4.015 -3.585 -1.795 -3.627 
Gly -0.544 0.869 -0.894 -2.880 -0.676 0.041 
Gln -7.842 -4.143 -15.846 -12.104 -12.108 -12.614 
Thr -1.104 -0.904 -1.700 -1.922 -1.770 -1.007 
Ala 19.365 21.366 20.886 24.219 20.925 22.921 
Pro -1.454 -0.192 -1.311 -1.291 -1.334 -1.106 
Tyr -1.185 -0.027 -1.021 -1.093 -0.806 -0.862 
Val -1.601 -0.842 -2.291 -3.264 -2.893 -0.695 
Met -1.662 -0.616 -2.005 -3.553 -2.491 -2.065 
Ile -1.528 -0.558 -1.888 -3.504 -3.026 -0.897 
Leu -2.208 -1.047 -2.446 -2.820 -2.808 -1.300 
Phe -1.294 -0.306 -2.150 -0.495 -2.173 -3.063 
His -0.503 -0.028 -0.563 -1.098 -0.141 -0.713 
Arg -1.467 -0.250 -2.576 -1.838 -1.903 -2.300 
Lys -0.571 -2.453 -2.473 -0.509 -3.270 -0.090 
Cys -0.229 -0.108 -1.676 -0.518 -1.888 -0.835 
Growth rate 
(/h) 
0.006 0.004 0.008 0.004 0.002 0.002 
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Figure 3.2A summarizes the results of BV production obtained from these 
exploratory experiments. Individual addition of 12 mM Pyr or 12 mM αKG 
resulted in significantly higher volumetric titers in comparison to the 
non-supplemented control (p<0.001), even reaching levels higher than the 
ones obtained from classical low cell density cultures (6.64±2.76×107 
IP/mL; p<0.01). Accordingly, specific yields increased on average 6-7 fold 
by individually adding Pyr or αKG, respectively (Figure 3.2B). A less 
pronounced but still significant improvement was obtained when these 
components were supplemented in conjunction (p<0.01), while neither the 
addition of 12 mM Gln, Gln plus Pyr (12 mM each), amino acids, lipids or 
complete Insect Medium Supplement resulted in significant production 
improvements. These results indicate that nutrient exhaustion is not the 
primary cause of decreased production levels at high cell density, while the 
uptake of energy-generating metabolic intermediates positively impacted 
cellular productivity. 
 
4.3. Quantification of metabolic fluxes to evaluate baculovirus 
production 
Metabolic flux analysis was used to assess the effects of infection and 
medium supplementation on cellular metabolism. The criterion for 
performing MFA was based on the highest baculovirus titers/specific yields 
obtained (12 mM Pyr, αKG, Pyr+αKG, 24 mM Pyr), including a control and 
a non-effective supplementation (12 mM Gln) for comparison. For the 
calculation of metabolic fluxes, culture time was divided in two 
post-infection phases: phase I extends from the time of infection until 48-72 
hpi, when the viable cells reach the maximum concentration, while phase II 
encompasses the remaining culture time until harvest (Figure 3.4). The 
following sub-sections provide a comprehensive analysis of the metabolic 
events undergone by cells in each supplementation setting. 
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Figure 3.2. Effect of medium supplementation on Ac-vp39egfp production. All 
supplements were added at infection time. Cultures were infected at a CCI of 
3-4×106 cells/mL with a MOI of 0.1 IP/cell. IMS refers to Insect Medium 
Supplement, described in Materials and Methods. (A) Average volumetric titers 
obtained at the end of the culture. Statistical significance against the control was 
assessed using at least 2 titration replicates (* p<0.01, ** p<0.001). (B) - Virus 
specific yields calculated as the final titer divided by either the mean cell 
concentration after infection (/MCC) or the cell concentration at infection (/CCI).  
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A priori, selecting between Pyr or αKG as medium additives is not 
straightforward since considerable differences in virus production are not 
apparent. In terms of metabolism, both compounds can be inter-converted 
in mitochondria through the TCA cycle. Because the feeding time, feeding 
regimen and total quantity supplied could result in further improvement of 
productivity, Pyr was chosen as a model compound for further optimization 
studies (Figure 3.3). Supplementing the culture before infection attempted 
to stimulate metabolic activity and thus cellular responsiveness to virus 
replication. On the other hand, high and low Pyr concentration fed-batches 
could lead to a more efficient allocation of nutrient sources and diminished 
overflow metabolism. However, neither of these approaches allowed 
surpassing the BV yields obtained with one-time addition of 12 mM Pyr, 
while doubling this concentration yielded very similar results. A 
cost-effective production process at high cell density based on one-time 
supplementation of Pyr or αKG can therefore be perceived. 
Network consistency and sensitivity analyses. In all scenarios, the 
consistency index h was below the χ2 value within a 95% confidence 
interval. This condition indicates that the model is well-posed and that no 
gross measurement errors are being propagated in the measured fluxes. 
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Figure 3.3. Baculovirus volumetric titers (A) and specific yields (B) for experiments 
with different schemes of pyruvate supplementation. All cultures were infected at 3-
4×106 cells/mL using a MOI of 0.1 IP/cell. See Materials and Methods for 
experimental details.  Statistical significance against the control was established 
using at least 2 titration replicates (** p<0.001). 
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Figure 3.4. Time profiles of viable Sf9 cells. All cultures were infected at 3-4×106 
cells/mL using a MOI of 0.1 IP/cell. Supplementations were performed as described 
in Materials and Methods. Dashed lines indicate phases used for flux analysis. See 
the text for details. 
The sensitivities of all 45 unknown reactions (excluding intracellular defined 
rates) were calculated with respect to each of the 27 measured fluxes. It is 
shown that fluxes through the central carbon metabolism and energetic 
reactions are less affected by noise in experimental data (Figure 3.5). 
Maximum relative variations do not go beyond 2-3% for glycolysis, the TCA 
cycle, NADH/FADH2 respiration and ATP generation rates, attesting the 
robustness of these pathways. The most affected fluxes, namely catabolic 
reactions of most essential and non-essential amino acids, are 
characterized by having low absolute rates and the metabolites involved 
have a lower participation in other cellular pathways. However, important 
reactions associated with nitrogen metabolism are among the least 
sensitive to measurement uncertainty, owing to the dampening effect 
caused by a higher connectivity to other pathways of the associated 
metabolites (Gln, Glu, Ala, αKG, Amm) and considerably higher fluxes. 
These reactions include the activities of GOGAT, AspAT, GDH and AlaAT, 
whose relative sensitivities do not go beyond 19%. Overall, the cellular 
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energetic state seems fairly robust and resilient to small changes in the 
extracellular environment, in conjunction with the overall carbon and 
nitrogen flows. 
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Figure 3.5. Sensitivity analysis of the intracellular unknown reactions with respect 
to uncertainty in experimentally determined fluxes (0-5 – relative variation of 
unknown flux with respect to unit variation in known flux). Equations used are 
described in Materials and Methods, and were computed using FluxAnalyzer 
(Klamt et al., 2003). 
Central carbon pathways: glycolysis and TCA cycle. In this section, the 
central carbon pathways of Sf9 cells subjected to infection and selected 
supplementation strategies are analyzed. Enhancing the activity of these 
pathways was one of the main purposes of the present study, as this would 
influence the cellular energetic state.  
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Figure 3.6A shows the main adaptations in the glycolytic fluxes to the 
different infection strategies. An obvious observation are the lower fluxes 
during the second phase (from 48-72 hpi until harvest), when cellular 
division no longer compensates for accentuated death rates, as the main 
viral replication events have already taken place (Roldão et al., 2008). This 
phase is characterized by a markedly lower consumption rate of glucose, 
while maltose and sucrose uptake rates are only slightly enhanced (Table 
3.2). Focusing on the initial phase after infection, considerable differences 
are obvious between different cultures, with the overall activity of the 
glycolytic pathway peaking after supplementation with 12 mM Pyr. In all 
other situations, activities were comparable to or smaller than in control 
cultures, specifically after supplementation with Pyr+αKG (12 mM each) or 
24 mM Pyr. These results are highly correlated with the decreased Glc 
uptake rates observed (Table 3.1), and has also been previously observed 
in mammalian cell lines upon supplementation with Pyr or αKG (Genzel et 
al., 2005; Hassell and Butler, 1990), possibly reflecting a feed-back 
controlling effect on the activity of glycolytic enzymes. On the other hand, 
the higher glycolytic flux after adding only 12mM Pyr resulted from a net 
uptake of sucrose, which was not observed in the control. Whilst glucose is 
considered as the preferred carbon source in insect cells, the consumption 
of disaccharides such as maltose and sucrose has been already reported 
(Bhatia et al., 1997; Chapter II). Interestingly, in our work sucrose 
consumption coincided with Pyr supplementation, individually or in 
combination. 
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Figure 3.6. Fluxes through the main carbon pathways of Sf9 cells after infection at 
high cell density, subjected to different supplementation strategies: (A) Glycolytic 
fluxes and (B) TCA cycle reactions. I, II represent the initial (from infection until 48-
72 hpi) and late (from 48-72 hpi until harvest) metabolic phases, respectively. Error 
bars correspond to standard deviations computed with the FluxAnalyzer software.  
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Table 3.2. Specific consumption/production rates of the main nutrients of Sf9 cells 
metabolism (nmol/106cells/h), for phase II post-infection (48-72 h until harvest). 
Supplementation strategies are described in Materials and Methods. 
 Control 
12mM 
Pyr 
12mM 
αKG 
12mM 
Gln 
Pyr +
αKG 
24mM 
Pyr 
Glc -24.461 -8.222 -21.478 -32.000 -18.181 -19.930 
Lac -3.445 -4.994 -6.238 -5.372 -7.431 -19.900 
Sucr 0 -8.746 0 0 -1.671 -7.459 
Malt -4.832 -9.280 0 -3.122 -6.475 -8.269 
Pyr n.a. -0.543 n.a. n.a. -13.992 -17.015 
αKG n.a. n.a. -2.230 n.a. -0.535 n.a. 
Amm 0.481 -4.494 -2.797 0.700 -6.371 -14.495 
Asp -3.866 -9.752 -8.210 -3.585 -12.027 -18.212 
Glu -1.735 0.596 0.720 -4.650 1.429 0.554 
Ser -2.607 -2.752 -2.885 -2.084 -1.604 -3.584 
Asn -1.977 -2.021 -1.801 -2.551 -2.258 -4.928 
Gly -0.613 -0.082 0.667 -0.338 0.043 0.049 
Gln -1.732 -2.908 -3.682 -6.213 -1.258 -0.475 
Thr -0.524 -0.308 -0.401 -0.303 -0.094 -0.679 
Ala 6.852 5.743 19.317 13.955 14.604 16.205 
Pro 0.286 -0.262 0.315 -1.494 -0.876 -0.249 
Tyr -0.111 -0.356 -0.203 -0.601 -0.438 -0.115 
Val -0.293 -0.472 -0.194 -0.379 -0.363 -0.828 
Met -0.005 -0.781 -0.727 -1.416 -1.490 -1.855 
Ile -0.092 -0.674 -0.313 -0.558 -0.628 -1.756 
Leu -0.593 -0.677 -0.676 -0.708 -0.367 -0.625 
Phe -1.467 -0.400 -0.528 -0.604 -1.757 -1.044 
His -0.118 -0.039 -0.012 -0.328 -0.176 -0.356 
Arg -0.603 -0.286 -0.230 -0.164 0.449 -0.382 
Lys -0.546 0.000 0 -0.621 0 -0.107 
Cys -0.207 -0.124 -0.634 -0.632 0.123 -0.078 
Growth rate 
(/h) 
0 0 0 0 0 0 
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As for the TCA cycle activity, an obvious up-shift can be seen after feeding 
cells with either Pyr, αKG or Pyr and αKG in combination, during the first 
phase post-infection (Figure 3.6B). Reaction rates increased to levels 
ranging between 173 and 177 nmol/106cells/h, approaching those obtained 
after infections performed at a low cell density of 1×106 cells/mL (Chapter 
II). This increment was lower for the cultures supplemented with 24 mM 
Pyr, owing to the strong inhibition of Glc consumption (Table 3.1). 
Interestingly, a bi-partitioning of TCA cycle rates can be seen, especially 
after the addition of αKG, with a higher flux through metabolites 
downstream the αKG node, due to an enhancement in carbon entrance. 
The incorporation of carbon backbones derived from amino acids at αKG 
also contributed to the overall activity of the TCA cycle. It has been 
previously observed that insect cells have a preference for the uptake of 
amino acids over their synthesis, even for the case of non-essential amino 
acids (Chapter I and II, Ferrance et al., 1993). Gln and Ser had the highest 
contribution in control cultures, whereas the supplementation of organic 
acids and Gln also elicited the uptake of other essential and non-essential 
amino acids (Table 3.1). As in the case of glycolysis, TCA cycle activities 
decreased considerably after the initial 48-72 hpi, owing not only to 
decreased consumption rates of sugars and organic acids, but also to a 
significant inhibition of amino acids consumption, particularly Gln (Table 
3.2), reinforcing the metabolic contraction previously mentioned. On the 
whole, these observations indicate that the uptake of either 12 mM Pyr or 
12 mM αKG efficiently boosted TCA cycle fluxes after high cell density 
infection, building on the carbon flow and energy generation in the cell, 
without repressing glucose consumption. 
Glutaminolysis and nitrogen metabolism. The contribution of amino acids 
integration into the TCA cycle was already addressed in the previous 
sub-section; a more in-depth analysis can be found in Chapter II. Here, 
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attention will be given to selected reactions related with nitrogen 
metabolism during phase I post-infection, as the main metabolic 
adaptations to the supplementation strategies employed are more evident 
during this time period. It should be noted that the following analysis in not 
compromised by the fact that the nitrogen balance closed to an average 
63%; this balance is mostly affected by unavoidable experimental errors in 
the biomass formation measurements, as well as uncertainty in its 
elementary composition (for details, see Chapter II). 
Glutamine consumption was preferential among all the amino acids, largely 
driving nitrogen inflow to the cells (Table 3.1). As shown in Figure 3.7, 
GOGAT activity closely followed the uptake rates of Gln. Through the 
concerted activity of GOGAT and AlaAT, Gln-derived ammonia could be 
efficiently transferred to Pyr for the production of Ala, the main by-product 
released to the culture medium. While Sf9 insect cells do not secrete 
significant amounts of Amm (Drews et al., 2000), Ala production was not 
significantly affected by the supplementation of Pyr and/or αKG, whereby 
added carboxylic acids were not primarily directed to an increment in AlaAT 
activity. Conversely, Gln addition resulted in a slightly higher Ala production 
rate, evidenced by increased fluxes through AlaAT and GOGAT. 
Interestingly, Amm was consumed in every case when organic acids were 
added to the cultures, correlating with the production of Glu through GDH. 
Negative GDH activities driving glutamate formation from ammonia and 
α-ketoglutarate condensation have been observed in Chapter II. In fact, this 
reaction is responsible for the ability of S. frugiperda cell lines to synthesize 
Glu and Gln from Amm supplied to the culture medium (Öhman et al., 
1996). This can be seen more markedly in the case of supplementation 
with Pyr plus αKG, owing to the accretion effect on the pool of αKG (Figure 
3.7). 
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Figure 3.7. (A) Consumption (negative) and production (positive) fluxes of amino 
acids involved in nitrogen metabolism after infection. (B) Reaction rates of the main 
nitrogen pathways in Sf9 cells metabolism calculated as model outputs in 
FluxAnalyzer. A negative rate indicates that a reversible reaction proceeds in the 
opposite direction, as defined in Appendix 1. 
From this analysis, it is evident how Sf9 cells can efficiently handle excess 
nitrogen intake through the flexible and combined activity of different 
reactions cooperating in this task. Importantly, the strategies that 
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contributed mostly to improve cellular productivity coped with an efficient 
control of nitrogen homeostasis, without a significant increment in alanine 
excretion. 
Analysis of pyruvate and α-ketoglutarate metabolic nodes. Taking a closer 
look at key nodes of cellular metabolism offers valuable information on the 
fine-tuning of flux distributions in response to perturbations. Previous 
studies on various metabolic adaptations of microorganisms attest the 
importance of this evaluation (Vallino and Stephanopoulos, 1993; Zhu and 
Shimizu, 2005). This is even more critical when the manipulations 
attempted in the present work targeted the two main crossroads within the 
central carbon and nitrogen pathways, i. e., the Pyr and αKG branch-points.  
Figure 3.8 schematizes the metabolic partitioning at the Pyr node occurring 
during the initial 48-72 hpi with the different supplementation schemes. 
Besides the partitioning coefficients associated with inflow and outflow 
reactions, significant increments or decreases in net reaction rates are 
highlighted. It is clear from the control that Sf9 cells have a rather efficient 
metabolism, with 80% of the Pyr formed being channelled into the TCA 
cycle. These results match our previous observations in Chapter II, also 
fitting with determinations by others (Neermann and Wagner, 1996). While 
the addition of Gln did not significantly affect the ratio between glycolytic 
(Pyr coming from PEP) and malic enzyme (Pyr coming from Mal) inflow 
reactions, Ala production was strongly enhanced (see Figure 3.7), resulting 
in a lower efficiency in the generation of ACoA. Noteworthy are the 
alterations observed after feeding cells with Pyr, namely a higher net flux 
towards the formation of ACoA, slightly increasing its partitioning coefficient 
in comparison to the control. As a result of higher Pyr consumption, the 
inflow contribution from malate decreased considerably. In contrast, the 
generation of Pyr molecules from Mal increased substantially when the 
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supplement was αKG, significantly rising the coefficient partitioning of this 
reaction. This observation supports what has already been mentioned on 
the characteristic behaviour of the TCA cycle after αKG supplementation 
(Figure 3.6B). In fact, the build up of the αKG pool leads to higher fluxes 
towards the formation of Mal, which needed to be apportioned into the 
formation of both OAA and Pyr, ensuring TCA cycle functionality and 
avoiding the accumulation of metabolic intermediates. Consequently, an 
indirect plumping of the Pyr pool after αKG supplementation resulted also in 
increased fluxes towards Lac production (see Table 3.1), although the 
outflow partitioning coefficients remained essentially unaltered (Figure 3.8).  
In a similar way, metabolic partitioning at the αKG node shows that the 
addition of Pyr or αKG resulted in a similar inflow and outflow flux 
partitioning when compared to the control (Figure 3.9). The main alterations 
in net fluxes were somewhat expected from the build up of the intracellular 
Pyr and αKG pools. Interestingly, addition of αKG resulted in an enhanced 
GOGAT activity, coping with the higher Gln uptake rate observed in this 
case (Table 3.1, Figure 3.7). On the other hand, a completely different 
scenario can be recognized when Gln was the supplement chosen, with 
partitioning coefficients of AlaAT and GOGAT/GDH catalyzed reactions 
increasing in relation to the TCA cycle reactions. 
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Figure 3.8. Metabolic partitioning coefficients at the pyruvate node of infected Sf9 
cells. A bold arrow indicates a net flux increase by at least 50% in relation to the 
control. A dashed arrow represents a 50% decrease or more. Coefficients were 
calculated based on all reaction rates leading to the formation or depletion of 
pyruvate in each case (see Appendix 2). Only the most representative pathways 
are pictured: Inflow reactions - ME (Mal), PK (PEP); Outflow reactions - PDH 
(ACoA), AlaAT (Ala), LDH (Lac). 
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Figure 3.9. Metabolic partitioning coefficients at the α-ketoglutarate node of 
infected Sf9 cells. A bold arrow indicates a net flux increase by at least 50% in 
relation to the control. A dashed arrow represents a 50% decrease or more. 
Coefficients were calculated based on all reaction rates leading to the formation or 
depletion of pyruvate in each case (see Appendix 2). The most representative 
pathways include: Inflow reactions – ICDH (Isocitrate), AlaAT (Pyr->Ala); Outflow 
reactions – αKGDH (SuCoA), GOGAT (Gln->Glu), GDH (Glu). The reaction 
catalyzed by ICDH is part of a lumped route in the model (see Appendix 2). 
The results above show that both Pyr and αKG additions resulted in an 
enhancement of fluxes through the TCA cycle, maintaining the already 
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efficient outflow flux partitioning at both metabolic nodes. Additionally, Pyr 
addition did not increase overflow metabolism, while the addition of αKG 
considerably increased the formation of Lac. In striking contrast, the 
addition of Gln clearly shows that nitrogen metabolism gained ground 
against the central carbon pathways, with potential negative implications for 
the cellular energetic state.  
Energetic metabolism: respiration and ATP synthesis. Most of the 
metabolic adaptations here reported have as a corollary the capacity of 
cells to generate energy in the form of ATP. Figure 3.10 shows the output 
model estimations for the main respiratory events and ATP synthesis 
occurring during phase I post-infection. It is clear how the net rate of ATP 
formation closely follows that of NADH respiration, which is known to have 
the largest contribution for the proton gradient across the inner 
mitochondrial membrane (Voet and Voet, 1995). In this work, a direct link 
between the energetic state of cells and the flow through the TCA cycle, 
where the majority of NADH equivalents are generated, can be established. 
Successful supplementation with key TCA cycle intermediates resulted in 
an anaplerotic effect causing the flow through the TCA cycle to increase, 
which in turn led to superior ATP synthesis rates. These were as high as 
2642 and 2170 nmol/106cells/h during the initial 48-72 hpi after 
supplementation with 12 mM Pyr or 12 mM αKG, respectively, 
corresponding to a mean 54% increase with respect to the control. This 
confirms MFA estimations by Sidorenko et al. (2008) performed in 
Madin-Darby canine kidney (MDCK) cells, yielding much higher net ATP 
synthesis rates for pyruvate-containing than for glutamine-containing media 
used as control. Importantly, a parallel up-shift in the estimated specific 
oxygen uptake rate (OUR) was observed, corroborating our previous 
observations that limitations in oxygen availability are not likely the main 
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cause for poor virus replication. A direct correlation can then be envisaged 
between target product specific yields and cellular energetic capacity. 
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Figure 3.10. Estimation of respiratory fluxes (left vertical axis) and net specific ATP 
synthesis rates in Sf9 cells during phase I post-infection. Reactions listed in 
Appendix 1 were considered as the only sources/sinks for ATP. Error bars are 
standard deviations computed with the FluxAnalyzer software. 
 
5. DISCUSSION 
The importance of the high-energy molecule ATP in industrial production 
processes has received much attention during the past decades, extending 
the border line of metabolic engineering (Zhou et al., 2009). Both 
mitochondrial respiration and ATP synthesis play a fundamental role in 
metabolism, largely determining the throughput and ability of cells to thrive 
in different environments. In fact, a central aspect determining cellular 
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responsiveness to virus replication seems to be the capacity to maintain an 
active metabolic state. Measurements of intracellular ATP content have 
been used to monitor infection and recombinant protein production in insect 
cell cultures (Olejnik et al., 2004), while total cellular ATP content has been 
shown to determine virus replication in Vero cell cultures (Burgener et al., 
2006). 
Both the TCA cycle and glycolysis provide most of the redox equivalents for 
cellular respiration, also contributing to ATP synthesis through 
substrate-level phosphorylation (Voet and Voet, 1995). Transfecting cells to 
express key enzymes bridging glucose utilization and oxidation through the 
TCA cycle has been previously attempted in some mammalian cell lines for 
enhanced recombinant protein production and decreased lactate 
accumulation (Irani et al., 1999; Kim and Lee, 2007). However, this is a frail 
strategy to be carried in S. frugiperda-derived cells, since they were shown 
to already possess a fully functional TCA cycle and accumulate low levels 
of lactate (Neermann and Wagner, 1996), suggesting that TCA cycle 
enzymatic activities are not limiting. Alternatively, feeding ATP directly to 
the cells holds relevant drawbacks, mainly due to higher costs involved and 
to the inhibitory effect upon glycolytic rates demonstrated in eukaryotic 
hosts, which could compromise cellular productivity (Larsson et al., 2000). 
For these reasons, supplementation schemes composed by intermediates 
involved in central metabolic pathways, such as pyruvate and 
α-ketoglutarate, were attempted to directly enhance TCA cycle fluxes and 
boost energy generation in the cell. To the best of our knowledge, the 
supplementation of these compounds to insect cells cultures has not been 
reported before. 
The use of organic acids as medium additives in previous studies of 
mammalian cell culture attempted at reducing ammonia production by 
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substituting glutamine in the culture medium (Genzel et al., 2005; Hassell 
and Butler, 1990). Feeding hybridoma cell lines with αKG has also been 
exploited as a strategy to increase monoclonal antibody production 
(Nilsang et al., 2008). Although Pyr and αKG transporters have not been 
specifically described in insect cells, a H+-monocarboxylate co-transporter 
is well described in mammalian plasma membranes, facilitating the 
diffusion of Pyr along with L-lactate and a wide range of other aliphatic 
monocarboxylates (Poole and Halestrap, 1993). αKG transporters are 
poorly described in the literature, though some mechanisms have been 
reported in mammals, including a Na+-dependent carrier in perfused rat 
liver with competition by different dicarboxylic acids (Stoll and Haussinger, 
1991), and a carrier-independent diffusion process in fibroblasts (Aussel et 
al., 1996). In the present work, we could accurately measure concentration 
profiles of Pyr and αKG in culture supernatants, and demonstrate that Sf9 
cells readily uptake these metabolites in a non-competitive manner (Figure 
3.1). 
The interpretation of baculovirus production results is not straightforward in 
the light of previous theories relating lower productivities at high cell density 
with nutrient depletion (Bédard et al., 1994; Bhatia et al., 1997). In fact, 
neither glucose nor any amino acid reached limiting concentrations before 
harvest time (data not shown), whereas supplementation of amino acids or 
lipids did not have an effect on productivity (see Figure 3.2). Interestingly, 
the addition of the Insect Medium Supplement, a complete nutritious and 
low-protein formulation developed as a serum replacement for insect cell 
growth, also did not impact significantly baculovirus production. These 
discrepancies could be explained by the different culture media used: the 
medium used in this work, SF900 II serum-free, has an exceptionally rich 
formulation, designed to support the high cell densities currently attained in 
insect cell cultures. Furthermore, the significant up-shift in the estimated 
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OUR observed after culture supplementation with Pyr and/or αKG further 
suggests that limitations in oxidative metabolism are not primarily 
responsible for decreased productivities at high cell densities. In face of 
these observations, we further reinforce the hypothesis carried along the 
previous chapters that the extracellular accumulation of conditioned 
medium factors down-regulating overall metabolic activity constitutes the 
main restraint to nutrient utilization at high cell densities, probably a 
protection mechanism avoiding medium exhaustion under stress conditions 
(Doverskog et al., 1997; Doverskog et al., 2000). The direct stimulation of 
central carbon pathways by supplemented Pyr or αKG seems to have 
by-passed most of these repressing mechanisms, with an overall positive 
effect on the cellular energetic and productive states. 
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1. SUMMARY 
Stoichiometric models constitute the basic framework for fluxome 
quantification in the realm of metabolic engineering. A recurrent bottleneck, 
however, is the establishment of consistent stoichiometric models for the 
synthesis of recombinant proteins or viruses. Although optimization 
algorithms for in silico metabolic redesign have been developed in the 
context of genome-scale stoichiometric models for small molecule 
production, still rudimentary knowledge of how different cellular levels are 
regulated and phenotypically expressed prevents their full applicability for 
complex product optimization. To address this issue, a hybrid framework 
was developed combining classical metabolic flux analysis with projection 
to latent structures to further link estimated metabolic fluxes with measured 
productivities. We first explored the functional metabolic decomposition of a 
baculovirus vector-producing insect cell line from experimental data, 
highlighting the TCA cycle and mitochondrial respiration as pathways 
strongly associated with viral replication. To reduce uncertainty in metabolic 
target identification, a Monte Carlo sampling method was used to select 
meaningful associations with the target, from which 66% of the estimated 
fluxome had to be screened out due to weak correlations and/or high 
estimation errors. The proposed hybrid model was then validated using a 
subset of independent experiments, enabling the accurate prediction of 
baculovirus productivity. Overall, the results indicate the hybrid metabolic 
flux analysis framework is an advantageous tool for metabolic identification 
and quantification in incomplete or ill-defined metabolic networks. 
 
2. INTRODUCTION 
The biotechnological industry is facing substantial pressure to achieve 
135 
Chapter IV 
global process optimization. Concomitantly, the exploitation of 
high-throughput cellular data to support metabolic engineering has 
intensified in recent years (Lee et al., 2005; Otero and Nielsen, 2010). At 
the top of the various “omic” layers, the metabolic fluxome resides as their 
integrated functional output, which in turn closely determines the 
phenotypic portrait of the cell, particularily productivity (Sauer, 2004). 
Therefore, the estimation of intracellular fluxes in stoichiometric models is 
essential (Gombert and Nielsen, 2000). 
 With the emergence of increasingly extensive genome annotations for 
several organisms, optimization algorithms for genome-wide fluxome 
estimations have become well popularized. Such estimations are based on 
flux balance analysis (FBA), which assumes a “metabolic objective” driving 
the behaviour of the cell (see for instance Kauffman et al., 2003). A set of 
derived frameworks have since been developed aiming to probe for 
genomic alterations (knock-outs, knock-ins, down-regulations and 
over-expressions) expected to yield better performances than the wild-type 
(Burgard et al., 2003; Patil et al., 2005; Pharkya and Maranas, 2006; 
Pharkya et al., 2004), and examples of successful FBA-driven predictions 
are available (Fong et al., 2005; Asadollahi, 2009). However, because 
fluxes are estimated in a landscape in which the amount of data is not 
enough to simply use metabolite balancing, as in small-scale metabolic flux 
analysis (MFA), the need for additional mathematical assumptions when 
searching for high yielding genetic alterations may render such predictions 
less dependable.  
In spite of their value, and regardless of size, currently available 
stoichiometric models by-pass a multi-layered web of regulatory events, 
thus constituting a simplification of cellular function (Oberhardt, 2009). 
Given the obvious gap between genome and fluxome, mutants “created” in 
silico by linear optimization/inspection may not exhibit the expected 
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metabolic behaviour in vivo. While methods for integration of regulatory and 
metabolic networks have been reported (Covert et al., 2008; Lee et al., 
2008; Kim and Reed, 2010), still fragmentary knowledge of kinetic and 
regulatory phenomena (e.g. transcriptional, translational, signalling), 
together with their cumbersome biological specificity (Herrgard, 2004), may 
preclude their full applicability in metabolic engineering. This is especially 
relevant when attempting to engineer complex, multi-genic phenotypes, 
such as improving the yields of recombinant proteins derived from animal 
cell cultures, for which reason stoichiometric models have been mostly 
confined to microbial systems producing small molecules (Kauffman et al., 
2003). In this respect, an additional important pitfall is the lack of 
mechanistic knowledge of processing pathways associated with the 
formation of proteins or viruses; simply lumping the necessary precursors in 
a set of synthesis reactions has proven a fruitless task since the 
stoichiometric requirements for these recombinant products are several 
orders of magnitude below those for host biomass formation, thus making 
their distinction practically impossible (Sidorenko and Reichl, 2004; 
Boghigian et al., 2010). As a result, the application of stoichiometric models 
to complex product formation has been restricted to the evaluation of 
optimal conditions for cell growth and metabolic efficiency rather than 
explicitly defining productivity in the models (Quek et al., 2010; Sheikh et 
al., 2005). 
These issues are herein addressed by proposing a hybrid 
stoichiometric/statistical framework to make sense of fluxome data either 
from small-scale or genome-scale metabolic models. In order to illustrate 
this approach, the metabolic behavior of the baculovirus-insect cells system 
is explored as a case-study for rapid bioprocess optimization. The results 
obtained in Chapter III are here combined with new data to present a 
scenario where MFA is employed to reliably estimate intracellular flux 
distributions in a small-scale network comprising the main pathways of 
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carbon and nitrogen flow. Then, projection to latent structures (PLS) (Wold 
et al., 2001) is used to search for correlations between a measured 
productivity target and the estimated metabolic state, whereby the inclusion 
of a statistical model allows filling the gaps in our knowledge of global 
regulation of anabolic processes. The ability of hybrid MFA to assign 
individual fluxes/pathways of central metabolism to cell-specific functions 
that cannot be completely defined in a stoichiometric description is 
demonstrated. 
 
3. MATERIALS AND METHODS 
Experimental data on infected Sf9 cultures used in this Chapter were 
obtained from Chapter 3. In addition, we simulated nutrient limitations by 
centrifuging cells prior to infection and ressuspending in a 1:1 dilution of 
conditioned medium with PBS buffer (adjusted to pH 6.1 and 370 mOsm). 
For AMP-activated protein kinase (AMPK) activation, aminoimidazole 
carboxamide ribonucleotide (Sigma Aldrich: A-9978) was added to the 
culture at 6-8h post-infection to a concentration of 500 μM (Sullivan et al., 
1994; Xiao et al., 2009). This kinase is a central energetic sensor in 
eukaryotic cells. Infections were performed with the recombinant 
baculovirus Ac-vp39egfp as previously described (Chapter III). 
 
 
3.1. Hybrid metabolic flux analysis and Monte Carlo sampling 
The input (predictor) data for hybrid MFA are the metabolic fluxes 
estimated by classical MFA in a well-described metabolic network. After 
standardization, the decomposition of the predictor matrix VeT (with different 
culture conditions/steady states as rows, and different fluxes as columns) is 
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performed iteratively and supervised by maximizing covariance with the 
target vector VtT. The result is the projection of the fluxome space into a 
“latent space” defined by a set of uncorrelated (orthogonal) latent variables 
(LVs): 
WVT Te ×= ,                                    (4) 
EQTV TTe +×= ,                    (5) 
where T is the matrix with LVs as columns, W is a matrix of weights, QT a 
matrix of “loadings”, and E a residuals matrix. Similarly, the target vector 
can also be decomposed using the same latent space as 
FPTV TTt +×= ,                               (6) 
with PT the corresponding loadings vector and F a vector of residuals. 
Finally, the linear model between the predictor and target variables is 
derived: 
FBVV Te
T
t +×= .                               (7) 
Here, B = W × PT is the column vector that maximizes the squared sample 
covariance between VtT and the latent variables in T (Boulesteix and 
Strimmer, 2006). It represents the set of regression coefficients establishing 
the statistical relationship between fluxome state and the target cellular 
function, containing quantitative and qualitative information on the potential 
impact that each flux has on the target variable. The main algorithm for 
these calculations is part of “The N-Way toolbox for MATLAB” (Andersson 
and Bro, 2000) and is described in Jong (1993). 
For the estimation of confidence intervals associated with each regression 
coefficient, 1000 fluxome states were randomly sampled considering 
normal error distributions associated with flux estimates that have been 
propagated in MFA calculations from an initial 16% error in measured 
exchange fluxes (including cellular growth rate). For the productivity target, 
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a 22% error was used (Roldão et al., 2009). PLS regression was then 
performed for the complete generated set of data, resulting in a 1001-sized 
population of regression coefficients for each flux. Confidence intervals 
were computed as 
dg)(0.975,(B)B T×±
∧σ ,              (8) 
with (B) the observed standard deviations of coefficients B and T(0.975,dg) 
the two-sided T-student distribution value for a 95% confidence level and 
number of degrees of freedom (dg) equal to 1001 (observations) minus 47 
(fluxes). All calculations were implemented by the authors in MATLAB 
(Version 7.0; Mathworks, USA).  
∧σ
 
3.2. Sensitivity analysis 
For the two scenarios where the measurement of product formation rate or 
cell growth rate are individually omitted from the complete model, the 
Jacobian of the corresponding overdetermined system (2) was calculated 
as 
( ) m#eVV AAJ me ×−= = 
jijm
e,i
v
v
,,
∂
∂
,             (3) 
representing the absolute sensitivity of each unknown flux to each 
metabolic constraint. This is the same equation used in Chapter III and 
described in Daae and Ison (1999). In order to compute fractional 
sensitivities for biomass and product synthesis rates, the corresponding (i,j) 
elements were appropriately factored with an average value of each 
measured metabolite consumption/production rate and the average value 
of measured cell growth rate or productivity, respectively, for all metabolic 
conditions. 
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3.3. Hierarchical clustering 
Groups of fluxes sharing similar strengths of association with productivity 
were hierarchically clustered on the two-dimensional space defined by the 
pair correlation coefficient/confidence interval. The Euclidian norm was 
chosen as distance measure. To evaluate if the classification presented in 
the dendrogram correlates well with the distance measurements between 
pairs of data objects, the cophenetic correlation coefficient (c) was 
calculated (Sokal and Rohlf, 1962). Values of c close to 1 indicate a good 
representation of the data. Additionally, for each link in the cluster tree, an 
inconsistency coefficient (I) was calculated, which compares the height of 
each link with that of neighbour links at the same level (Cordes et al., 
2002). The higher the value of I is, the less similar the objects are. Thus, 
when plotting the number of emerging tree clusters against decreasing I 
values, a steep discontinuity, along with the appearance of clusters with 
unacceptable small size, suggest a natural division in the dataset. All 
calculations were performed using predefined functions available in 
MATLAB (Statistics Toolbox, Multivariate Statistics section). 
 
4. RESULTS  
4.1. Limitations of classical metabolic flux analysis 
Supposing the composition of a recombinant product of interest is known 
(e.g. protein amino acids sequence or detailed virus structure), a lumped 
reaction system comprising all metabolic precursors in stoichiometric 
quantities to synthesize a unit amount of product can be formulated. If the 
number of measured flux constraints is high enough to yield a determined 
or overdetermined system, then an estimation of the rate of product 
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synthesis can be obtained (see Chapter II for a description of MFA). 
However, this estimation will generally be inaccurate, often lying outside 
feasible biological boundaries, even for a consistent, overdetermined 
system with carbon and nitrogen balances closed within experimental error. 
The problem of the ill-definition of protein/virus formation in a metabolic 
network is mathematically expressed by its extremely large sensitivity to the 
measured uptake and production metabolic fluxes. As a corollary, it is only 
possible to accurately estimate such a rate if all measurements are 
precisely known, devoid of experimental error. To illustrate this, a 
comprehensive metabolic model of Spodoptera frugiperda cells (Sf9) 
comprising a well-defined central carbon and nitrogen metabolism 
(Appendix 1; Chapter II and III) was combined with a set of biosynthesis 
reactions for recombinant baculovirus synthesis (Appendix 3; Bergold and 
Wellington, 1954; Wellington, 1954). The final system of equations is 
overdetermined with the same 4 redundant measurements as before. Then, 
the relative sensitivity of the rate of product formation in this metabolic 
network was compared to that of the cell growth rate (see Materials and 
Methods). As presented in Figure 4.1, the existence of measurement errors 
is significantly dampened when estimating the rate of biomass formation 
(μ), having sensitivity values lower than 1 (calculated as the fractional 
variation in μ produced by an infinitesimal fractional variation in a given 
measured flux). However, they are amplified when estimating the flux of 
baculovirus formation (vBV), often by several orders of magnitude.  
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Figure 4.1. Sensitivity analysis of virus production and biomass production fluxes. 
Sensitivity analysis of biomass or product synthesis estimations was performed 
when the measured value of each of these fluxes was individually omitted from the 
complete model, yielding an overdetermined system of equations (see text and 
Materials and Methods section). The estimation of fractional sensitivities was 
achieved by factoring the appropriate average value of measured metabolite 
consumption/production rates and average value of measured cell growth rate or 
productivity, respectively, from all available culture conditions (see Table 4.2). 
Horizontal axis marks indicate computed sensitivities are zero. 
If a representative scenario is chosen, the impact of individually omitting the 
measurements of µ or rBV, or of deleting the complete set of biomass or 
product synthesis reactions, can be assessed in terms of overall fluxome 
variation in relation to that estimated by the complete model (Table 4.1). As 
shown, leaving out µ has a small effect in the fluxome estimation; 
moreover, the respective estimated µ corresponds roughly to the 
measurement in the complete model, indicating that the assumed 
stoichiometry is consistent with experimental data. On the other hand, 
leaving out vBV has a more profound effect in the intracellular flux 
distribution, evidenced by the considerably higher total fluxome variation. 
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As expected, the estimated viral replication rate is completely unrealistic, 
even though the model remained consistent, evidencing that viral 
replication cannot be directly inferred from the nutrients uptake and 
metabolites production rates affected by experimental error. This is a result 
of the negligible requirement of anabolic precursors for viral synthesis as 
compared to biomass formation. Therefore, it is essentially impossible to 
accurately estimate how much complex product is being synthesized, per 
cell and unit time, for a given metabolic state. Finally, taking out reactions 
associated with virus biosynthesis has a virtually null effect on the 
remaining fluxes, which contrasts with the massive fluxome variation 
obtained after deleting reactions for biomass formation. It is important to 
note that model consistency is independent of incorporating the 
stoichiometry of virus formation. This clearly shows that the mechanisms of 
complex product synthesis are ill-defined in a purely stoichiometric 
description. 
Table 4.1. Impact of biomass and virus synthesis information on the estimation of 
Sf9 cells post-infection metabolism. 
 
Complete 
model 
W/o µ W/o vBV 
W/o biomass 
reactions 
W/o viral 
reactions 
Fluxome var. a - 12.2 32.5 370.2 0.0 
µ b 8.6 8.9 8.0 - 8.6 
vBV  c 920.5 920.5 3995861.2 920.6 - 
Redundancies d 4 3 3 4 4 
h / χ2 e 0.3 / 7.8 0.0 / 7.8 0.0 / 7.8 102.0 / 9.5 0.3 / 9.5 
aFluxome variation (%), calculated as the average relative variation of all 
intracellular fluxes estimated by the model, excluding biosynthetic reactions for 
biomass or virus formation; bAdjusted (underlined) or estimated specific biomass 
formation rate (/h × 1000); cAdjusted (underlined) or estimated specific viral 
synthesis rate (103 infectious particles (IP)/106 cells/h); dThe number of 
redundancies in an overdetermined model corresponds to flux measurements in 
excess of the degrees of freedom of the system (see Materials and Methods); eA 
consistency index (h) that is lower than the corresponding χ2 (95%) value indicates 
consistency between flux measurements and the assumed network stoichiometry 
in each case (see Materials and Methods). 
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4.2. Hybrid metabolic flux analysis 
In the absence of sufficient mechanistic detail, the unknown or ill-defined 
part of a metabolic network can be substituted by an empirical (statistical) 
sub-model bridging the well-defined stoichiometry with a given cellular 
function, such as the synthesis of a complex recombinant product (Figure 
4.2A). The herein proposed hybrid MFA takes advantage of using PLS to 
find a regression model between input fluxes, Ve (estimated through 
classical MFA), and a vector of target productivity, Vt, which is not directly 
linked with the known part of the network (Figure 4.2B). The result is a 
vector of regression coefficients (B) representing how strongly each flux 
correlates with the target. This statistical association can be used to derive 
hypothesis on how to perturb the metabolic network towards increased 
productivity (refer to Materials and Methods for a detailed mathematical 
description). 
To assess the performance of this methodology, original and previously 
obtained (Chapter III) MFA data were pooled together, comprising a diverse 
set of 13 independent infection cultures (Table 4.2). Included are infections 
performed with a recombinant baculovirus, at different cell densities, in 
different culture systems and subject to various supplementation and 
treatment schemes. In all experiments, the Sf9 insect cell line was infected 
at a low multiplicity of infection (number of infectious particles added per 
cell) in serum-free medium. Fluxes estimated by MFA were used as 
predictor data for the PLS model. In all cases, the pseudo-steady state 
hypothesis on intracellular metabolites was assumed, since extracellular 
metabolite profiles were approximately linear during the initial 48h to 72h 
productive phase after infection. Data from the end of infection cultures 
were not taken into account to avoid confounding effects due to cell lysis. 
As target, specific baculovirus productivities were measured as described 
in Chapter III, covering on the whole 3 orders of magnitude. 
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Figure 4.2. Data-driven framework for predictive metabolic flux analysis. 
(A) Schematic representation of a metabolic network with an unknown or ill-defined 
portion corresponding to the synthesis of a complex recombinant product. These 
poorly defined pathways are substituted by a statistical sub-model bridging the 
known well-defined stoichiometry with the target product formation rate. (B) Given 
a set of measured fluxes (Vm - usually exchange fluxes of metabolic consumption 
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and production), metabolic flux analysis is used to estimate the entire flux 
distribution (Ve) in a predefined metabolic network. Then, PLS is performed to find 
a linear regression model between the estimated fluxome and the vector of a 
measured target such as productivity, Vt. As a result, a list of regression 
coefficients representing how strongly each flux correlates with the target is 
obtained (B), making it possible to predict the productivity of independent cultures 
after metabolic manipulation. 
Table 4.2. Experimental cultures used for model establishment. 
# Virus CCIa 
Culture 
system 
Supplementation/
Treatmentb 
Productivityc References 
1 
Ac-vp39egfp 
1 
Spinner 
vessel 
- 1420.7 
Chapter III 
2 
3 
- 117.0 
3 Gln 174.3 
4 Amino acids mix 177.1 
5 IMS 227.3 
6 Pyr 644.2 
7 αKG 920.5 
8 Pyr/ αKG 462.4 
9 Pyr (24 mM) 455.2 
10 
Ac-vp39egfp 3 
Shake 
flask 
- 23.2 
This work 
11 - 29.1 
12 PBS (50%) 0.9 
13 AICAR 3.1 
In every case, cells were grown to the appropriate cell density in SF900II 
serum-free medium and infected with 0.1 infectious particles per cell; aCell 
concentration at infection (106 cells/mL); “1” and “3” stand for 1-1.5 and 3-4×106 
cells/mL, respectively; bNutrient supplementation and culture treatment were 
performed as described in Materials and Methods (see indicated references for 
details). IMS – complete insect medium supplement; cMeasured specific viral 
synthesis rate (103 IP/106 cells/h). 
Our PLS model was able to capture most of the variance in the target 
productivity, despite using only 3 latent variables to describe the input data 
(Figure 4.3A). Because in latent variable models, such as PLS, there is no 
direct relationship between predictor and target variables, the calculation of 
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reliable confidence intervals for the regression coefficients is not 
straightforward, limiting their interpretability. Namely, regression coefficients 
in PLS models have been found to reflect primarily the underlying latent 
structure of the data, rather than accounting for the error variances of the 
predictor variables (Burnham et al., 2001). To circumvent this problem, 
Monte Carlo sampling was used to generate 1000 data matrices based on 
the error variances of all 47 metabolic fluxes and specific baculovirus 
productivity. PLS models were then built on the generated data, allowing 
the estimation of confidence intervals associated with each regression 
coefficient. The procedure revealed that 31 out of 47 regression coefficients 
were not statistically meaningful, having strengths of association (α – here 
defined as the ratio between the regression coefficient and the respective 
confidence interval) lower than 1 (Figure 4.3B). It should be underlined that 
the flux discrimination criterion includes both observed correlations with the 
target and precision of measurement/estimation. 
In view of these results, engineering strategies aiming to increase carbon 
flow through central oxidative pathways, possibly by rearranging flux 
partitioning at key metabolic nodes or feeding energy-generating 
metabolites, could potentially be beneficial for virus replication. To this 
respect, it is possible to find in Table 4.2 a group of cultures that, based on 
previous empirical inspection, were purposefully designed to increase 
productivity by the addition of energy-generating metabolites (experiments 
6, 7, 8, 9) (Chapter III). Metabolic node rearrangement was not an issue 
since Sf9 cells naturally possess a highly efficient oxidative metabolism 
(Chapter II and III). Additionally, in face of preliminary simulations, we 
thought of some treatment to simulate a depressed energetic state and 
negatively impact productivity, namely through the addition of AICAR 
(experiment 13), a cell permeable AMP mimetic that strongly binds AMPK, 
inducing downstream effects typical of ATP starvation such as inhibition of 
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protein synthesis (Menze et al., 2005). This experiment, together with the 
substitution of half the culture medium by PBS (experiment 12), comprised 
the lower segment in the baculovirus productivity range. 
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Figure 4.3. Functional metabolic decomposition of baculovirus-producing Sf9 cells. 
(A) Performance of hybrid MFA in describing baculovirus productivity based on 
metabolic data from 13 independent cultures (see Table 4.2). In all cases, Sf9 
insect cells were infected with a low multiplicity of infection in serum-free medium. 
A total of 3 latent variables were used to describe the data. Productivity is 
expressed in 103 IP/106 cells/h. (B) In order to estimate confidence intervals for the 
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model regression coefficients, Monte Carlo sampling was used to generate 1000 
data matrices based on the error variances of all predictor and target variables (see 
Materials and Methods section for details). The strength of association (α) was 
defined as the regression coefficient to confidence interval ratio, allowing the 
exclusion of those fluxes with α values lower than 1. (C) After hierarchical 
clustering, the TCA cycle and mitochondrial respiration naturally arised as a closely 
connected group of fluxes strongly correlated with high productivities. With lighter 
association strengths, one additional cluster corresponds to the catabolization 
fluxes of the essential amino acids phenylalanine, methionine and histidine. 
Excluded fluxes (α<1) include: glycolysis, pentose-phosphate pathway, by-product 
formation, pyruvate recycling, amino acids metabolism, biomass synthesis and 
transhydrogenation. 
 
4.3. Predictive power 
To validate an empirical model it is mandatory to test its predictive power 
with new independent experiments not used in the calibration step. We 
selected the above mentioned subset of experiments (6, 7, 8, 9 and 13) to 
be used for validation. In a second validation strategy, the three 
experiments with the highest productivities (1, 6 and 7) were left aside as a 
means to prevent data interpolation. In both strategies, the number of latent 
variables was chosen based on maximum total variance explained 
(calibration and validation) and constrained by a limit of 3. As presented in 
Figure 4.4A, the productivities of experiments 6, 7, 8, 9 and 13 were 
reasonably predicted, considering the challenging partition of the data 
(validation 1), while the results for validation 2 were considerably sounder. 
More importantly, the hybrid MFA-PLS structure clearly outperformed 
classical MFA in modeling baculovirus production, as demonstrated by 
comparing the predicted productivities obtained in both validation data sets 
with the corresponding values predicted by MFA (Table 4.3).  
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In terms of metabolic decomposition, these models corroborate our 
previous conclusions. Indeed, the most important pathways for viral 
replication previously discriminated, namely TCA cycle and respiration, 
showed a significant correlation with productivity for both validation 
strategies (Figure 4.4B). Also for validation strategy 1, the catabolism of 
phenylalanine, methionine and histidine had again α values higher than 1, 
though other fluxes with lighter correlations were also selected. Overall, 
despite the somewhat limited collection of data, these results indicate the 
hybrid MFA framework should prove a valuable tool in designing metabolic 
optimization strategies for complex products, with potential applicability to a 
range of cellular systems. 
 
5. DISCUSSION  
In this chapter, a cost-effective hybrid methodology is reported to make 
sense of accessible fluxome data for rapid optimization of complex 
productivity phenotypes. PLS modelling is used in tandem with classical 
metabolic flux analysis to establish a link between an estimated metabolic 
state and system productivity, therefore providing a predictive in silico 
platform to assist genetic/environmental metabolic engineering when a 
well-defined stoichiometric description of product formation is not available. 
An important feature of PLS is that it decomposes complex data sets into 
subsets of uncorrelated vectors, called latent variables, while eliminating 
redundant information. This permits to address biological problems where 
the number of variables assessed largely exceeds the number of 
observations, reason why this method has gathered significance in 
interpreting “omic” data sets (Boulesteix and Strimmer, 2006). As reviewed 
in Teixeira et al. (2007), combining such data-mining tools with mechanistic 
models gives rise to hybrid parametric-nonparametric systems, which 
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enable cost-effective analysis of complex problems with fragmentary 
knowledge. 
Our method is conceived to perform on the basis of an informative, yet not 
exhaustive, preliminary set of experiments easily available at laboratory 
scale. It is especially suited to deal with complex products whose synthesis 
mechanisms are ill-defined by considering a simple stoichiometric 
description as part of a global metabolic model, or whose composition is 
unknown. Productivity enhancement in the case of simpler molecules, for 
instance amino acids or TCA cycle intermediaries, has been previously 
achieved by stoichiometric analysis of their respective synthesis pathways 
(Lee et al., 2007; Zelle et al., 2008). Here, the main output is the global 
identification of fluxes strongly correlated with a highly productive state, 
which are discriminated from a background of less significant metabolic 
reactions contributing to product synthesis. Thus, as opposed to classical 
MFA, our approach enables predicting the productivity in independent 
experiments based on a previous calibration, and the identification of 
metabolic targets for production optimization. This was demonstrated here 
by replicating the results obtained in Chapter III following a 
hypothesis-driven metabolic engineering strategy. In this respect, the 
estimation of reliable confidence intervals for the flux regression coefficients 
is crucial to remove a large portion of uncertainty in the systematic 
selection of metabolic targets, considerably improving the odds of 
successful experimental validation. Methods that assure a higher precision 
in fluxome estimations, such as isotopic tracer experiments (Sauer, 2006), 
could in principle expose other targets for manipulation. 
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Figure 4.4. Validation of predictive MFA for metabolic engineering. (A) To validate 
our framework as a powerful tool to assign targets for metabolic engineering, the 
complete set of 13 experiments was purposefully split into calibration and validation 
subsets in two manners. In strategy 1, experiments 6, 7, 8, 9 and 13, which have 
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been rationally designed to manipulate the cellular energetic state, were left aside 
for validation. In strategy 2, the top three producers (experiments 1, 6 and 7) were 
chosen as validation cultures to avoid data interpolation. The number of latent 
variables used to build the calibration models in each case was 1 and 3, 
respectively. Productivity is expressed in 103 IP/106 cells/h. (B) Metabolic 
decomposition for each validation strategy, showing the common selection of TCA 
cycle/respiration as important pathways for viral replication. Also for validation 
strategy 1, the catabolism of phenylalanine, methionine and histidine had  α values 
higher than 1, as well as other fluxes with lighter correlations with the target (other: 
catabolism of maltose, proline and tyrosine, formation of alanine). 
Table 4.3. Predictive power of the hybrid MFA-PLS structure compared to MFA. 
Experiment # Productivitya MFA prediction 
Hybrid MFA 
prediction 
1 1420.7 28915535.7 1214.6c 
6 644.2 -15477747.1 389.9c / 586.4b 
7 920.5 3995861.2 665.7c / 625.6b 
8 462.4 18837398.3 637.7b 
9 455.2 9971383.5 353.5b 
13 3.1 -7199746.4 -130.8b 
aMeasured specific viral synthesis rate (103 IP/106 cells/h); bValidation strategy 1; 
cValidation strategy 2. 
It should be noted that the predictive capacity for the phenotypic change 
does not necessarily translate in the ability to predict the means to deliver 
this change. Specifically, finding a strong statistical correlation between a 
given metabolic route and productivity does not translate into a direct 
cause-effect relationship. While this may often be the case for the synthesis 
of single molecules, production of correctly formed proteins or viruses 
depends on a complex series of steps ranging from gene transcription to 
protein secretion or virus assembly, along with their regulation through 
even less understood signalling events (O’Callaghan and James, 2008). 
Therefore, the identification of genetic targets may at times be beyond the 
domain of central metabolic fluxes, which themselves are upstream 
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regulated along with the productivity phenotype. On this issue, the 
methodology herein presented could at least allow to hypothesize how 
different cell pathways/functions are commonly regulated. 
Besides providing a list of prospective metabolic targets to be exploited for 
engineering, the proposed framework adds a functional dimension to 
previous metabolic decomposition studies based solely on structural 
properties of the underlying network, namely connectivity (Ma et al., 2004; 
Guimerà and Amaral, 2005) or pathway feasibility (Schuster et al., 2000; 
Papin et al., 2004). Here, clusters of fluxes are defined by sharing the same 
relationship with a given cellular output. As a main drawback, our method is 
constrained by data availability on cellular fluxome and target phenotype, 
thus demanding some experimental effort.  
As mentioned earlier, when used to handle flux distributions estimated by 
FBA in genome-scale models, this approach represents an alternative 
hybrid framework to linear optimization techniques during metabolic target 
selection, which could significantly surpass existing limitations in modeling 
complex phenotypes. A recent paper by Melzer et al. (2009) also explores 
the use of multivariate statistics to correlate stoichiometrically-derived 
elementary modes in complex networks with stoichiometrically-defined 
productivity targets, as opposed to common search algorithms for strain 
improvement. However, our approach differs conceptually to the cited work 
in that we define a statistical bridge between a well-defined stoichiometry 
and a complex phenotype, therefore substituting for a metabolic link that 
may be ill-defined in a purely stoichiometric representation and otherwise 
hampered by insufficient kinetic and regulatory information. This should 
prove an advantage in predicting non-obvious metabolic targets associated 
with the synthesis of more complex recombinant products in animal cells, 
particularly multimeric proteins, multi-protein particles and viruses, the later 
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adding an additional degree of complexity due to the virus-coded regulation 
of cellular machinery.  
Finally, from a practical point of view, several issues are worth considering 
before opting for a genome-scale model. In one respect, the availability of a 
well sequenced and annotated genome may constitute a major limitation: 
while accurate metabolic reconstructions are available for un-mutated, 
standard microorganisms such as E. coli and S. cerevisiae, in an industrial 
setting a larger diversity of organisms are used, particularly animal cell 
systems for which cellular data is much scarcer (Blazeck and Alper, 2010). 
Another consideration is the cost and time associated with the creation of 
these models. Even if a comprehensive genome-scale stoichiometric model 
is already at disposal, a considerable experimental effort is necessary to 
overlay high-throughput metabolomic and isotopomer flux data for better 
constraining fluxome estimations (Lee et al., 2006). In particular, the 
computational power required for 13C flux analysis may become prohibitive 
for very complex networks by today’s standards. Overall, our framework 
could potentially be more useful to steer rapid development of a broad 
range of organisms on the basis of a representative small-scale metabolic 
network. As such, it would significantly enhance the quality of information 
extracted from exploratory experiments compared to traditional metabolic 
flux analysis. 
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1. SUMMARY 
Baculovirus infection of Spodoptera frugiperda cells is a system of choice to 
produce a range of recombinant proteins, vaccines and, potentially, gene 
therapy vectors. While baculovirus genomes are well characterized, the 
genome of S. frugiperda is not sequenced and the virus-host molecular 
interplay is sparsely known. Herein, we describe the application of stable 
isotope labeling by amino acids in cell culture (SILAC) to obtain the first 
comparative proteome quantitation of S. frugiperda cells during growth and 
early baculovirus infection. The proteome coverage was maximized by 
compiling a search database with protein annotations from insect species. 
Of interest were differentially proteins related to energy metabolism, 
endoplasmic reticulum and oxidative stress, yet not investigated in the 
scope of baculovirus infection. Further, the differential expression of 
viral-encoded proteins early in the infection cycle is suggested to be related 
with decreased viral replication in high cell density cultures. These findings 
have implications for virological research and improvement of 
baculovirus-based bioprocesses.  
 
2. INTRODUCTION 
The application of high-throughput omic techniques in cell culture studies 
can generate hypotheses on how to improve bioprocesses through the 
design of better cell factories. Among the omic technologies available, 
quantitative proteomics based on stable isotope labeling by amino acids in 
cell culture (SILAC) has become a preferred choice for large-scale 
expression profiling, combining quantitative accuracy with straightforward 
sample processing and control over culture conditions (Mann, 2006). Not 
surprisingly, a wealth of information has been gained by investigating how 
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several mammalian viruses manipulate their host’s proteome, including 
adenovirus (Lam et al., 2010), influenza virus (Coombs et al., 2010) and 
hepatitis C virus (Mannová et al., 2006), among others.  
In spite of the biotechnological interest of the baculovirus expression 
system, the genomes of insect cell lines susceptible to the prototype 
Autographa californica multicapsid nucleopolyhedrovirus (AcMNPV) have 
not been sequenced to date. This constitutes a major disadvantage for the 
use of genome-wide technologies for better understanding this 
host-pathogen interplay. So far, global expression patterns of Sf9 cells at 
the mRNA level have been recorded at various time-points following 
infection (Nobiron et al., 2003; Salem et al., 2011). Also, a recent proteomic 
analysis based on 2D-gel electrophoresis (2DGE) identified 18 (out of 21) 
proteins differentially expressed 24 h after AcMNPV infection in a different, 
permissive cell line (Popham et al., 2010). However, a large-scale 
quantitative proteomic analysis during baculovirus infection has not been 
tackled to date. 
Knowledge on the AcMNPV infection cycle has accumulated over many 
years of research. Briefly, replication and assembly take place in the 
nucleus, where viral particles travel by reorganizing the actin cytoskeleton 
upon cell entry (Ohkawa et al., 2010). The molecular life cycle is broadly 
divided in three consecutive phases according to gene expression 
programming. Early genes (0-6 hours post-infection (hpi)), requiring the 
transcriptional activity of the cell-encoded RNA polymerase II, mainly act as 
master transactivators essential for both subsequent viral gene expression 
and subversion of host cell activity by performing tasks common to other 
DNA viruses, including cell cycle arrest (Prikhod’ko and Miller, 1997; 
Ramachandran et al., 2001). Block of apoptosis by the viral protein P35 
(Beidler et al., 1995) is also a required activity to establish productive 
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infections. The transition from early to late phase is marked by the onset of 
viral DNA replication (6-18 hpi) and the activity of a virus-encoded, 
α-amanitin resistant RNA polymerase (Grula et al., 1981). Concomitant with 
the onset of the very late phase (18 hpi-), a pronounced down-regulation of 
host transcriptional activity occurs (Ooi and Miller, 1988), followed by a shut 
off of most protein synthesis by 24 hpi (Carstens et al., 1979). This 
phenomenon reflects increased viral autonomy during the later phases of 
infection, confirmed by the observation that translation of the very-late 
genes p10 and polh is relatively insensitive to the presence of 5’-
cap-binding eukaryotic initiation factor eIF4E (Scheper et al., 1997; van 
Oers et al., 2001). 
In the present work, we investigate proteome expression changes in Sf9 
cells associated with culture growth and baculovirus infection. Since most 
of the host proteome is down-regulated at later times in the AcMNPV life 
cycle, we focused on the transition from early to late phase (around 6 hpi) 
to investigate the establishment of infection. The lack of a complete 
genome sequence was overcome by cross-referencing to a database 
constructed from S. frugiperda and related insect species. For quantitation, 
cells were cultured in the presence of heavy arginine and lysine, commonly 
used SILAC reagents (Mann, 2006). The adoption of biotechnologically 
relevant culture conditions in rich medium led to sub-optimal SILAC 
labelling, from which protein expression ratios were corrected by factoring 
the experimentally measured isotope incorporation in each protein. A 
statistical procedure is further described to handle data variability, revealing 
several proteins regulated by growth and infection that are hereby 
discussed. Our results provide a data repository that can help the scientific 
community to accelerate virological research of baculovirus infection and 
optimization of S. frugiperda-based bioprocesses. 
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3. MATERIALS AND METHODS 
3.1. Stable isotope labeling of Sf9 cells and experimental cultures 
Maintenance of Sf9 cells in culture was done as in the previous chapters. 
For labeling, customized serum- and protein-free SF900II medium 
(Invitrogen, Life Technologies) without Arg and Lys was supplemented with 
(13C)-Arg and (13C15N)-Lys at 1.35 mM each (Cambridge Isotope 
Laboratories). Cells were cultured in this medium for 5 passages growing 
as 20 mL flask suspension cultures and then up-scaled to 70 mL for an 
additional 1-2 passages. In parallel, cells were cultured in light medium 
containing (12C)-Arg and (12C14N)-Lys at the same concentration. For 
infection experiments, cells were grown to the desired cell density and 
inoculated with a recombinant AcMNPV (Ac-hisgfp, Chapter I) at a MOI of 5 
infectious particles (IP)/cell. Information on virus handling and quantification 
are provided in Chapter I. About 100 million cells were harvested either 
before infection (in growth experiments) or at 6 h post-infection and seeded 
by centrifugation. Cell pellets were washed with ice-cold PBS, instantly 
frozen and stored at -85ºC until analysis. 
 
3.2. Sample processing 
Cells were lysed in basic RIPA buffer containing 25 mM Tris (pH 7.6), 150 
mM NaCl, 1% NP-40, 1% Na deoxycholate, 1 mM EDTA, and 
supplemented with 1 mM PMSF and 1× complete protease inhibitor cocktail 
(Roche, Switzerland). Before further handling, the protein content was 
quantified for each extract (BCA Protein Assay Kit, Thermo Scientific, USA) 
and equal protein amounts of labeled and unlabeled material from each 
culture were pooled. Incorporation of iosotopically labeled amino acids was 
checked on pooled samples from light and heavy cultures as well as 
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unmixed samples. For this, proteins from the lysate were precipitated by 
adding 9 volumes of ice-cold 13.3% trichloroacetic acid/0.07% β-
mercaptoethanol (β-ME) in acetone and incubated overnight at -20ºC. 
Protein content was collected by centrifugation, washed twice with 90% 
acetone/0.07% β-ME and dissolved in 50 mM Tris-HCL/8 M urea (pH 8).  
Samples were reduced with 10 mM dithiothreitol and alkylated with 50 mM 
iodoacetamide, followed by overnight dialysis against 50 mM Tris-HCL/6 M 
urea (pH 8). Before trypsin digestion, the dialysate was first digested with 
20 μg of Lys-C at 30ºC for 2 h and then diluted with 5 volumes of 50mM 
Tris-HCl (pH 8). Trypsin digestion was carried out overnight at 37ºC using a 
50:1 protein to enzyme ratio. The peptide mixtures were acidified and 
approximately 1 mg of the initial protein content was desalted in 0.1% 
trifluoroacetic acid (TFA) using MacroSpin Column, Silica C18, 30-300 μg 
capacity (The Nest Group, Inc., MA, USA). Peptides were biochemically 
stepwise eluted with 0.1% TFA containing 20%, 40%, and 60% acetonitrile. 
Before LC-MS/MS analysis, peptide fractions were dried in a speed vac 
and dissolved in 0.1% TFA. 
 
3.3. LC-MS/MS analysis, database searching and isotope ratio 
quantification 
LC-MS/MS analysis was performed on an LTQ-Orbitrap hybrid instrument 
(Thermo Scientific, San José, CA, USA). 2 μl of peptide digest were 
injected with an autosampler (CTC Analytics, Agilent Technologies) onto a 
C18 trapping column (ProteoCol C18 0.15 x 10 mm, SGE, Ringwood, AU) 
that was connected to a separation column (0.1 mm x 10 cm) packed with 
Magic 300Å C18 reverse-phase material (5 μm particle size, Michrom 
Bioresources, Inc., Auburn, CA, USA). A linear 80-min gradient from 2 to 
50% solvent B (80% acetonitrile/0.1% acetic acid) in solvent A (2% 
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acetonitrile/0.1% acetic acid) was delivered with an Agilent 1200 nano 
pump (Agilent, Basel, Switzerland) at a flow rate of 300 nL/min. The eluting 
peptides were ionized at 1.7 kV. The LTQ-Orbitrap was operated in data-
dependent mode. A survey scan between m/z 400-1600 was acquired in 
profile mode in the Orbitrap at 60,000 resolution and the 10 most abundant 
ions were then selected for fragmentation in the LTQ part of the instrument 
at normalized collision energy of 35%. Singly charged ions were omitted 
from fragmentation and previously selected ions were dynamically excluded 
for 25 sec. Scan-to-scan calibration was allowed by setting the lock mass to 
m/z 445.120025 (Olsen et al., 2005).  
The LC-MS/MS data were searched with the SEQUEST search engine 
(version 3.3.1 SP1) (Eng et al., 1994) against an indexed insect database 
constructed as a subset of the non-redundant protein database maintained 
by NCBI (October 2010). The precursor ion and fragment ion mass 
tolerances were set to 10 ppm and 0.6 Da, respectively. Two missed 
cleavages were allowed. Dynamic modification was set for oxidized 
methionine, while cysteine carbamidomethylation was set as a fixed 
modification. The results were filtered for Xcorr values of 1.5 for single-, 2.0 
for double-, 2.5 for triple-, and 3.0 for quadruple-charged peptides, 
respectively. Delta CN was set to 0.1, and the peptide and protein 
probabilities were set to 0.5 and 0.01, respectively.  
For SILAC ratio quantification, the area of those precursor ions that had 
been identified by SEQUEST were integrated by the PepQuan option of 
Bioworks (Thermo Scientific, version 3.3.1 SP1). Precursor ion and 
fragment ion mass tolerances were set to 10 ppm and 0.6 Da, respectively. 
Searched files corresponding to different fractions of the same sample were 
merged together. Relative abundances were calculated as area ratios of 
heavy and light peptides, and the protein ratios were calculated as 
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averages of all quantified peptides. The mass shift tolerance of “Arg 6” and 
“Lys 8” was set to 0.02 Da. 
 
3.4. Data analysis  
The corrected unlabeled/labeled culture ratio for each protein was derived 
from Liao et al. (2008) as follows:  
RRi
RRiRc ×+
−=
)1(
, for all Ri > R,      (1) 
where R represents the heavy/light isotope ratio from a 1:1 mixed sample 
and Ri the heavy/light isotope ratio from the corresponding unmixed labeled 
sample. The error propagation from R and Ri into Rc is based on the 
unbiased standard deviation from triplicate experiments and was calculated 
according to the equation: 
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Sensitivity analysis of equation (1) was performed by calculating the 
relative gradient with respect to R and Ri: 
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The corrected SILAC ratio distributions were symmetrized around 0 through 
logarithmic transformation. Using the natural logarithm (ln) has the 
advantage of preserving data dispersion by only dividing each S.D. (Rc) by 
the respective Rc to yield S.D. (ln Rc). Maximum S.D. (ln Rc) cutoffs were 
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then applied to each data set resulting in more focused normal 
distributions. The two-tailed Student’s t-test was performed assuming 
unequal variances and unequal sample sizes. 
 
4. RESULTS 
4.1. A draft Sf9 proteome 
The major challenge for a large-scale assessment of the Sf9 proteome is 
the lack of an annotated genome sequence for protein identification. After 
experimental analysis of the cellular proteome, this missing knowledge was 
overcome by compiling a search database with available annotations from 
insect species, constructed as a subset of the non-redundant protein 
database maintained by the National Center for Biotechnology Information 
(NCBI). The proteome coverage was further maximized by enriching raw 
datasets with MS spectra recorded from different experimental conditions, 
biological replicates and biochemical fractionation of samples. When 
analyzing these MS spectra, a total of 648 high-confidence hits were 
identified as protein homologs from 31 species and 2 baculovirus genomes 
(Figure 5.1A). In this database, protein sequence redundancy is defined 
such that the same Sf9 or baculovirus protein may be identified multiple 
times in closely related insect organisms or viruses. Thus, to provide an 
estimation of interspecies redundancy, the Protein Information Resource 
SuperFamily (PIRSF) classification system was adopted to group proteins 
sharing homology (common ancestry) and homeomorphy (full-length 
sequence and domain architecture similarity) (Wu et al., 2004). 233 out of 
418 proteins could be assigned to unique PIRSF designations, indicating a 
total of 56% different proteins (approximately 361 out of 648).  
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Among the organisms with the highest number of identifications are the 
only sequenced lepidopteran, the silkworm Bombyx mori (Mita et al., 2004), 
and the model insects Drosophila melanogaster and Anopheles gambiae. 
Genomic information on S. frugiperda derives primarily from constructed 
EST libraries of larval hemocyte, fat body and midgut tissues, as well as the 
Sf9 cell line (Landais et al., 2003; Nègre et al., 2006). As for viral genes, we 
identified 8 known early/late proteins from the related BmNPV, which 
shares an average 90% homology with AcMNPV (Acharya et al., 2002): 
P143 (helicase), DBP (DNA-binding protein), ME53, LEF3 (late expression 
factor 3), P35, HE65, 39K and GP64. In addition, 3 hits from the 
Spodoptera litura NPV correspond to the same P35 and the large (RR1) 
and small (RR2b) subunits of ribonucleotide reductase, a virally encoded 
enzyme involved in synthesizing deoxyribonucleotides (Pang et al., 2001). 
However, the latter two genes are known not to be present in the AcMNPV 
genome and the pronounced homology with their eukaryotic counterparts 
indicates they originate from the cellular proteome (Pang et al., 2001, van 
Strien et al., 1997); their expression ratios could be quantified in uninfected 
samples at different cell concentrations (data not shown). 
Figure 5.1B, C and D represent the overall proteome classification 
according to the gene ontology (GO) vocabulary. For an unbiased 
compilation, GO terms for the 648 protein identifications were directly 
retrieved from the online resource iProClass (Wu et al., 2001) and the 15 
most abundant terms in each class are shown without further curation. 576 
were assigned to at least one molecular function, 408 to at least one 
cellular component and 497 to one biological process, while 368 were 
retrieved that belong to three categories. On the whole, the assigned 
categories are dominated by components of the translation machinery 
(ribosomal proteins, translation factors), followed by metabolic enzymes. 
Noteworthy, the proteome distribution across molecular functions and 
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cellular components is substantially more heterogeneous than in the GO 
Process category, highlighting the higher degree of hierarchization in the 
former classes. Also, the number of different biological processes retrieved 
is much higher, mirroring the total number of terms available to date in each 
class. This indicates that the proteome here presented, though certainly 
incomplete, achieves a certain level of comprehensiveness.  
Unfortunately, an enrichment analysis of GO annotations across the 
different database species is hindered by incomplete sequence information. 
For example, it is assumed that the S. frugiperda EST libraries contain at 
least 35% of the potential total gene number (Nègre et al., 2006); however, 
it is the ribosomal proteins that have mostly been confidently annotated 
(Landais et al., 2003), explaining why 51 of the 69 identified proteins in this 
study are ribosomal. The complete set of proteins with NCBI identifiers, 
species, PIRSF and GO assignments will be published as electronic 
supplementary material to the accompanying paper. 
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GO Function (38)
B. mori: 181
D. melanogaster: 106
D. pseudoobscura: 99
A. Gambiae str. PEST: 81
S. frugiperda: 69
M. sexta: 19
S. exigua: 13
D. grimshawi: 9
D. persimilis: 8
S. litura: 6
D. ananassae: 6
D. willistoni: 5
D. virilis: 5
B. Mori NPV: 8
Other: 30
n = 648
56%44%
GO Component (48)
GO Process (105)
A B
C D
nucleotide binding (16.9)
structural molecule activity (10.7)
nucleoside binding (9.9)
nucleic acid binding (9.3)
protein binding (9.0)
hydrolase activity (8.6)
catalytic activity (5.4)
binding (4.8)
oxidoreductase activity (4.0)
ion binding (3.5)
transferase activity (2.9)
cofactor binding (2.3)
transporter activity (2.1)
peptidase activity (1.7)
helicase activity (1.0)
translation (11.6)
regulation of biological process (5.2)
metabolic process (5.0)
oxidation reduction (3.3)
transport (2.6)
multicellular organismal process (2.6)
response to stimulus (2.6)
carbohydrate metabolic process (2.5)
organic acid metabolic process (2.4)
nucleotide metabolic process (2.4)
cellular ketone metabolic process (2.4)
protein folding (2.4)
developmental process (2.3)
alcohol metabolic process (2.2)
organelle organization (2.2)
cytoplasm (19.2)
cell part (15.6)
ribosome (13.8)
ribonucleoprotein complex (9.9)
protein complex (8.6)
cytoskeleton (5.7)
nucleus (5.2)
membrane (4.5)
proteasome complex (2.3)
small ribosomal subunit (1.8)
mitochondrion (1.8)
proton-transporting two-sector ATPase complex (1.5)
endoplasmic reticulum (1.3)
chromosome (1.0)
golgi apparatus (1.0)
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Figure 5.1. Species distribution and classification of a draft Sf9 proteome. (A) A 
total of 648 protein hits were retrieved from an insect subset of the NCBI 
non-redundant database. Due to high interspecies homology, some hits 
correspond to the same protein identified from different organisms. An estimated 
56% correspond to unique PIRSF designations, indicating approximately 361 
different proteins. (B) (C) (D) Proteome classification according to the gene 
ontology (GO) vocabulary. A total of 48 Component, 105 Process and 38 Function 
terms were manually retrieved from the online resource iProClass. The 15 most 
abundant terms in each class are shown. As each protein is generally assigned to 
more than one term, the percentage of proteins in each term is shown instead of 
total number to avoid redundancy. 
 
4.2. Stable isotope labeling and quantitative analysis of protein 
expression ratios 
Sf9 cells were cultured for at least 6 passages in customized medium 
where Arg and Lys have been replaced by their respective heavy isotope 
counterparts (13C)-Arg (“Arg 6”) and (13C15N)-Lys (“Lys 8”). In parallel, 
cultures in light media were maintained as a control. The feasibility of 
performing SILAC in this cell line was confirmed by comparable average 
duplication times (22-24 h), high viability (>90%) and normal morphology. 
To assess the effect of culture growth and recombinant AcMNPV infection 
on the cellular proteome, a full factorial design of 2×2 comparisons was 
applied, whereby cells were grown and infected with a high MOI at both low 
(1.5-2×106 cell/mL; LCC) and high (4-4.5×106 cell/mL; HCC) cell 
concentrations (Figure 5.2). In infection experiments, cells were harvested 
at 6 hpi. 
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Figure 5.2. Schematic representation of the SILAC experimental design. For each 
comparison, cells maintained in unlabeled medium and medium labeled with heavy 
Arg (“Arg 6”) and heavy Lys (“Lys 8”) were grown to the desired cell density (CC) 
and infected (CCI) when appropriate. Protein extracts were mixed in equal 
amounts and subject to further processing until LC-MS/MS analysis. 
A preliminary analysis of expected mass shifts of “Arg 6” and “Lys 8” clearly 
revealed the presence of unlabelled peptides. This was further confirmed 
by monitoring isotope incorporation into the proteome of the unmixed 
protein extracts Figure 5.3A). Incorporation efficiency was, on average, 
slightly over 50% after 21 cell duplications, and did not improve by an 
additional passage, suggesting that equilibrium was reached. We also 
performed cultures in media lacking Arg, Lys or both amino acids, and 
observed that the cells maintained high viability and the growth rates 
achieved in all media were comparable to those obtained when using 
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medium containing both amino acids at 1.35 mM (data not shown). 
However, there is a possibility that the culture medium contains undefined 
amino acid sources derived from plant or yeast hydrolysates, which are 
essential for cell growth and infection efficiency. In view of this, the primary 
heavy-to-light isotope ratios (R) were mathematically corrected with the 
measured ratios of incorporated label (Ri) in a protein-specific manner, 
adapting the method described in Liao et al. (2008). With this procedure 
(outlined in Figure 5.3B), the distribution of the resulting set of corrected 
SILAC ratios (Rc) can be centered around 1 (for simplicity, this is shown 
only for the comparison between uninfected and infected cultures at LCC, 
Figure 5.3C). Deviations of individual proteins are more likely to reflect 
biological variability than different turnover rates, given the high number of 
cell duplications. Between 68% and 75% of the proteins quantified in each 
of the 4 comparisons could be covered by this procedure. The remaining 
proteins were excluded to preserve quantitative accuracy. 
Since all cultures were performed in triplicates, for each average R and Ri 
an associated standard deviation (S.D.) was calculated for most of the 
proteins. Naturally, each of these ratios constitutes a source of 
experimental error and biological variability in the calculation of Rc. The 
question therefore is whether the previously applied mathematical 
correction of the SILAC ratios introduces additional data variability by 
means of error amplification. It could lead one to assume that a statistical 
outlier has biological significance, or produce a distribution of corrected 
ratios that is too spread out, hampering the identification of differentially 
expressed proteins.  To investigate this, a sensitivity analysis of Rc with 
respect to R and Ri was performed (Figure 5.3D). It can be seen that the 
lower the efficiency of label incorporation is, the more the error amplifies in 
the corrected ratios, increasing asymptotically for very low R, while being 
negligible for very high values. This heterogeneity is given by the 
176 
Quantitative proteomics during growth and infection 
non-linearity of the correction and correlates well with the experimentally 
propagated S.D. of Rc.  
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Figure 5.3. Correction and statistical analysis of SILAC ratios based on suboptimal 
label incorporation. (A) The proteome enrichment with heavy Arg and Lys was 
monitored after 21 and 24 cell duplications by analyzing unmixed protein extracts 
from labeled cultures. (B) Flow chart of the data analysis methodology. Briefly, 
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protein isotope ratios directly obtained from LC-MS/MS analysis of 1:1 mixed 
labeled/unlabeled cultures (R) are corrected in a protein-specific manner with the 
respective isotope enrichment ratios (Ri). The resulting set of corrected SILAC 
ratios (Rc) reflecting differential expression within each experimental comparison is 
symmetrized by logarithmic transformation and fitted with a Gaussian curve. In 
parallel, the unbiased standard deviations (S.D.) from triplicate experiments of R 
and Ri are propagated into standard deviations of Rc. Data distributions are then 
constructed by filtering out ratios with S.D. (ln Rc) values larger than 1 or 0.5, 
yielding more focused Gaussian fittings. For each distribution, differentially 
expressed proteins are defined as being different than the average by a t-test with 
at least 95% confidence. The combined set of proteins arising from the 3 
distributions is considered to be regulated in the particular experimental 
comparison. (C) Protein-specific and global correction of ratios obtained from 
uninfected and infected cultures at LCC. (D) The introduction of data variability by 
the mathematical operation was investigated by performing a sensitivity analysis of 
Rc. (E) Added variability in the final ln-transformed distribution of Rc is substantially 
reduced after applying a 0.5 maximum S.D. cutoff (shown for the 
uninfected/infected comparison at LCC). Equations and definitions are available in 
Materials and Methods. 
As hypothesized, the distribution of ln-transformed ratios after correction in 
the uninfected/infected comparison at LCC is too outspread (Figure 5.3E, 
left panel). In order to obtain a more focused normal fitting, the original data 
distribution was successfully decomposed by considering only proteins with 
S.D. (ln Rc) values lower than 1 or 0.5 (Figure 5.3B and E, right panel). For 
the proteins that lacked an experimental S.D. in R, Ri or both, an estimation 
was calculated considering the average relative S.D. of the remaining 
proteins. This error filtering methodology allowed a considerable reduction 
in data variability, with comparable results obtained for the other 3 
experimental comparisons. 
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For each transformed SILAC ratio distribution, a protein was considered to 
be differentially expressed when ln Rc was different from the average by a 
t-test with at least 95% confidence. This definition accounts simultaneously 
for the overall dispersion of the data as well as for the propagated S.D. 
associated with each corrected protein ratio, thus avoiding arbitrary 
definitions based only on location (Coombs et al., 2010; Lam et al., 2010; 
Liao et al., 2008; Mannová et al., 2006). For each protein, a different 
number of replicates (n) exists for uncorrected and incorporation ratios, 
those proteins that pass the test for the higher n value, but not for the lower 
one, were considered differentially expressed only if they lie outside of the 
bulk 95% of the data (Average ± 1.96 S.D.). This was also done for those 
proteins lacking a replicate for either R, Ri or both. Only protein ratios lying 
outside 68% of the distribution were considered to have biological 
relevance (Average ± S.D.). The combined set of proteins with statistically 
significant expression changes from the unfiltered and filtered distributions 
is considered to be the regulated sub-proteome for each experimental 
comparison (Figure 5.3B). 
 
4.3. Global assessment of growth- and infection-regulated proteins 
As previously stated, two experimentally different sources of information 
regarding the impact of growth and infection on the cellular proteome are 
available. Yet, infection and growth constitute physiological “treatments” 
with substantially different strengths (comparing for instance the 
viral-induced halt in cell division with the cell density-associated decrease 
of growth rate). In the presence of experimental error and biological 
variability, their interacting effect can significantly obscure the assessment 
of how growth affects the cell proteome when comparing two infected 
cultures at different cell densities, for which reason we considered only 
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uninfected cells in this case. Direct comparison of two infected cultures at 
different cell densities was carried out to discriminate possible changes in 
the expression levels of early baculovirus proteins. On the other hand, the 
infection effect was evaluated not just separately for LCC and HCC 
cultures, but also globally by pooling together as “infection replicates” the 
six experimental comparisons performed in both conditions. Those proteins 
identified as differentially expressed from this pool will form a subset that 
has higher associated confidence.  
According to the statistical analysis described, a total of 13, 14, 14 and 9 
proteins had significantly changed expression caused by culture growth, 
infection (globally), infection at LCC and infection at HCC, respectively 
(detailed quantitative and statistical information will be published 
electronically as supplementary material to the accompanying paper). Not 
surprisingly, some proteins only emerged as differentially expressed after 
applying S.D. filters to the distributions, hidden by the high variability in the 
original data sets (Figure 5.4). In addition, the only viral protein with 
significantly changed expression levels detected in this study was the late 
expression factor LEF3, found to be more expressed following infection at 
LCC than at HCC. 
We also carried out a comparative analysis of the overall quantification 
results in the various experimental settings. The subsets of corrected 
SILAC ratios simultaneously quantified for the “treatment” pairs 
Growth/Infection (globally) and Infection (LCC)/Infection (HCC) were 
standardized and plotted against each other (Figure 5.5A and B). It is clear 
that proteins considered to be regulated only by one condition either have 
large S.D. values or locate close to the average, hence suggesting they 
were regulated in only one case. This is particularly interesting when 
infections at LCC and HCC are contrasted, since the absence of statistical 
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significance in one of the conditions that is not due to high associated S.D. 
suggests an underlying cell density effect on baculovirus infection. 
Nevertheless, viral infection is not expected to have an opposed effect on 
expression of any given protein at different cell densities. This is confirmed 
by our data since when a protein is less expressed at LCC, it is not 
significantly over expressed at HCC, and vice versa. 
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Figure 5.4. Allocation of differentially expressed proteins for each experimental 
comparison after the application of S.D. (ln Rc) cutoffs to data distributions. 
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Figure 5.5. Comparative analysis of simultaneously quantified proteins in the 
various experimental settings. Standardization of the ln-transformed corrected 
ratios was performed against the respective unfiltered distributions. Error bars 
presented for differentially expressed proteins correspond to propagated S.D. 
values from triplicate experiments. The vicinity of the average distributions is 
delimited by Average ± S.D. of the more focused distribution in each case (cutoff 
S.D. (ln Rc) = 0.5), after standardizing as above. (A) (B) Comparative analyses of 
286 and 249 proteins simultaneously quantified for the treatment pairs 
Growth/Infection (globally) and Infection (LCC)/Infection (HCC), respectively. 
Proteins considered to be regulated only by one condition are highlighted so they 
can be easily tracked in the other condition. For simplicity, statistically unmeaning 
or unregulated proteins are not shown. 
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4.4. Regulatory modulations associated with culture growth and early 
baculovirus infection 
Cellular proteins with changed expression levels across the 4 experimental 
comparisons were grouped according to their potential physiological roles 
in growth and infection (Figure 5.6). In conformity with the statistical 
analysis described, evaluating the relative strength of regulation among 
different proteins based directly on the corrected SILAC ratios could be 
misleading, due to the associated S.D. values. Thus, a simple code 
indicating up- or down-regulation was chosen to reflect the directional 
change.   
Of the metabolic enzymes suggested to be regulated during culture growth, 
dihydrolipoyl dehydrogenase (E3 subunit of the mitochondrial PDH 
complex) and aldehyde dehydrogenase (ALDH, conversion of alcohols to 
carboxylic acids) are known to fuel energetic metabolism and were 
overexpressed at high cell densities. In contrast, several enzymes involved 
in different metabolic pathways were less expressed at HCC 
(6-phosphogluconate dehydrogenase – PGDH, malic enzyme - ME, 
S-adenosyl-L-homocysteine hydrolase – SAHCH and hydroxysteroid 
dehydrogenase - HSDH), consistent with the typical slowdown of growth 
along culture time. In particular, decreased fluxes through ME were already 
observed in Chapter II. Also relevant was the increased expression of the 
70-KDa heat shock protein 5 (HSP70-5 or BiP), a resident ER factor that is 
up-regulated during the unfolded protein response (UPR) triggered by 
various cell stresses. Other changes associated with signaling pathways 
include down-regulation of a GTPase, the catalytic subunit of protein 
phosphatase 1 (PP1c) and the increased expression of tumor necrosis 
factor receptor (TNFR)-associated protein 1, the later being involved in the 
transmission of apoptotic signals. Changes were also observed in some 
ribosomal proteins.  
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A total of 11 cellular proteins were differentially expressed at the same time 
for the global infection assessment and either of the LCC or HCC infection 
conditions, showing consistent regulation in all cases. This indicates that 
gross quantitative errors are not present in our study. In terms of metabolic 
enzymes, PDH-E3 and ALDH were upregulated in at least one infection 
condition, underlying the importance of the energetic metabolism for 
baculovirus replication assessed in Chapter II and III. In opposition to 
culture growth, SAHCH was overexpressed after infection, an enzyme 
involved in methionine degradation and possibly associated with increased 
viral replication (Chapter IV). An interesting observation was the 
down-regulation of glycogen phosphorylase (GP) upon viral expression, an 
enzyme responsible for glycogen degradation and thus potentially 
important as an additional energy source. However, the apparent 
contradiction is in agreement with the fact that GP is repressed by 
dephosphorylation through PI3K-Akt signaling, a pathway stimulated very 
early in infection and shown to be essential for replication of baculoviruses 
and other DNA viruses (Buchkovich et al., 2008; Xiao et al., 2010). This 
suggests a compromise between positive and negative outcomes from viral 
manipulation of functionally branched cellular pathways.  
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Figure 5.6. Differentially expressed proteins during growth and baculovirus 
infection. Under- or over-expression imply statistical significance as described in 
the text. Proteins suggested to be unregulated locate within Average ± S.D of the 
respective distributions (cutoff S.D. (ln Rc) = 0.5). 
In terms of protein processing pathways, the up-regulation of HSP 
chaperones (sHSP, HSC70) has been associated with several viral 
infections, including AcMNPV (Nobiron et al., 2003; Salem et al., 2011), 
most likely as a result of UPR initiation. Strikingly, our data indicates that 
central UPR effectors HSP70-5 and ERp57 are not over-expressed after 
infection, the later being even repressed, suggesting a previously unknown 
active role of AcMNPV genes in the modulation of ER stress. This is 
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consistent with the observed up-regulated signal recognition particle 
SRP54, involved in targeting newly synthesized polypeptides for processing 
in the ER. The protein Mod(Mdg4)-heS00531, under expressed in this 
study, is part of the gypsy chromatin insulator complex and can trigger 
apoptosis by a specific pathway known to be blocked by baculovirus IAP 
and P35 proteins (Harvey et al., 1997). Other interesting discoveries 
concern the modulation of proteins involved in cytoskeleton motility, 
underscoring its importance for the viral life cycle, and the down-regulation 
of a thioredoxin-like protein (TRXL) involved in oxidative stress, among 
histone H2B and several translation initiation factors.  
Finally, of the proteins suggested to be only regulated by infection at LCC, 
the physiological roles of HSC70, Mod(Mdg4)-heS00531 and TRXL may 
imply limitations to baculovirus replication during high cell density culture. 
Moreover, the lower levels of LEF3 detected following infection at HCC, 
compared to cells infected at LCC, are consistent with the lower 
baculovirus progeny produced after infection at HCC when compared with 
LCC (Chapters I-III): LEF3 is one of 6 virally encoded genes (called 
replicative LEFs) that essential for DNA replication (Okano et al., 2006). 
 
5. DISCUSSION 
In this work, a comprehensive SILAC-based proteome analysis of the 
popular Sf9 cell factory was presented. The effect of baculovirus infection 
and culture growth on the cellular proteome was investigated to gain 
insights into regulatory modulations associated with a productive infection 
cycle, thus relevant from both the virological and bioprocess points of view. 
Despite not having a complete genome sequence for this insect species, 
homology-based mass spectra interpretation gave the framework for 
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genome-wide data extraction from limited knowledge. Inarguably, 
reanalyzing the data generated against a complete S. frugiperda database 
would unravel many more important players in this complex molecular 
interaction. 
The analysis of differentially expressed proteins in SILAC experiments is 
straightforward when an almost complete incorporation (>95%) of heavy 
amino acids in cellular proteins is possible. However, atypical growth 
behavior of certain cellular types may complicate or completely prevent this 
ideal scenario (Gruhler et al., 2005; Liao et al., 2008). Compared to 
mammalian cells, the metabolic capacity for amino acids biosynthesis in 
insect cell lines is less known, with reports pointing to a greater flexibility 
(Adam et al., 2005; Doverskog et al., 1997). Our results are not conclusive 
on this point given the presence of undefined amino acids sources in 
serum-free culture medium. Alternative chemically defined media for growth 
of S. frugiperda cell lines require supplementation with serum or yeastolate. 
Cell adaptation to a minimal supplementation of these components could 
be cumbersome and induce alterations to normal culture behavior, affecting 
the infection cycle. Furthermore, serum dialysis was recently shown to 
induce marked changes in the proteomes and phosphoproteomes of 
several mammalian cell lines, despite the generalized practice (Imami et 
al., 2010). Instead of invasive cell culture manipulation, the mathematical 
correction of the primary SILAC ratios with experimentally measured 
enrichment ratios can be profitably applied to analyze industrially relevant 
culture conditions, while preserving quantitative accuracy. Further, the 
statistical implications of this procedure were thoroughly analyzed and a 
process to circumvent added variability in the final data sets caused by 
error amplification was described, which would otherwise preclude the 
identification of several proteins with changed expression levels. This bears 
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relevance for studies where for various reasons complete protein labeling is 
not attainable.  
Our study was conducted at 6 hpi to assess cellular proteomic modulations 
associated with the establishment of infection, which will ultimately 
determine the outcome in terms of viral replication and recombinant protein 
expression. At this stage in the infection cycle, Nobiron et al. (2003) and 
Salem et al., (2011) showed most host transcript levels are not 
pronouncedly changed (an exception is HSC70, which was increased), 
suggesting a post-translational regulation. Here we report protein 
expression changes in several cellular pathways. For example, three 
metabolic enzymes are shown to be up-regulated after infection, 
emphasizing the dependency of baculovirus replication on cell metabolism. 
In particular, a higher TCA cycle activity driven by an efficient glycolytic 
bridge (PDH-E3) and anaplerotic feeding of carboxylic acids (ALDH) is 
important for efficient energy generation and diversion of substrates to lipid 
biosynthesis. This agrees with the increased productivities obtained when 
organic acids are supplemented to the culture along with infection (Chapter 
III). Other viruses were also found to actively modulate energetic and 
anabolic pathways (Diamond et al., 2010; Munger et al., 2008), collectively 
contributing to the view that viruses behave as natural metabolic engineers, 
instead of representing a simple metabolic burden (Maynard et al., 2010).  
The induction of energetic metabolism as a response to culture growth was 
also observed, a phenomenon previously described to be associated with a 
low proliferative, quiescent physiological state (Heiden et al., 2009), and 
which represents an apparent paradox in relation with the mentioned 
negative cell density effect on baculovirus replication. However, this can be 
explained by a concomitant growth-associated repression of anabolic 
processes (for instance PGDH and ME decreased in this study) and 
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reduced substrate uptake rates as can be seen in Chapter I and II, 
consistent with an overall lower metabolic rate.  
The early up-regulation of HSC70 and the related sHSP after LCC infection 
(but not HCC) indicate a disturbance of ER homeostasis known to be 
associated with viral infection. Interestingly, we observed expression 
changes in two proteins that together are counterintuitive with an activation 
of UPR, namely decreased levels of the chaperone ERp57, a central UPR 
effector also involved in Ca2+ homeostasis, and the polypeptide transporter 
SRP57. These findings suggest that, through unknown mechanisms, 
baculoviruses are able to take advantage of ER stress while avoiding 
negative effects associated with UPR, probably in different ways than 
already described for other viruses (Lucas et al., 2001; Tardif et al., 2005). 
Failure to induce HSC70 expression at HCC infection can mean less ER 
capacity for viral protein processing and thus less baculovirus progeny.  
Also interesting are the decreased levels of TRXL (only after LCC 
infection), since human thioredoxin (TRX) related proteins are known to 
integrate signals and prevent apoptosis from ER, oxidative and 
mitochondrial stresses. This complexity draws further curiosity into the 
strategies that different viruses have evolved to manipulate the cell for their 
advantage. For instance, the endogenous human T-cell leukemia retrovirus 
type I was shown to promote cell growth through elevation of TRX levels, 
while the apoptotic HIV infection is associated with decreased TRX 
expression (Masutani et al., 2005). In contrast, Popham et al. (2010) 
observed unaltered levels of TRXL in the lepidopteran Heliothis virescens, 
although at very late times after AcMNPV infection. More relevant, 
however, is the discovery that the multifaceted early P35 protein also acts 
as an antioxidant by quenching ROS (Sah et al., 1999), reinforcing the fact 
that an induction of oxidative stress is only observed late in infection (Wang 
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et al., 2001). One hypothesis is that this additional role of P35 compensates 
for decreased TRXL levels in preventing oxidative stress-induced apoptosis 
early in infection. Alternatively, the possibility of a direct viral-mediated 
regulation of TRXL levels concurs with unaltered levels of this protein 
following HCC infection, when viral replication is less efficient. An 
involvement of P35 in the modulation of TRXL, as it seems conclusive in 
the case of Mod(Mdg4)-heS0053, remains to be elucidated. 
The role of LEF3 as a key determinant of a productive infection cycle is 
suggested by its lower expression at HCC compared to LCC infections. 
Noteworthy, a recent study has demonstrated that silencing of the 
replicative LEFs (including LEF3) during AcMNPV infection not only blocks 
viral DNA replication and late gene expression, but also prevents the 
induction of apoptosis and shutoff of cellular protein synthesis in S. 
frugiperda cells (Schultz and Friesen, 2009). Hence, this protein can be a 
potential target to overcome the negative cell density effect on baculovirus 
production (Chapters I-III). Moreover, one may speculate a link between 
energetic metabolism and the differential accumulation of other 
viral-encoded proteins in regulating the level of baculovirus replication and 
recombinant protein expression. 
Finally, among changed expression levels in several translation factors and 
ribosomal proteins, we found diminished levels of kinesin heavy chain 
(Khc), a tubulin motor protein, and up-regulation of a calponin-like protein 
(CLP), an inhibitor of myosin ATPase activity, which in turn is an actin 
motor protein. These observations suggest baculoviruses reorganize the 
cytoskeleton not only through actin polymerization (Goley et al., 2006; 
Ohkawa et al., 2010), but possibly also by regulating other proteins to 
enhance their own intracellular transport. 
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In conclusion, as a hypotheses generation tool, this proteomic study offers 
new insights and potential research targets for a better understanding of 
the complex AcMNPV infection cycle. One exciting point remains to be 
discriminating active modulations induced by the virus and the natural 
cellular response to infection. The complete resolution of this puzzle will 
probably require complementary information from targeted, scale-down 
experiments and other high-throughput assessments of protein-protein, 
protein-DNA and protein phosphorylation networks. From a distinct 
perspective, our data highlights possible regulatory bottlenecks associated 
with the described cell density effect on viral replication. This is one of few 
examples where large-scale quantitative proteomics was used with a focus 
on improved performance of an animal cell factory, in the scope of Systems 
Biotechnology. In a broader sense, this work provides a case-study of the 
application of advanced omic technologies in poorly characterized 
organisms. 
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1. BACULOVIRUS VECTORS BIOPROCESSING AND THE CELL 
DENSITY EFFECT 
The work presented in this thesis focuses on the optimization of baculovirus 
vectors (BV) productivity in Sf9 cultures. Optimization of virus-based 
bioprocesses is a daunting task due to the number of culture parameters 
affecting product delivery. When to infect, how many infectious particles to 
be added and what medium composition to use are amongst the important 
questions that need to be answered to achieve an efficient bioprocess.  
Our results support previous observations that, in order to obtain a 
productive infection, cells must be infected at an early stage of growth if no 
additional manipulations are performed, owing to the so-called cell density 
effect (Chapter I). In the literature, the optimal inflection point in the culture 
growth curve, referred to as the optimal peak cell density, is defined as the 
cell density which gives the greatest product formation under synchronous 
(high MOI) infection (Aucoin et al., 2010; Wong et al., 1996). Since 
infections at low MOI lead to subsequent culture growth, the peak cell 
density is higher than the actual CCI, explaining why the cell density effect 
is apparently “delayed” when infections are performed at high MOI. In these 
conditions, we could obtain the highest specific BV yield at CCI 2×106 
cells/mL (2475 IP/cell), decreasing thereafter at CCI 3×106 cells/mL  to 
2060 IP/cell; otherwise, a step decline in BV specific yields was observed 
already at CCI 2×106 cells/mL with a low MOI.  
In strike contrast to previous suggestions (Bédard et al., 1994; Weiss et al., 
1992), nutrient depletion could not explain the decrease in productivity 
associated with high cell density infections, even though medium exchange 
significantly improved BV yields. In fact, neither of the analysed medium 
components (including sugars and amino acids) was depleted during 
infected cultures, whereas toxic by-product accumulation has been shown 
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not to be an issue in Sf9 cells (Bédard et al., 1993; Drews et al., 2000; 
Öhman et al., 1995; Öhman et al., 1996). These observations clearly 
indicate more complex mechanisms underlie the cell density effect, 
probably a means to control population size that is regulated by 
constitutively secreted autocrine/paracrine factors, which are screened out 
after medium replenishment (Doverskog et al., 1997; Doverskog et al., 
2000). An in-depth analysis of cellular metabolism during culture growth 
and its response to infection is therefore needed. 
Although specific aspects of Sf9 cells physiology in culture can be found 
dispersed among several reports (Bhatia et al., 1997; Doverskog et al., 
1997; Drews et al., 2000; Ferrance et al., 1993; Ikonomou et al., 2003), to 
date a comprehensive analysis of cellular metabolism and its response to 
infection has not been conducted. To gain a quantitative understanding, a 
metabolic flux analysis (MFA) model of this cell line capable of describing 
metabolic shifts occurring at different cell densities and also as a result of 
baculovirus infection was developed (Chapter II). Supported by extensive 
experimental data, the model revealed metabolic modulations associated 
with cellular energetics and the redox state; namely, a decrease in central 
metabolic activity (glycolysis, tricarboxylic acids (TCA) cycle) and energetic 
output (cellular respiration and ATP synthesis) was observed along culture 
growth. In terms of post-infection metabolism, it was found that viral 
infection exerts a positive effect on the metabolic activity at an early stage 
of culture growth, which fails to occur when infections are performed at high 
cell densities. Furthermore, a positive dose-response trend could be 
observed for different MOIs at low cell density; for instance, cellular 
respiration increased only 6% after low MOI infection but soared 63% when 
a high MOI was used. This suggests that the post-infection metabolic state 
is actively regulated during the BV life-cycle at low cell density. Overall, 
these findings correlated well with our previous production results, pointing 
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for a strong association between per cell BV yields and the cellular 
energetic state. 
Hypothesizing that the energetic state of the cells is a feasible controlling 
constraint for the production of BVs, we engaged in the selection of 
targeted strategies to improve BV productivity at high cell density, 
attempting to meet viral vector delivery requirements associated with 
clinical gene therapy (Chapter III). It was demonstrated that one-time 
supplementation of 12 mM pyruvate or 12 mM α-ketoglutarate, along with 
infection of 0.1 IP/cell, is able to boost an increase in specific viral yields at 
high cell density of up to 7 fold, reaching volumetric quantities of infectious 
particles significantly higher than those obtainable by infection at a lower 
cell concentration (12.2±3.6×107 IP/mL and 6.6±2.8×107 IP/mL, 
respectively). A low MOI was used since it allows for the highest BV 
amplification, at the same time minimizing the expenditure of viral stocks. 
The intrinsic mechanism of this cost-effective approach comprised the 
direct stimulation of energetic pathways as demonstrated by MFA, while the 
supplementation of amino acids, lipids or even a complete medium additive 
did not restore cell specific productivity. Together with our previous 
observations, this further brings down the classical nutrient exhaustion 
explanation for the cell density effect. Also, because carboxylic acids 
supplementation bypasses most of the peripheral nutrient utilization routes, 
it is consistent with the possible negative regulation of metabolic activity by 
cell secreted factors. Finally, since a stimulation of energetic output is 
oxygen demanding, the positive results obtained in spinner vessels 
demonstrate that oxygen was not the primary cause for poor productivities 
at high cell densities.  
Other biological systems have been affected by a negative cell density 
effect on productivity, including viral-based systems (Nadeau and Kamen, 
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2003; Ferreira et al., 2005) and microorganisms (Yoon et al., 2003). 
Interestingly, in Ferreira et al. (2005), the cell density effect on a human 
293 cell line producing a recombinant adenovirus was assessed in 
oxygen-controlled bioreactors and productivity could not be enhanced by 
the simple replenishment of limiting nutrients, whereas it could be improved 
by changing to non-ammoniagenic medium. Considering the highly efficient 
carbon utilisation and physiological robustness of Sf9 cells, the work 
developed in this thesis demonstrates that the complexity of the cell density 
effect goes beyond the basic bioprocess variables, nutrient availability and 
by-product formation, and was successful in generating an hypothesis 
leading to a dramatic increase in specific productivity. However, the direct 
extrapolation of this strategy to other animal cell systems, including those 
used in stable expression, should be considered with care, as it depends 
on an efficient glycolysis-TCA cycle bridge, which is significantly impaired in 
the majority of mammalian cell lines (Doverskog et al., 1997; Petch and 
Butler, 1994). Beyond previous efforts in alleviating this bottleneck through 
cell engineering strategies (Chen et al., 2001; Irani et al., 1999), a complete 
reprogramming of carbon usage would be a significant breakthrough for 
mammalian cell culture, possibly leading to unprecedented levels of 
specific productivity. 
One important question that was not addressed in the previous chapters 
but that was also analyzed in this thesis is the effect of energetic 
stimulation on recombinant protein production. Given that virus replication 
is correlated with viral gene expression, supplementation of pyruvate or 
α-ketoglutarate should in principle exert a positive effect on protein 
production as well. However, our results with a BV expressing the 
recombinant vp7 rotavirus capsid glycoprotein show a very modest effect 
when compared to the improvement seen in BV specific yields (Figure D.1). 
These results are likely related to the very-late, polh-driven expression of 
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the recombinant proteins, overlapping a phase prior to cell lysis during 
which most of the cell activity, including protein processing pathways, is 
quickly deteriorating (Chapter V; van Oers et al., 2001).  
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Figure D.1. Effect of cell density and pyruvate supplementation on recombinant 
vp7 and BV production. Cultures were infected at a concentration of 1×106 cells/mL 
(CCI 1) or 3×106 cells/mL (CCI 3) with a MOI of 0.1 IP/cell. 12 mM of pyruvate were 
added at infection time as previously described (Chapter III). 
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2. THE BACULOVIRUS-SF9 CELL AS A SYSTEM: HYBRID 
METABOLIC MODELING AND OMIC-BASED HYPOTHESES 
GENERATION 
The need to understand and manipulate cellular systems for increased 
biosynthesis of target products has been a consistent focus of research, 
more recently supported supported by the huge flows of data being 
obtained at different cellular levels. Likely the near future will witness a 
substantial growth in cell-wide resources for a variety of organisms with 
biotechnological interest (Otero and Nielsen, 2010); in particular, the 
expansion of annotated genomes and omic technologies downstream of 
gene expression profiling should progressively close the gap with the 
phenotype, enabling combined analysis of different layers of information. At 
the same time, it is clear that simply accumulating data will not directly 
translate into dependable strategies for optimization, since the link between 
the molecular traits and the desired phenotypic properties would still remain 
a black box. The real challenge will be to incorporate these data into 
mechanistic systems enabling accurate prediction of cell behaviour in 
response to perturbations, which can be exploited for forward cell 
engineering. However, our knowledge so far only grants us the possibility to 
have ‘hybrid cellular models’, as detailed mechanistic understanding of 
specific cell processes can only be connected at a higher level by 
multivariate statistical/mining methods, filling the gaps in our understanding 
of regulatory phenomena (Ideker and Lauffenburger, 2003; Ortega et al., 
2008; Teixeira et al., 2007; Tomita, 2001). 
In the context of the present thesis, we were interested in the possibility of 
developing a predictive tool able to quantitatively link metabolic flux 
distributions and BV production beyond simple empirical inspection. This 
was attempted by integrating MFA with partial least squares (PLS) 
regression into a hybrid (statistical) metabolic flux analysis framework as a 
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valuable complement to purely stoichiometric models for the optimization of 
complex productivity phenotypes (Chapter IV). This modeling effort was 
applied to the same small-scale metabolic network developed in Chapter II, 
although being readily scalable to genome-wide metabolic reconstructions, 
when available. Model calibration was based on the data accumulated in 
the previous chapters, and we were able to predict the importance of the 
TCA cycle fluxes and mitochondrial respiration as pathways strongly 
associated with viral replication. This was then validated using only a 
subset of preliminary experiments to pinpoint the same determinant 
pathways, while predicting the productivity of independent cultures within 
measurement error. Therefore, the positive effect of supplementing 
pyruvate or α-ketoglutarate could have been suggested not by an 
observational hypothesis, but as a result of model prediction. Though still 
far from the ultimate objective of developing a comprehensive global 
cellular model, the contribution presented herein proved to be valuable in 
harnessing the central metabolism for improved productivity in this system. 
Given a preliminary set of experimental data, hybrid MFA should also be 
straightforwardly applicable to other insect and mammalian production 
systems, including stable recombinant protein expression, for the design of 
customized optimization strategies. 
Taking a different Systems Biology approach, Chapter V describes an 
attempt to apply advanced omic technologies in the baculovirus-Sf9 cell 
system as high-throughput hypotheses generating tools. As briefly 
mentioned in the Introduction section, there is a “macroscopic” gap 
between genomic annotation, gene expression profiling and cell function, 
whereby regulatory phenomena at multiple levels modulate the information 
flow inside the cell. For instance, quantitative inconsistencies between 
mRNA and protein levels have been reported before (Liao et al., 2008; Seth 
et al., 2007). For this reason, we opted to quantitatively analyze the Sf9 
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proteome during culture growth and as a response to BV infection. The 
challenge here was not only to identify a large-scale Sf9 proteome, 
constrained by the unavailability of a genome sequence and annotation for 
S. frugiperda, but also to assure the accuracy of protein expression 
changes. In fact, quantitative accuracy is a fundamental issue in the 
generality of large-scale or high-throughput measurement techniques, 
particularly in the context of the omic sciences (see Wolfinger et al., 2001). 
Overall, homologs of 361 non-redundant proteins were identified from 31 
insects and 2 baculoviruses, representing the opening block for an 
organized S. frugiperda proteome. Through stable isotope labelling with 
amino acids in cell culture (SILAC) and a thorough statistical analysis of 
biological replicates, we were able to confidently discriminate differentially 
expressed proteins due to growth or infection, including several proteins 
related to energy metabolism, endoplasmic reticulum stress and oxidative 
stress, which can be effective targets for the design of improved 
bioprocesses. In particular, the viral-induced up-regulation of enzymes 
involved in energy metabolism (dihydrolipoyl dehydrogenase and aldehyde 
dehydrogenase) further confirmed the induction of these pathways found in 
terms of reaction flux at low cell density (Chapter II). Another meaningful 
result of this study was the suggestion that, based on the relative 
quantification of the viral protein LEF3, the differential accumulation of 
BV-encoded proteins early in infection at different cell densities could play a 
role in the cell density effect. The mechanism involved is that the 
expression of early proteins determines the level of viral DNA replication 
and recombinant protein expression later in the infection cycle (Lin et al., 
2001; Ramachandran et al., 2001). 
The collective proteome data generated does not clarify the overall 
molecular mechanisms underlying the cell density effect, but complement 
our previous findings in providing a few target proteins whose expression is 
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influenced by culture growth and baculovirus infection, which can in turn 
determine viral replication and recombinant protein expression. Some 
unanswered question are 1) what and how cell secreted factors influence 
the energetic state and the growth/productivity phenotypes?; 2) What are 
the virus-host molecular protein-protein and protein-DNA interaction 
networks established upon infection? Certainly the needed fundamental 
understanding of these questions will depend on creating a cell-wide 
integration of multi-level information. As such, we expect this work to 
constitute a catalyst for further developments, of which a full genomic 
characterization would represent a major achievement. This would allow 
the generation of more comprehensive, genome-scale omic data, the 
reconstruction of a genome-scale metabolic model with increased 
predictive capacity, and the development of tailored molecular tools for 
biological discovery and cell engineering. 
 
3. SYSTEMS BIOTECHNOLOGY OF ANIMAL CELLS: A COMPROMISE 
BETWEEN WHAT IS POSSIBLE AND WHAT IS DOABLE 
The application of systems biology in bioprocess optimization has been 
previously set forth by several authors. For instance, Lee et al. (2005) 
described it in this way: “Systems biotechnology will have an increasing 
impact on industrial biotechnology in the future. All steps of 
biotechnological development, from up-stream (strain, cell and organism 
development) and mid-stream (fermentation and other unit operations) to 
down-stream processes, will benefit significantly by taking systems 
biotechnological approaches.” Since such an all-inclusive approach for the 
systematic improvement of bioprocesses is significantly beyond what we 
have been accustomed to, doubts are likely not confined to the most 
skeptical minds; in particular, Systems Biology currently faces unsolved 
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challenges regarding the integrative tasks (Stephanopoulos et al., 2004). A 
positive argument in this regard is that computer aided design is today 
routinely used in other manufacturing industries, such as electrical, 
automotive and aircraft. Though biological systems are not a human 
mechanic construction, it is worth noticing that engineering systems have 
begun to have almost comparable complexity levels, judging by the number 
of components (Csete and Doyle, 2002). It is therefore expectable that the 
building blocks of life may also one day be simulated in their complex 
systems environment.  
Besides these inherent challenges facing the systems biologist, a critical 
question in the biopharmaceutical context is the cost-effectiveness of these 
endeavors. In particular, the application of systems approaches in animal 
cells bioprocessing is constrained by the availability of database resources 
and the increased complexity of recombinant products, requiring deeper 
and wider cell state characterization (regulation of gene expression, protein 
processing and secretion, host-virus interactions, etc.). As pointed out in 
the Introductory section to this thesis, R&D spending on generating 
systems-level knowledge for bioprocess improvement competes for 
financial resources with other activities, including the development of new 
investigational biologicals and clinical testing, where acceptable returns on 
investment have been achieved to date. Even for the biosimilars business, 
the benefits of systems biotechnology have to clearly outpace the overall 
manufacturing costs pressured by market competition. Therefore, it is 
envisaged that companies will keep following systems biology 
developments mostly from the sidelines, leveraging on academic 
collaborations where expertise is available without taking full risk. Future 
breakthroughs will probably blossom first in the fields of biomedicine and 
drug discovery, as suggested by the recently issued “Strategic Priorities 
2011-2015: Responding to the Public Health Challenges of the 21st 
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Century” by the Food and Drug Administration. Nevertheless, the Systems 
Biotechnology laggard should also cross the end line. 
 
REFERENCES 
Aucoin MG, Mena JA, Kamen AA (2010) Bioprocessing of baculovirus vectors: a review. 
Curr Gene Ther 10: 174-186 
Bédard C, Kamen A, Tom R, Massie B (1994) Maximization of recombinant protein yield in 
the insect cell/baculovirus system by one-time addition of nutrients to high-density 
batch cultures. Cytotechnology 15: 129-38 
Bédard C, Tom R, Kamen A (1993) Growth, nutrient consumption, and end-product 
accumulation in Sf-9 and BTI-EAA insect cell cultures: insights into growth limitation 
and metabolism. Biotechnol Prog 9: 615-24 
Bhatia R, Jesionowski G, Ferrance J, Ataai MM (1997) Insect cell physiology. 
Cytotechnology 24: 1-9 
Chen K, Liu Q, Xie L, Sharp PA, Wang DIC (2001) Engineering of a mammalian cell line for 
reduction of lactate formation and high monoclonal antibody production. Biotechnol 
Bioeng 72: 55-61 
Csete ME, Doyle JC (2002) Reverse engineering of biological complexity. Science 295: 
1664-1669 
Doverskog M, Bertram E, Ljunggren J, Öhman L, Sennerstam R, Häggström L (2000) Cell 
cycle progression in serum-free cultures of Sf9 insect cells: modulation by 
conditioned medium factors and implications for proliferation and productivity. 
Biotechnol Prog 16: 837-846 
Doverskog M, Ljunggren J, Öhman L, Haggstrom L (1997) Physiology of cultured animal 
cells. J Biotechnol 59: 103-115 
Drews M, Doverskog M, Ohman L, Chapman BE, Jacobsson U, Kuchel PW, Haggstrom L 
(2000) Pathways of glutamine metabolism in Spodoptera frugiperda (Sf9) insect cells: 
evidence for the presence of the nitrogen assimilation system, and a metabolic switch 
by 1H/15N NMR. J Biotechnol 78: 23-37 
Ferrance JP, Goel A, Ataai MM (1993) Utilization of glucose and amino acids in insect cell 
cultures: Quantifying the metabolic flows within the primary pathways and medium 
development. Biotechnol Bioeng 42: 697-707 
Ferreira TB, Ferreira AL, Carrondo MJT, Alves PM (2005) Effect of reefed strategies and 
non-ammoniagenic medium on adenovius production at high cell densities. J 
Biotechnol 119: 272-280 
Ideker T, Lauffenburger D (2003) Building with a scaffold: emerging strategies for high- to 
low-level cellular modeling. Trends Biotechnol 21: 255-262 
Ikonomou L, Schneider YJ, Agathos SN. 2003. Insect cell culture for industrial production of 
recombinant proteins. Appl Microbiol Biotechnol 62: 1-20 
Irani, N., Wirth, M., van Den Heuvel, J. and Wagner, R., 1999. Improvement of the primary 
metabolism of cell cultures by introducing a new cytoplasmic pyruvate carboxylase 
reaction. Biotechnol Bioeng 66, 238-46 
Lee SY, Lee D-Y, Kim TY (2005) Systems biotechnology for strain improvement. Trends 
Biotechnol 23: 349-358 
Liao L, Park SK, Xu T, Vanderklish P, Yates III JR (2008) Quantitative proteomic analysis of 
primary neurons reveals diverse changes in synaptic protein content in fmr1 knockout 
mice. Proc Natl Acad Sci 105: 15281-15286 
209 
Discussion 
210 
Lin G, Li G, Granados RR, Blissard GW (2001) Stable cell lines expressing baculovirus P35: 
resistance to apoptosis and nutrient stress, and increased glycoprotein secretion. In 
Vitro Cell Dev-An 37:293-302 
Nadeau I, Kamen A (2003) Production of adenovius vector for gene therapy. Biotechnol Adv 
20: 475-489 
Öhman L, Alarcon M, Ljunggren J, Ramqvist A-K, Häggström L (1996) Glutamine is not an 
essential amino acid for Sf-9 insect cells. Biotechnol Lett 18: 765-70 
Öhman L, Ljunggren J, Häggström L (1995) Induction of a metabolic switch in insect cells by 
substrate-limited fed-batch cultures. Appl Microbiol Biotechnol 43: 1006-13 
Ortega F, Sameith K, Turan N, Compton R, Trevino V, Vannucci M, Falciani F (2008) 
Models and computational strategies linking physiological response to molecular 
networks from large-scale data. Phil Trans R Soc A 366: 3067-3089 
Otero JM, Nielsen J (2010) Industrial systems biology. Biotechnol Bioeng 105: 439-460 
Petch D, Butler M (1994) Profile of energy metabolism in a murine hybridoma: glucose and 
glutamine utilization. J Cell Physiol 161: 71–76 
Radford KM, Reid S, Greenfield PF (1997) Substrate limitation in the baculovirus expression 
vector system. Biotechnol Bioeng 56: 32-44 
Ramachandran A, Bashyam MD, Viswanathan P, Ghosh S, Kumar MS, Hasnain SE (2001) 
The bountiful and baffling baculovirus: the story of polyhedrin transcription. Curr Sci 
81:998-1010 
Seth G, Philp RJ, Lau A, Jiun KY, Yap M, Hu W-S (2007a) Molecular portrait of high 
productivity in recombinant NS0 cells. Biotechnol Bioeng 97: 933-951 
Stephanopoulos G, Alper H, Moxley J (2004) Exploiting biological complexity for strain 
improvement through systems biology. Nat Biotechnol 22: 1261-1267 
Teixeira AP, Carinhas N, Dias JML, Cruz P, Alves PM, Carrondo MJT, Oliveira R (2007) 
Hybrid semi-parametric mathematical systems: bridging the gap between systems 
biology and process engineering. J Biotechnol 132: 418-425 
Tomita M (2001) Whole-cell simulation: a grand challenge for the 21st century. Trends 
Biotechnol 19: 205-210 
van Oers MM, Thomas AAM, Moormann RJM, Vlak JM (2001) Secretory pathway limits the 
enhanced expression of classical swine fever virus E2 glycoprotein in insect cells. J 
Biotechnol 86: 31-38 
Weiss SA, Whitford WG, Godwin GP, Reid S (1992) Media design: optimizing of 
recombinant proteins in serum free culture. In: Vlak JM, Schlaeger E-J, Bernard AR, 
editors. Workshop on Baculovirus and Recombinant Protein Production Processes, 
March 29-April 1, Interlaken, Switzerland 
Wolfinger RD, Gibson G, Wolfinger ED, Bennett L, Hamadeh H, Bushel P, Afshari C, Paules 
RS (2001) Assessing gene significance from cDNA microarray expression data via 
mixed models. J Comput Biol 8: 625-637 
Wong KTK, Peter CH, Greenfield PF, Reid S, Nielsen LK (1996) Low multiplicity infection of 
insect cells with a recombinant baculovirus: the cell yield concept. Biotechnol Bioeng 
49: 659-666 
Yoon SH, Han M-J, Lee SY, Jeong KJ, Yoo J-S (2003) Combined transcriptome and 
proteome analysis of Escherichia coli during high cell density culture. Biotechnol 
Bioeng 81: 753-767 
 
 
 
 
 APPENDIX 
 
 
 
 
 
Appendix  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
212 
TABLE OF CONTENTS 
1. Biochemical reactions of Spodoptera frugiperda metabolism ........................... 215 
2. Calculation of metabolic partitioning coefficients at the pyruvate and 
α-ketoglutarate nodes ............................................................................................ 219 
3. Viral synthesis reactions used for complete MFA model establishment ........... 221 
 
 
 
Appendix  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
214 
Systems Biotechnology of insect cells 
1. BIOCHEMICAL REACTIONS OF SPODOPTERA FRUGIPERDA´S 
METABOLISM 
Passive transport/diffusion 
Glce = Glc (“e” denotes extracellular metabolite) 
Lac = Lace 
Malte = Malt 
Sucre = Sucr 
Pyre = Pyr (reaction only considered in Chapter III) 
αKGe = αKG (reaction only considered in Chapter III) 
Amm = Amme 
Ala = Alae 
O2,e = O2 
CO2 = CO2,e  
Active (ATP-dependent) transport 
XAG Transport System:  
Aspe + 1 ATP = Asp + 1 ADP 
Glue + 1 ATP = Glu + 1 ADP 
A/L Transport System:  
Glne + 0.33 ATP = Gln + 0.33 ADP 
A Transport System: 
Sere + 0.33 ATP = Ser + 0.33 ADP 
Asne + 0.33 ATP = Asn + 0.33 ADP 
Glye + 0.33 ATP = Gly + 0.33 ADP 
Thre + 0.33 ATP = Thr + 0.33 ADP 
Proe + 0.33 ATP = Pro + 0.33 ADP 
Mete + 0.33 ATP = Met + 0.33 ADP  
L Transport System: 
Hise + 0.33 ATP = His + 0.33 ADP 
Tyre + 0.33 ATP = Tyr + 0.33 ADP 
Vale + 0.33 ATP = Val + 0.33 ADP 
Ilee + 0.33 ATP = Ile + 0.33 ADP 
Leue + 0.33 ATP = Leu + 0.33 ADP 
Phee + 0.33 ATP = Phe + 0.33 ADP 
y+L Transport System: 
Arge + 0.33 ATP = Arg + 0.33 ADP 
Lyse + 0.33 ATP = Lys + 0.33 ADP 
X-C Transport System:  
Cyse + 1 ATP = Cys + 1 ADP 
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Glycolysis and Pentose-phosphate pathway 
Malt = Glc + G6P 
Sucr + 2 ATP = G6P + F6P 
Glc + ATP = G6P + ADP (hexokinase, HK) 
G6P = F6P (6-phospho-D-glucose isomerase, PGI) 
F6P + ATP = 2 GAP  
GAP + NAD+ + ADP = NADH + ATP + PEP 
ADP + PEP = Pyr + ATP (pyruvate kinase, PK) 
3 G6P + 6 NADP+ = 3 CO2 + 3 R5P + 6 NADPH (pentose-phosphate 
pathway, PPP) 
Pyruvate node 
Pyr + NADH = Lac + NAD+ (lactate dehydrogenase, LDH) 
Pyr + Glu = Ala + αKG (alanine aminotransferase, AlaAT) 
Pyr + NAD+ = CO2 + ACoA + NADH (pyruvate dehydrogenase, PDH) 
Mal = Pyr + CO2 (malic enzyme, ME) 
TCA Cycle 
ACoA + OAA = Cit (citrate synthase, CS) 
Cit + NAD+ = CO2 + αKG + NADH 
αKG + NAD+ = CO2 + SuCoA + NADH (αKG dehydrogenase, αKGDH) 
SuCoA + ADP = Suc + ATP (SuCoA synthetase, SuCoAS) 
Suc + FAD = Fum + FADH2 (Succinate dehydrogenase, SucDH) 
Fum = Mal (fumarase, Fum) 
Mal + NAD+ = OAA + NADH (malate dehydrogenase, MDH) 
Amino acids metabolism 
αKG + Gln + NADH = 2 Glu + NAD+ (glutamate synthase, GOGAT) 
Glu + NAD+ = αKG + Amm + NADH (glutamate dehydrogenase, GDH) 
2 Gly + NAD+ = CO2 + Amm + Ser + NADH 
Ser = Pyr + Amm 
2 αKG + Lys + 4 NAD+ + NADPH + FAD = 2 CO2 + 2 Glu + 2 ACoA + 4 
NADH + NADP + FADH2 
αKG + Leu + NAD+ + ATP + FAD = CO2 + Glu + 2 ACoA + NADH + ADP + 
FADH2 + mevalonate 
αKG + Ile + 2 NAD+ + ATP + FAD = CO2 + Glu + ACoA + SuCoA + 2 
NADH + ADP + FADH2 
αKG + Arg + NAD+ = 2 Glu + NADH + urea 
Glu + OAA = αKG + Asp (aspartate aminotransferase, AspAT) 
Thr + NAD+ = ACoA + Gly + NADH 
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αKG + Val + 3 NAD+ + ATP + FAD = CO2 + Glu + SuCoA + 3 NADH + ADP 
+ FADH2 
Ser + Met + NAD+ + ATP = SuCoA + Amm + Cys + NADH + 2 ADP 
Phe + NADH + O2 = Tyr + NAD+ 
αKG + Tyr + O2 = CO2 + Glu + ACoA + Fum 
His = Glu + Amm 
Asn = Amm + Asp (asparaginase, Asnase) 
Pro + NADP+ + 0.5 O2 = Glu + NADPH 
Cys = Pyr + Amm 
Energy Production (respiration, ATP expenditure and redox balance) 
NADH + 2.5 ADP + 0.5 O2 = NAD+ + 2.5 ATP 
1.5 ADP + FADH2 + 0.5 O2 = 2.5 ATP + FAD 
ATP = Energy (unidirectional flux for cell maintenance and futile cycles) 
NAD+ + NADPH = NADH + NADP+ (transhydrogenase, TransH) 
Biomass Synthesis 
1000 Protein + 111 FA + 89.5 DNA + 224.7 RNA = Biomass 
Nucleic Acids 
0.5 CO2 + R5P + 1.9 Gln + 1.3 Ser + 1.3 Asp + 0.7 NAD+ + NADPH + 9 
ATP = 1.9 Glu + 0.8 Fum + 0.8 Gly + DNA + 0.7 NADH + NADP+ + 9 ADP 
CO2 + R5P + 1.9 Gln + Ser + 1.3 Asp + NAD+ + ATP = Glu + 0.8 Fum + 0.5 
Gly + RNA + NADH + ADP 
Protein Synthesis 
0.417 Ala + 0.251 Glu + 0.315 Gln + 0.432 Gly + 0.348 Ser + 0.344 Lys + 
0.410 Leu + 0.213 Ile + 0.301 Arg + 0.238 Asp + 0.290 Thr + 0.305 Val + 
0.109 Met + 0.162 Phe + 0.131 Tyr + 0.109 His + 0.266 Pro + 0.223 Asn + 
0.142 Cys + 10.014 ATP = 1 Protein + 10.014 ADP 
Lipids metabolism 
9 AcoA + 7 NADPH + 26 ATP + 10 NADH + 1 O2 = 1 FA + 7 NADP+ + 26 
ADP + 10 NAD+ 
Metabolite abbreviations 
ACoA - acetyl-coenzyme A 
ADP - adenosine diphosphate 
Ala - alanine 
Amm - ammonia 
Arg - arginine 
Asn - asparagine 
Asp - aspartate 
ATP - adenosine triphosphate 
217 
Appendix  
Cit - citrate 
CO2 - carbon dioxide  
Cys - cysteine 
DNA - deoxyribonucleic acids 
F6P - fructose-6-phosphate 
FA - fatty acids 
FAD/FADH2 –-flavin adenine dinucleotide 
Fum - fumarate 
G6P - glucose-6-phosphate 
GAP - glyceraldehyde-3-phosphate 
Glc - glucose 
Gln - glutamine 
Glu - glutamate 
Gly - glycine 
His - histidine 
Ile - isoleucine 
Lac - lactate 
Leu - leucine 
Lys - lysine 
Mal - malate 
Malt - maltose 
Met - methionine 
NAD+/NADH - nicotinamide adenine dinucleotide 
NADP+/NADPH - nicotinamide adenine dinucleotide phosphate 
O2 - oxygen 
OAA - oxaloacetate 
PEP - phosphoenolpyruvate 
Phe - phenylalanine 
Pro - proline 
Pyr - pyruvate 
R5P - ribose-5-phosphate 
RNA - ribonucleic acids 
Ser - serine 
Suc - succinate 
SuCoA - succinyl-coenzyme A 
Sucr - sucrose 
Thr - threonine 
Tyr - tyrosine 
Val - valine 
αKG - α-ketoglutarate 
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2. CALCULATION OF METABOLIC PARTITIONING COEFFICIENTS AT 
THE PYRUVATE AND Α-KETOGLUTARATE NODES 
Pyruvate node. To analyze flux partitioning at the pyruvate node, all intracellular 
fluxes leading to pyruvate formation or utilisation were considered, as estimated by 
metabolic flux analysis. The pyruvate uptake rate was not considered to allow 
comparable coefficients between the different cultures. From these reactions, only 
the most representative in terms of total contribution are shown. 
Incoming 
fluxes 
PEP 
(glycolysis) 
Pyruvate kinase 
(PK) otherMEPK
PK
vvv
v
++  
Malate Malic enzyme (ME) 
otherMEPK
ME
vvv
v
++  
Outgoing 
fluxes 
Lactate 
Lactate 
dehydrogenase 
(LDH) otherPDHAlaATLDH
LDH
vvvv
v
+++  
Alanine 
Alanine 
aminotransferase 
(AlaAT) otherPDHAlaATLDH
AlaAT
vvvv
v
+++  
ACoA 
Pyruvate 
dehydrogenase 
(PDH) otherPDHAlaATLDH
PDH
vvvv
v
+++  
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α-Ketoglutarate node. To analyze flux partitioning at the αKG node, all fluxes 
leading to αKG formation or utilisation were considered. The αKG uptake rate was 
not considered to ensure comparable coefficients between cultures. Only the most 
representative in terms of total contribution are shown. 
Incoming 
fluxes 
Isocitrate 
Isocitrate 
dehydrogenase 
(ICDH) otherAlaATICDH
Isocit
vvv
v
++  
Alanine 
Alanine 
aminotransferase 
(AlaAT) otherAlaATICDH
AlaAT
vvv
v
++  
Outgoing 
fluxes 
Glutamate 
Glutamate 
dehydrogenase 
(GDH) otherGOGATKGDHGDH
GDH
vvvv
v
+++ α
 
Succinyl-CoA 
α-Ketoglutarate 
dehydrogenase 
(αKGDH) otherGOGATKGDHGDH
KGDH
vvvv
v
+++ α
ε  
Glutamate 
Glutamate synthase 
(GOGAT) otherGOGATKGDHGDH
GOGAT
vvvv
v
+++ α
 
Isocitrate and the enzyme ICDH are not explicitly considered in the metabolic 
model, being lumped in the following reaction: Cit + NAD+ = CO2 + αKG + NADH 
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3. VIRAL SYNTHESIS REACTIONS USED FOR COMPLETE MFA 
MODEL ESTABLISHMENT 
Insect baculoviruses were considered to be composed of 77% protein and 
8% DNA (Bergold and Wellington, 1954; see full reference in Chapter IV). 
Molar percentages of amino acids in insect viruses were taken as the 
average values from Wellington (1954; see full reference in Chapter IV). 
Each viral particle was considered to weight 1.07×10-17 g and has a circular 
genome of 262000 deoxyribonucleotides. 
Lumped reaction for baculovirus synthesis 
0.000435 bvDNA + 0.001 bvProtein = 1 bvMass  
(“bv” denotes baculovirus component; 1 bvMass represents 106 particles; the 
coefficients represent the nmol content of each component in 106 particles) 
Viral protein synthesis 
0.00305 Ala + 0.00371 Glu + 0.00231 Gln + 0.00388 Gly + 0.00703 Ser + 0.00226 
Lys + 0.00513 Leu + 0.00374 Ile + 0.01229 Arg + 0.00603 Asp + 0.00449 Thr + 
0.0028 Val + 0.00167 Met + 0.0037 Phe + 0.00385 Tyr + 0.00095 His + 0.00431 
Pro + 0.00336 Asn + 0.00057 Cys = 1 bvProtein 
(1 bvProtein represents the pmol content of protein amino acids present in 106 
particles; ATP utilization was not taken into account.)  
Viral DNA synthesis 
0.5 CO2 + R5P + 1.9 Gln + 1.3 Ser + 1.3 Asp + 0.7 NAD + NADPH + 9 ATP = 1.9 
Glu + 0.8 Fum + 0.8 Gly + bvDNA + 0.7 NADH + NADP + 9 ADP 
(1 DNA represents 1 “average” deoxyribonucleotide, considering a G/C content of 
40% (The International Lepidopteran Genome Project).) 
Measured outflux of viral particles 
vBV 
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